<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub" publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">66960</article-id><article-id pub-id-type="doi">10.7554/eLife.66960</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Neuroscience</subject></subj-group></article-categories><title-group><article-title>Somatostatin interneurons activated by 5-HT<sub>2A</sub> receptor suppress slow oscillations in medial entorhinal cortex</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" id="author-190013"><name><surname>de Filippo</surname><given-names>Roberto</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-4085-9114</contrib-id><email>roberto.de-filippo@charite.de</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-179185"><name><surname>Rost</surname><given-names>Benjamin R</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="fund2"/><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-125531"><name><surname>Stumpf</surname><given-names>Alexander</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-190014"><name><surname>Cooper</surname><given-names>Claire</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-190015"><name><surname>Tukker</surname><given-names>John J</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-4394-199X</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-190016"><name><surname>Harms</surname><given-names>Christoph</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-2063-2860</contrib-id><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="other" rid="fund5"/><xref ref-type="other" rid="fund6"/><xref ref-type="other" rid="fund7"/><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" equal-contrib="yes" id="author-225079"><name><surname>Beed</surname><given-names>Prateep</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="other" rid="fund9"/><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" equal-contrib="yes" id="author-190017"><name><surname>Schmitz</surname><given-names>Dietmar</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-2741-5241</contrib-id><email>dschmitz-office@charite.de</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund3"/><xref ref-type="other" rid="fund4"/><xref ref-type="other" rid="fund8"/><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution>Charité–Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health; Neuroscience Research Center</institution><addr-line><named-content content-type="city">Berlin</named-content></addr-line><country>Germany</country></aff><aff id="aff2"><label>2</label><institution>Charité–Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health; Cluster of Excellence NeuroCure</institution><addr-line><named-content content-type="city">Berlin</named-content></addr-line><country>Germany</country></aff><aff id="aff3"><label>3</label><institution>German Centre for Neurodegenerative Diseases (DZNE)</institution><addr-line><named-content content-type="city">Berlin</named-content></addr-line><country>Germany</country></aff><aff id="aff4"><label>4</label><institution>Charité–Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health; Department of Experimental Neurology</institution><addr-line><named-content content-type="city">Berlin</named-content></addr-line><country>Germany</country></aff><aff id="aff5"><label>5</label><institution>Charité–Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health; Center for Stroke Research Berlin</institution><addr-line><named-content content-type="city">Berlin</named-content></addr-line><country>Germany</country></aff><aff id="aff6"><label>6</label><institution>Charité–Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health; Einstein Center for Neurosciences Berlin</institution><addr-line><named-content content-type="city">Berlin</named-content></addr-line><country>Germany</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="senior_editor"><name><surname>Colgin</surname><given-names>Laura L</given-names></name><role>Senior Editor</role><aff><institution>University of Texas at Austin</institution><country>United States</country></aff></contrib><contrib contrib-type="editor"><name><surname>Vinck</surname><given-names>Martin</given-names></name><role>Reviewing Editor</role><aff><institution>Ernst Strüngmann Institute (ESI) for Neuroscience in Cooperation with Max Planck Society</institution><country>Germany</country></aff></contrib></contrib-group><author-notes><fn fn-type="con" id="equal-contrib1"><label>†</label><p>These authors contributed equally to this work</p></fn></author-notes><pub-date date-type="publication" publication-format="electronic"><day>31</day><month>03</month><year>2021</year></pub-date><pub-date pub-type="collection"><year>2021</year></pub-date><volume>10</volume><elocation-id>e66960</elocation-id><history><date date-type="received" iso-8601-date="2021-01-27"><day>27</day><month>01</month><year>2021</year></date><date date-type="accepted" iso-8601-date="2021-03-10"><day>10</day><month>03</month><year>2021</year></date></history><permissions><copyright-statement>© 2021, de Filippo et al</copyright-statement><copyright-year>2021</copyright-year><copyright-holder>de Filippo et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-66960-v2.pdf"/><abstract><p>Serotonin (5-HT) is one of the major neuromodulators present in the mammalian brain and has been shown to play a role in multiple physiological processes. The mechanisms by which 5-HT modulates cortical network activity, however, are not yet fully understood. We investigated the effects of 5-HT on slow oscillations (SOs), a synchronized cortical network activity universally present across species. SOs are observed during anesthesia and are considered to be the default cortical activity pattern. We discovered that (±)3,4-methylenedioxymethamphetamine (MDMA) and fenfluramine, two potent 5-HT releasers, inhibit SOs within the entorhinal cortex (EC) in anesthetized mice. Combining opto- and pharmacogenetic manipulations with in vitro electrophysiological recordings, we uncovered that somatostatin-expressing (Sst) interneurons activated by the 5-HT<sub>2A</sub> receptor (5-HT<sub>2A</sub>R) play an important role in the suppression of SOs. Since 5-HT<sub>2A</sub>R signaling is involved in the etiology of different psychiatric disorders and mediates the psychological effects of many psychoactive serotonergic drugs, we propose that the newly discovered link between Sst interneurons and 5-HT will contribute to our understanding of these complex topics.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>serotonin</kwd><kwd>somatostatin interneurons</kwd><kwd>slow oscillations</kwd><kwd>MDMA</kwd><kwd>fenfluramine</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100002347</institution-id><institution>Bundesministerium für Bildung und Forschung</institution></institution-wrap></funding-source><award-id>SFB1315-327654276</award-id><principal-award-recipient><name><surname>Schmitz</surname><given-names>Dietmar</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001659</institution-id><institution>Deutsche Forschungsgemeinschaft</institution></institution-wrap></funding-source><award-id>SPP1926</award-id><principal-award-recipient><name><surname>Rost</surname><given-names>Benjamin R</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001659</institution-id><institution>Deutsche Forschungsgemeinschaft</institution></institution-wrap></funding-source><award-id>SPP1665</award-id><principal-award-recipient><name><surname>Schmitz</surname><given-names>Dietmar</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001659</institution-id><institution>Deutsche Forschungsgemeinschaft</institution></institution-wrap></funding-source><award-id>01GQ1420B</award-id><principal-award-recipient><name><surname>Schmitz</surname><given-names>Dietmar</given-names></name></principal-award-recipient></award-group><award-group id="fund5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001659</institution-id><institution>Deutsche Forschungsgemeinschaft</institution></institution-wrap></funding-source><award-id>HA5741/5-1</award-id><principal-award-recipient><name><surname>Harms</surname><given-names>Christoph</given-names></name></principal-award-recipient></award-group><award-group id="fund6"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001659</institution-id><institution>Deutsche Forschungsgemeinschaft</institution></institution-wrap></funding-source><award-id>TRR295</award-id><principal-award-recipient><name><surname>Harms</surname><given-names>Christoph</given-names></name></principal-award-recipient></award-group><award-group id="fund7"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100002347</institution-id><institution>Bundesministerium für Bildung und Forschung</institution></institution-wrap></funding-source><award-id>01EO0801</award-id><principal-award-recipient><name><surname>Harms</surname><given-names>Christoph</given-names></name></principal-award-recipient></award-group><award-group id="fund8"><funding-source><institution-wrap><institution>NeuroCure Exzellenzcluster</institution></institution-wrap></funding-source><award-id>EXC-2049 - 390688087</award-id><principal-award-recipient><name><surname>Schmitz</surname><given-names>Dietmar</given-names></name></principal-award-recipient></award-group><award-group id="fund9"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100002839</institution-id><institution>Charité – Universitätsmedizin Berlin</institution></institution-wrap></funding-source><award-id>BIH Fellowship</award-id><principal-award-recipient><name><surname>Beed</surname><given-names>Prateep</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Somatostatin interneurons are novel mediators of serotonergic modulation in entorhinal cortex via activation of 5-HT<sub>2A</sub> receptors, a receptor involved in the etiology of different psychiatric disorders.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>5-HT is one of the most important neuromodulators in the central nervous system. Projections originating from the Raphe nuclei, the brain-stem structure that comprises the majority of 5-HT releasing neurons in the brain, innervate all cortical and sub-cortical areas (<xref ref-type="bibr" rid="bib19">Descarries et al., 2010</xref>). 5-HT levels in the brain are closely linked to the sleep-wake cycle: the activity of serotonergic raphe neurons is increased during wakefulness, decreased during slow-wave sleep (SWS) and virtually silent during REM sleep (<xref ref-type="bibr" rid="bib57">McGinty and Harper, 1976</xref>; <xref ref-type="bibr" rid="bib74">Oikonomou et al., 2019</xref>; <xref ref-type="bibr" rid="bib105">Unger et al., 2020</xref>). Cortical activity is also influenced by the behavioral state of the animal: SWS is generally associated with ‘synchronized’ patterns of activity, characterized by low-frequency global fluctuations, whereas active wakefulness and REM sleep feature ‘desynchronized’ network activity, in which low-frequency fluctuations are absent. The shifting of cortical networks between different patterns of activity is controlled, at least in part, by neuromodulators (<xref ref-type="bibr" rid="bib103">Tukker et al., 2020</xref>; <xref ref-type="bibr" rid="bib48">Lee and Dan, 2012</xref>). For instance, Acetylcholine (ACh) can profoundly alter cortical network activity by inducing desynchronization via activation of Sst interneurons (<xref ref-type="bibr" rid="bib16">Chen et al., 2015</xref>). However, ACh is not solely responsible for suppressing cortical synchronized activity, as lesions of cholinergic neurons are not sufficient to abolish desynchronization (<xref ref-type="bibr" rid="bib41">Kaur et al., 2008</xref>). On the other hand, blocking ACh and 5-HT transmission at the same time causes a continuous ‘synchronized’ cortical state, even during active behavior, thus suggesting that 5-HT plays an important role in mediating transitions between different network states (<xref ref-type="bibr" rid="bib109">Vanderwolf and Baker, 1986</xref>). In agreement with this line of thought, electrical and optogenetic stimulation of the Raphe nuclei reduce low frequency (1–10 Hz) power in the cortex, implying a reduction in neuronal synchronization at these frequencies (<xref ref-type="bibr" rid="bib78">Puig et al., 2010</xref>; <xref ref-type="bibr" rid="bib30">Grandjean et al., 2019</xref>). Moreover, optogenetic stimulation of serotonergic neurons is sufficient to awaken mice from SWS (<xref ref-type="bibr" rid="bib74">Oikonomou et al., 2019</xref>). These data suggest a relationship between 5-HT levels and patterns of cortical activity (<xref ref-type="bibr" rid="bib48">Lee and Dan, 2012</xref>; <xref ref-type="bibr" rid="bib34">Harris and Thiele, 2011</xref>). The exact mechanism by which 5-HT modulates network activity in the cortex however, is still not fully understood.</p><p>Here, we used electrophysiological techniques together with pharmacology, optogenetics, and pharmacogenetics to investigate the effect of 5-HT on slow oscillations (SOs), a network oscillation characterized by synchronized transitions (&lt;1 Hz) between periods of high activity (upstates) and relative quiescence (downstates) (<xref ref-type="bibr" rid="bib94">Steriade et al., 1993</xref>; <xref ref-type="bibr" rid="bib67">Neske, 2015</xref>; <xref ref-type="bibr" rid="bib40">Isomura et al., 2006</xref>). SOs are a global phenomenon observed throughout the cerebral cortex and are considered to be the default emergent activity of cortical networks during SWS and anesthesia (<xref ref-type="bibr" rid="bib67">Neske, 2015</xref>; <xref ref-type="bibr" rid="bib84">Sanchez-Vives et al., 2017</xref>; <xref ref-type="bibr" rid="bib113">Wolansky et al., 2006</xref>). We performed our experiments in the medial entorhinal cortex (mEC), a region where SOs can be recorded both under anesthesia and in acutely prepared cortical slices (<xref ref-type="bibr" rid="bib97">Tahvildari et al., 2012</xref>; <xref ref-type="bibr" rid="bib10">Beed et al., 2020</xref>). Pyramidal neurons located in L3 of mEC provide the excitatory drive underlying each upstate (<xref ref-type="bibr" rid="bib66">Namiki et al., 2013</xref>; <xref ref-type="bibr" rid="bib10">Beed et al., 2020</xref>). Similarly to other mammalian cortical areas, mEC comprises different types of inhibitory GABAergic neurons that can be grouped into three main classes according to immunoreactivity: parvalbumin (PV), somatostatin (Sst), and 5-HT<sub>3</sub> (<xref ref-type="bibr" rid="bib60">Miao et al., 2017</xref>; <xref ref-type="bibr" rid="bib83">Rudy et al., 2011</xref>). Most PV neurons target the soma and the spike initiation zone, have low input resistance and minimal spike frequency adaptation. Sst neurons are divided into two groups, one showing features similar to PV interneurons and a second one (i.e. Martinotti cells) that, in contrast, tend to form synapses onto the dendritic trees of their target cells, have high input resistance and show a considerable adaptation. 5-HT<sub>3</sub> neurons are usually located in the superficial layers, have high input resistance and mixed adaptation. While these different classes of interneurons are all depolarized during upstates, PV interneurons receive decidedly the strongest excitation (<xref ref-type="bibr" rid="bib97">Tahvildari et al., 2012</xref>; <xref ref-type="bibr" rid="bib68">Neske et al., 2015</xref>). Recurrent excitation and temporal summation of inputs contribute to the transition from downstate to upstate (<xref ref-type="bibr" rid="bib84">Sanchez-Vives et al., 2017</xref>; <xref ref-type="bibr" rid="bib103">Tukker et al., 2020</xref>). This excitation propagates to L5 and differentially entrains L5a and L5b excitatory neurons. L5a neurons do not participate in SOs, whereas L5b neurons are steadily synchronized. Both intrinsic and synaptic mechanisms have been implicated in upstate termination (<xref ref-type="bibr" rid="bib67">Neske, 2015</xref>; <xref ref-type="bibr" rid="bib103">Tukker et al., 2020</xref>). Activity-dependent K<sup>+</sup> channels decrease excitability of neurons over time causing a generalized reduction of facilitation (<xref ref-type="bibr" rid="bib67">Neske, 2015</xref>; <xref ref-type="bibr" rid="bib34">Harris and Thiele, 2011</xref>). At the same time, blockage of GABA<sub>B</sub> receptors significantly extends upstate duration (<xref ref-type="bibr" rid="bib17">Craig et al., 2013</xref>) and inhibitory drive has been observed to increase during upstate termination (<xref ref-type="bibr" rid="bib49">Lemieux et al., 2015</xref>). Sst interneurons, and in particular Martinotti cells, characterized by strongly facilitating synapses (<xref ref-type="bibr" rid="bib11">Beierlein et al., 2003</xref>; <xref ref-type="bibr" rid="bib28">Gibson et al., 1999</xref>) have been proposed as an important source of inhibition in the termination of upstates (<xref ref-type="bibr" rid="bib58">Melamed et al., 2008</xref>; <xref ref-type="bibr" rid="bib44">Krishnamurthy et al., 2012</xref>).</p><p>Our results show that (±)3,4-methylenedioxymethamphetamine (MDMA) and fenfluramine (Fen), two substitute amphetamines that induce robust 5-HT release, suppress SOs in anesthetized mice and, concurrently, activate a small group of neurons characterized by an intermediate waveform shape. Using cortical slices in vitro, we demonstrate that 5-HT inhibits SOs in the mEC and that Sst interneurons, activated by 5-HT<sub>2A</sub>R, are involved in the modulatory effect of 5-HT. While previous studies have shown that parvalbumin (PV) interneurons are excited by 5-HT<sub>2A</sub>R (<xref ref-type="bibr" rid="bib78">Puig et al., 2010</xref>; <xref ref-type="bibr" rid="bib6">Athilingam et al., 2017</xref>), our results identify cortical Sst interneurons as novel targets of the 5-HT neuromodulatory system via 5-HT<sub>2A</sub>R.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>Pharmacological release of 5-HT inhibits SOs in anesthetized mice</title><p>We investigated the effect of 5-HT on network activity in anesthetized mice using multisite silicon microelectrodes placed in the mEC L3, a region located in the medial temporal lobe interconnected to a variety of cortical and subcortical areas, including the Raphe nuclei (<xref ref-type="fig" rid="fig1">Figure 1A</xref>; <xref ref-type="bibr" rid="bib108">van Strien et al., 2009</xref>; <xref ref-type="bibr" rid="bib65">Muzerelle et al., 2016</xref>). Under urethane anesthesia, EC, like the rest of the cortex, displays SOs (<xref ref-type="fig" rid="fig1">Figure 1B</xref>). As expected, we found that upstates were present synchronously in the local field potential (LFP) of all the recording channels (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>), and that every upstate coincided with large increases in population spiking activity (<xref ref-type="fig" rid="fig1">Figure 1B</xref>). 5-HT does not cross the blood brain barrier (<xref ref-type="bibr" rid="bib32">Hardebo and Owman, 1980</xref>), therefore, to understand the effect of 5-HT on SOs we used MDMA, a potent presynaptic 5-HT releaser and popular recreational drug (<xref ref-type="bibr" rid="bib31">Green et al., 2003</xref>) that has shown promising results in the treatment of post-traumatic stress disorder (PTSD) (<xref ref-type="bibr" rid="bib39">Inserra et al., 2021</xref>).</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>MDMA/Fen inhibit SOs in anesthetized mice.</title><p>(<bold>A</bold>) Immunocytochemical analysis of an ePet-YFP mouse showing serotonergic fibers in medial entorhinal cortex, horizontal slice (M = medial, L = lateral, P = posterior, A = anterior). Scale bar: 20 µm. (<bold>B</bold>) LFP (top) and instantaneous population activity (bottom) of a representative in vivo recording during SOs (spikes/s units in thousands), cyan rectangles represent detected upstates. (<bold>C</bold>) 3D visualization of the microelectrode location of the recording shown in E. EC represented in gray. (<bold>D</bold>) Left: microelectrode tracks (red) of the recording shown in (<bold>E</bold>). Right: EC position represented in green. (<bold>E</bold>) Top: Cyan lines represent detected upstates. Bottom: LFP (black) and average upstate incidence per minute (cyan). Pink dotted line represents MDMA application time. (<bold>F</bold>) Fourier transformation and (<bold>G</bold>) instantaneous population activity for the recording shown in E. (<bold>H</bold>) Mean upstate incidence after saline (control), Fen or MDMA application (control: n = 5, Fen: n = 6, MDMA: n = 7; p&lt;10<sup>−4</sup>, unpaired t test with Holm-Šidák correction). (<bold>I</bold>) Mean normalized spike rate after saline (control), Fen or MDMA application (control: n = 5, Fen: n = 6, MDMA: n = 7; p&lt;10<sup>−4</sup>, unpaired t test with Holm-Šidák correction).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-66960-fig1-v2.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title>In vivo upstate spatial features.</title><p>(<bold>A</bold>) Microelectrode implant location and microelectrode features. Sixty-four channels (n<sub>animals</sub> = 15, n<sub>shanks</sub> = 4) and 32 channels (n<sub>animals</sub> = 3, n<sub>shanks</sub> = 2) microelectrodes were used in this study, analysis shown in this figure excludes data recorded with 32 channels probe due to the different spatial configuration of the channels. (<bold>B</bold>) Average upstate voltage deflection for each channel of the microelectrode. For experiments with drug application (either MDMA or Fen), only baseline upstates were taken in account. (<bold>C</bold>) Left: Average upstate voltage deflection grouped by shank. Right: Average upstate voltage deflection grouped by depths (right). Insets show the normalized correlation between averages in the two different groups.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-66960-fig1-figsupp1-v2.tif"/></fig><fig id="fig1s2" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 2.</label><caption><title>LFP power analysis for saline and MDMA/Fen injection.</title><p>(<bold>A</bold>) Average normalized LFP power during baseline and saline injection. (<bold>B</bold>) Average LFP power during baseline and MDMA/Fen injection. (<bold>C</bold>) Box plots of normalized LFP power per frequency band: delta (Control: 0.98 ± 0.01, MDMA/Fen: 0.82 ± 0.04, p=0.019, Mann-Whitney test), theta (Control: 0.90 ± 0.01 µV, MDMA/Fen: 0.76 ± 0.04, p=0.046, Mann-Whitney test), alpha (Control: 0.77 ± 0.01, MDMA/ Fen: 0.45 ± 0.03, p&gt;0.05, Mann-Whitney test), beta(Control: 0.49 ± 0.02, MDMA/ Fen: 0.30 ± 0.03, p&gt;0.05, Mann-Whitney test), and gamma (Control: 0.28 ± 0.02, MDMA/ Fen: 0.25 ± 0.02, p&gt;0.5, Mann-Whitney test).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-66960-fig1-figsupp2-v2.tif"/></fig><fig id="fig1s3" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 3.</label><caption><title>In vivo upstate metrics for saline and MDMA/Fen injection.</title><p>(<bold>A</bold>) Average upstate voltage deflection for control and MDMA/Fen, patches represent one standard deviation. Scale bars: 0.5 s, 200 µV. (<bold>B</bold>) Violin plots of duration (control: 0.98 ± 0.02 s, MDMA/ Fen: 0.69 ± 0.04 s, p&lt;0.001, Mann-Whitney test). (<bold>C</bold>) Violin plots of peak one amplitude (control: 434.3 ± 13.09 µV, MDMA/Fen: 248.1 ± 10.49 µV, p&lt;0.001, Mann-Whitney test). (<bold>D</bold>) Violin plots of peak two amplitude (control: 232.4 ± 3.53 µV, MDMA/ Fen: 187.3 ± 7.40 µV, p&lt;0.001, Mann-Whitney test). (<bold>E</bold>) Violin plots of area (control: 185.6 ± 4.14 µV•s, MDMA/ Fen: 187.3 ± 7.40 µV, p&lt;0.001, Mann-Whitney test). (<bold>F</bold>) Violin plots of inter-event intervals (control: 5.55 ± 0.26 s, MDMA/ Fen: 12.02 ± 1.75 2, p&lt;0.001, Mann-Whitney test).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-66960-fig1-figsupp3-v2.tif"/></fig></fig-group><p>Intraperitoneal injections of MDMA (1.25 mg/kg) caused a strong suppression of upstate incidence (<xref ref-type="fig" rid="fig1">Figure 1E–H</xref>), a decrease in power of low frequencies (1–20 Hz) (<xref ref-type="fig" rid="fig1">Figure 1F</xref>), and a reduction of population spiking activity (<xref ref-type="fig" rid="fig1">Figure 1G–I</xref>). In addition to 5-HT, MDMA has been shown to cause the release of other neuromodulators, such as dopamine and noradrenaline (NE), although to a much lesser extent (<xref ref-type="bibr" rid="bib31">Green et al., 2003</xref>). To test whether the effect of MDMA was mediated specifically by 5-HT, we repeated the experiment using Fen (5 mg/kg), a more selective 5-HT releaser (<xref ref-type="bibr" rid="bib81">Rothman and Baumann, 2002</xref>; <xref ref-type="bibr" rid="bib35">Heifets et al., 2019</xref>; <xref ref-type="bibr" rid="bib9">Baumann et al., 2000</xref>). Intraperitoneal injection of Fen had a comparably strong suppressive effect on both the occurrence of upstates and population spiking activity (<xref ref-type="fig" rid="fig1">Figure 1H–I</xref>). Given the similarity of the observed effects, we grouped the results of Fen and MDMA application and found that both of these drugs significantly decreased LFP power in the delta and theta frequency ranges (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2</xref>). Furthermore, the duration and area of upstates were also significantly reduced (<xref ref-type="fig" rid="fig1s3">Figure 1—figure supplement 3</xref>). These results point to a likely involvement of 5-HT in modulating ongoing oscillatory activity and suppressing low-frequency fluctuations.</p></sec><sec id="s2-2"><title>MDMA and Fen activate a subgroup of cortical neurons</title><p>In addition to the LFP signal, we recorded the activity of 355 single units within the EC. Because of the similar effect of MDMA and Fen on spike rates (<xref ref-type="fig" rid="fig1">Figure 1I</xref>), we pooled all units recorded in both types of experiments. We found that drug injections differentially affected spiking rates (<xref ref-type="fig" rid="fig2">Figure 2A</xref>) of recorded units: while spiking decreased in most units (‘non-activated’), a small group of units (‘activated’) responded in the opposite fashion (n = 31/355, 8.7%).</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>Divergent unit responses to MDMA/Fen application.</title><p>(<bold>A</bold>) Spike rate of the activated units versus all the other units during MDMA/Fen application (activated: n = 31, Non-activated: n = 324). (<bold>B</bold>) Top: TP latencies color-coded by group. Middle: cumulative distribution of TP latencies (Kolmogorov-Smirnov test, p Activated vs Int &lt;10–4, p Activated vs Exc &lt;10–4). Bottom: bar plot representing probability distribution of TP latencies, on the right y axis dashed line representing the percentage of ‘activated’ units per TP latency bin. (<bold>C</bold>) Distribution of units according to trough-to-peak (TP) latencies and repolarization time. Units were classified as putative interneurons (Int, blue) and putative excitatory neurons (Exc, dark gray) according to a threshold at 0.55 ms; activated units (red) could belong to either group but were mostly intermediate as shown by the covariance (2 STD) of each group (Ellipses). Units recorded during control experiments are represented by empty circles. (<bold>D</bold>) Waveforms of recorded units (n = 355). Units were divided into ‘putative excitatory’ (black) and ‘putative inhibitory’ (blue) neurons according to TP latencies. Units activated by either MDMA or Fen application are represented in red. Inset shows the average waveform for each group. Scale bars: 0.5 ms.</p><p><supplementary-material id="fig2sdata1"><label>Figure 2—source data 1.</label><caption><title>Source data for <xref ref-type="fig" rid="fig2">Figure 2A</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-66960-fig2-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-66960-fig2-v2.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 1.</label><caption><title>Cross-correlogram (CCG) based connectivity analysis.</title><p>(<bold>A</bold>) Units are plotted according to TP latencies and repolarization time and color-coded according to the number of inhibitory connections detected. Units displaying a TP latency &lt;0.55 ms were classified as putative inhibitory interneurons (‘Putative int’), the remaining units were classified as putative excitatory neurons (‘Putative exc’). Inhibitory connections were detected using Total Spiking Probability Edges (TSPE) (see Supplementary materials). Putative interneurons had a 40.0% chance of displaying at least one inhibitory connection in the CCGs with an average number of 3.38 ± 0.68 inhibitory connections while putative excitatory cells had a 0.33% chance of displaying inhibitory connections. Units with a spiking rate lower than 0.3 spikes/s were discarded from the analysis. Units from control experiments are included in the analysis. (<bold>B</bold>) Connectivity scheme of one putative inhibitory unit (source unit, black circle) displaying 10 inhibitory connections with surrounding clusters. Gray rhombi represent recording channels on the probe with the tip of the shanks pointing north. Each colored circle represents the location of an inhibited unit. Waveforms of the inhibited units are plotted nearby the location using the same color. Inset shows the location of the source unit on the probe. (<bold>C</bold>) CCGs of the connections displayed in (<bold>B</bold>) using the same color code. Solid lines represent mean, dashed lines represent one standard deviation.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-66960-fig2-figsupp1-v2.tif"/></fig><fig id="fig2s2" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 2.</label><caption><title>TP latency density distributions.</title><p>(<bold>A</bold>) Dashed lines represent kernel density estimations of probability density functions of the TP latencies of putative inhibitory (blue), putative excitatory (black) and ‘activated’ units. Solid lines represent Gaussian fitting curves for each group. Peak inhibitory Gaussian: 0.31 ms, peak excitatory Gaussian: 0.81 ms and peak ‘activated’ Gaussian: 0.56 ms. (<bold>B</bold>) Goodness of fit metrics for each Gaussian fit. Sse = Sum of squares due to error, rsquare = R-squared (coefficient of determination), dfe = Degrees of freedom in the error, adjrsquare = Degree-of-freedom adjusted coefficient of determination.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-66960-fig2-figsupp2-v2.tif"/></fig></fig-group><p>We then calculated the trough-to-peak (TP) latency of the spike waveforms, which has been consistently used as a metric to classify units. In accordance with previous studies (<xref ref-type="bibr" rid="bib89">Senzai et al., 2019</xref>; <xref ref-type="bibr" rid="bib82">Roux et al., 2014</xref>), we found a clear bimodal distribution of TP latencies distinguishing putative excitatory (Exc) and fast-spiking inhibitory (Int) groups. Analysis of cross-correlograms confirmed the inhibitory nature of a subset of putative FS units (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>; <xref ref-type="bibr" rid="bib8">Barthó et al., 2004</xref>). The cumulative distribution of TP latencies of ‘activated’ units was significantly different from both Exc and Int groups (<xref ref-type="fig" rid="fig2">Figure 2B</xref>). Specifically, the average TP latency of ‘activated’ units was situated in between the Int and Exc groups (<xref ref-type="fig" rid="fig2">Figure 2B–D</xref>, <xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2</xref>), possibly suggesting a non-FS interneuron identity (<xref ref-type="bibr" rid="bib101">Trainito et al., 2019</xref>; <xref ref-type="bibr" rid="bib46">Kvitsiani et al., 2013</xref>). Notably, the intermediate TP latency of ‘activated’ units is not the result of an equal distribution between high and low values. Units with intermediate TP latency (between 0.4 and 0.6 ms) are unique in showing a 40–80% likelihood of being ‘activated’ by drug application (<xref ref-type="fig" rid="fig2">Figure 2B</xref>).</p></sec><sec id="s2-3"><title>5-HT suppresses SOs and activates Sst interneurons via 5-HT<sub>2A</sub>R in vitro</title><p>To understand the mechanism underlying the suppression of SOs by MDMA/Fen, we performed in vitro experiments combining electrophysiology and pharmacology. First, we recorded simultaneously from up to four neurons in the superficial layers of the EC (<xref ref-type="fig" rid="fig3">Figure 3A</xref>). Brain slices were perfused with an extracellular solution containing Mg<sup>2+</sup> and Ca<sup>2+</sup> in concentrations similar to physiological conditions. With this method we could reliably detect SOs reminiscent of the in vivo network activity (<xref ref-type="bibr" rid="bib97">Tahvildari et al., 2012</xref>). Release of 5-HT in vitro, induced by Fen application (200 µM), caused a suppression of SOs similar to what we observed in vivo (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>). Likewise, application of low concentrations of 5-HT (5 µM) resulted in the suppression of SOs (<xref ref-type="fig" rid="fig3">Figure 3B,C</xref>). This effect was highly consistent across different slices and was readily reversible (<xref ref-type="fig" rid="fig3">Figure 3D</xref>). Similarly to spontaneous upstates, electrically evoked upstates (<xref ref-type="bibr" rid="bib68">Neske et al., 2015</xref>) were also suppressed by 5-HT (<xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2</xref>). Increasing the stimulation intensity did not rescue upstate generation, indicating that a lack of excitation alone cannot explain the suppressive effect of 5-HT on SO. In accordance with these results, we decided to focus solely on 5-HT, however, we acknowledge that other neurotransmitters might be involved in the effect of MDMA/Fen we observed in vivo.</p><fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>5-HT suppresses SOs and activates Sst interneurons.</title><p>(<bold>A</bold>) Biocytin staining of four simultaneously recorded cells shown in (<bold>B</bold>) WFS1 expression (in red) delimits L2/3 border. (<bold>B</bold>) Intracellular recordings showing synchronous upstate events in four simultaneously recorded cells before (left) and after (right) 5-HT application. Scale bars: 1: 7.5 mV, 2: 25 mV, 3: 25 mV, 4: 10 mV; 10 s. (<bold>C</bold>) Upstate raster plot before and after 5-HT application, orange box represents 5-HT application (n = 17, p&lt;10<sup>−4</sup>, Wilcoxon signed rank test). (<bold>D</bold>) Representative recording showing the temporary inhibitory effect of 5-HT on SOs in two simultaneously recorded cells. Scale bars: 5 min, 20 mV. (<bold>E</bold>) PCA projection plot of all the cells recorded (n = 48). Cells are color-coded according to group identity: Exc (black), FS (light blue), or LTS (green). Typical voltage responses to current injection (−150 and +250 pA) are plotted for each group. Inset shows the average spike waveform for each group. (<bold>F</bold>) Representative recording of an excitatory (black) and a low-threshold (green) neuron simultaneously recorded during 5-HT application. Scale bars: 10 mV, 30 s. (<bold>G</bold>) Average change of RP before and after 5-HT application, across excitatory, fast-spiking and low-threshold neurons (Exc: n = 34, FS: n = 6; LTS: n = 9; p&lt;10<sup>−4</sup>, unpaired t test with Holm-Šidák correction). (<bold>H</bold>) Biocytin staining of cells recorded in Sst-tdTomato mouse. Biocytin in green, tdTomato in red. Scale bar: 50 µm. (<bold>I</bold>) Representative recording of a Sst interneuron during 5-HT application. Scale bars: 10 mV, 30 s. (<bold>L</bold>) Average RP of Sst interneurons during 5-HT (red) and ketanserin + 5-HT (blue) application, orange bar represents 5-HT (5-HT: n = 19, ketanserin + 5-HT: n = 22).</p><p><supplementary-material id="fig3sdata1"><label>Figure 3—source data 1.</label><caption><title>Source data for <xref ref-type="fig" rid="fig3">Figure 3G</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-66960-fig3-data1-v2.xlsx"/></supplementary-material></p><p><supplementary-material id="fig3sdata2"><label>Figure 3—source data 2.</label><caption><title>Source data for <xref ref-type="fig" rid="fig3">Figure 3L</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-66960-fig3-data2-v2.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-66960-fig3-v2.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 1.</label><caption><title>Effect of Fen on SOs in vitro.</title><p>(<bold>A</bold>) Top: upstate raster plot during Fen application. Bottom: Histogram of upstate incidence before and after Fen application (n = 6, baseline: 1.13 ± 0.17 upstates/10 s, Fen: 0.04 ± 0.03 upstates/10 s). (<bold>B</bold>) Top: upstate raster plot during ketanserin + Fen application. Bottom: Histogram of upstate incidence before and after ketanserin + Fen application (n = 5, baseline: 1.18 ± 0.07 upstates/10 s, Fen: 1.03 ± 0.17 upstates/10 s). (<bold>C</bold>) Upstate metrics during baseline and ketanserin + Fen. Left: violin plots of inter-event interval (baseline = 9.46 ± 0.28 s, ketanserin + Fen = 9.63 ± 0.74 s). Middle: violin plots of inter-event upstate duration (baseline = 2.13 ± 0.08 s, ketanserin + Fen = 2.21 ± 0.05 s). Right: violin plots of upstates area (baseline = 45.55 ± 2.45 mV•s, ketanserin + Fen = 39.45 ± 2.92 mV•s).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-66960-fig3-figsupp1-v2.tif"/></fig><fig id="fig3s2" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 2.</label><caption><title>5-HT suppresses evoked upstates in vitro.</title><p>(<bold>A</bold>) Experimental protocol: recording and stimulation electrode were placed in mEC layer 3, stimulation electrode was located toward the lateral side of the slice. (<bold>B</bold>) Effect of electrical stimulation before (black) and after 5-HT application (orange). 5-HT consistently suppressed spiking. Increasing the stimulation power up to 10x (n = 40/80 in four slices) had no rescue effect. Top: voltage responses to electrical stimulation of a representative neuron. Middle: summary spike raster plot before and after 5-HT application. Bottom: spike rate line histogram (<bold>C</bold>) Scatter plot showing area (top, n = 8 neurons, mean <sub>control</sub> = 16.22 ± 0.80, mean<sub>5-HT</sub> = 1.24 ± 0.97, p&lt;10<sup>−4</sup>, Wilcoxon matched-pairs signed rank test) and duration (bottom, n = 8 neurons, mean <sub>control</sub> = 1.92 ± 0.07, mean<sub>5-HT</sub> = 0.24 ± 0.01,, p&lt;10<sup>−4</sup>, Wilcoxon matched-pairs signed rank test) of evoked upstates before (black) and after 5-HT application (orange). (<bold>D</bold>) Representative voltage responses to 1 s 4 Hz stimulation following wash-in (left) and wash-out (right) of 5-HT. 5-HT prevents spiking from input summation.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-66960-fig3-figsupp2-v2.tif"/></fig><fig id="fig3s3" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 3.</label><caption><title>5-HT<sub>2A</sub>Rs are involved in 5-HT mediated SOs suppression in vitro.</title><p>(<bold>A</bold>) Top: upstate raster plot during application of WAY 100635 (5-HT<sub>1A</sub> antagonist) + 5-HT. Bottom: change in RP in putative excitatory cells after application of WAY 100635 (5-HT<sub>1A</sub> antagonist) + 5-HT (n = 25 cells). (<bold>B</bold>) Top: upstate raster plot during application of ketanserin (5-HT<sub>2A</sub> antagonist) + 5-HT. Bottom: change in RP in putative excitatory cells after application of ketanserin (5-HT<sub>2A</sub> antagonist) + 5-HT (n = 21 cells). (<bold>C</bold>) Top: upstate raster plot during application of α-methyl-5-HT (5-HT<sub>2</sub> agonist). Bottom: change in RP in putative excitatory cells after application of α-methyl-5-HT (5-HT<sub>2</sub> agonist) (n = 11 cells). (<bold>D</bold>) Dot plot showing change in RP for each pharmacological condition (5-HT: −4.52 ± 0.64 mV, WAY + 5-HT: −2.09 ± 0.47 mV, ketanserin + 5-HT: −3.68 ± 0.60 mV and α-methyl-5-HT: −1.67 ± 1.13 mV; p=0.0329, Kruskal-Wallis with Dunn's multiple comparisons test). (<bold>E</bold>) Dot plot showing percentage reduction of upstate incidence for each pharmacological condition (5-HT: 95 ± 4%, WAY + 5-HT: 100 ± 0%, ketanserin + 5-HT: 57 ± 10.1% and α-methyl-5-HT: 100 ± 0%; p&lt;10<sup>−4</sup>, Kruskal-Wallis with Dunn's multiple comparisons test).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-66960-fig3-figsupp3-v2.tif"/></fig><fig id="fig3s4" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 4.</label><caption><title>5-HT<sub>3</sub> receptor is not involved in 5-HT mediated SOs suppression.</title><p>(<bold>A</bold>) Top: upstate raster plot during application of m-CPBG (5-HT3 agonist). Bottom: histogram of upstate incidence before and after m-CPBG application (n = 6, baseline: 1.04 ± 0.19 upstates/10 s, m-CPBG: 1.11 ± 0.21 upstates/10 s). Patches represent 95% confidence interval, lines represent standard deviation. (<bold>B</bold>) Top: upstate raster plot during application of tropisetron (5-HT3 antagonist) + 5-HT. Bottom: histogram of upstate incidence before and after tropisetron + 5-HT application (n = 6, baseline: 1.23 ± 0.18 upstates/10 s, tropisetron + 5-HT: 0.01 ± 0.01 upstates/10 s). Patches represent 95% confidence interval, lines represent standard deviation.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-66960-fig3-figsupp4-v2.tif"/></fig><fig id="fig3s5" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 5.</label><caption><title>In vitro upstates metrics during baseline and ketanserin + 5-HT application.</title><p>(<bold>A</bold>) Box plot showing spiking rate before and after ketanserin + 5-HT (baseline: 0.38 ± 0.14 spikes/s, ketanserin + 5-HT: 0.15 ± 0.06 spikes/s, p=0.011, Mann-Whitney test). patches represent 95% confidence interval, lines represent standard deviation. (<bold>B</bold>) Violin plots of upstate inter-event interval (baseline = 10.92 ± 0.34 s, ketanserin+5-HT = 15.28 ± 1.34 s, p=0.071, Mann-Whitney test). (<bold>C</bold>) Violin plots of upstate duration (baseline = 3.11 ± 0.16 s, ketanserin +5-HT = 1.91 ± 0.15 s, p&lt;0.001, Mann-Whitney test). (<bold>D</bold>) Violin plots of upstate area (baseline = 31.55 ± 1.13 mV•s, ketanserin+5-HT = 28.16 ± 1.91 mV•s, p=0.0825, Mann-Whitney test).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-66960-fig3-figsupp5-v2.tif"/></fig><fig id="fig3s6" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 6.</label><caption><title>LTS neurons are depolarized by 5-HT.</title><p>(<bold>A</bold>) PCA projection plot of all the cells recorded. Cells are color-coded according to group identity (posterior probability &gt;0.9): excitatory (black), fast-spiking (blue), low-threshold spiking (green). Red circles represent PCA loadings. (<bold>B</bold>) PCA projection plot color-coded according to ΔRP after 5-HT application. Inset shows a recording from one LTS neuron during 5-HT application. Scale bars: 20 mV, 25 s. Dotted line showing −70 mV. (<bold>C</bold>) PCA projection plot color-coded according to Δspikes/s after 5-HT application. (<bold>D</bold>) Posterior probability of being classified as Exc, FS, or LTS.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-66960-fig3-figsupp6-v2.tif"/></fig><fig id="fig3s7" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 7.</label><caption><title>Excitatory, fast-spiking, and LTS cells have unique sets of electrophysiological features.</title><p>(<bold>A</bold>) Box plot showing the values of input resistance (R<sub>in</sub>), delta after-hyperpolarization (ΔAHP), SAG, RP, rheobase and spike width of excitatory (Exc, black), fast-spiking (FS, blue) and low-threshold spiking (LTS, green) cells (n<sub>EXC</sub> = 33, n<sub>FS</sub> = 6, n<sub>LTS</sub> = 9; asterisk means p&lt;0.05, double asterisk means p&lt;0.01). Patches represent 95% confidence interval, lines represent standard deviation. (<bold>B</bold>) Table showing values plotted in (<bold>A</bold>).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-66960-fig3-figsupp7-v2.tif"/></fig><fig id="fig3s8" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 8.</label><caption><title>Classification of cells recorded in Sst-tdTomato mice.</title><p>(<bold>A</bold>) PCA projection plot of cells recorded in Sst-tdTomato mice. Cells are color-coded according to group identity (posterior probability &gt;0.9): fast-spiking (blue) or low-threshold spiking (green). Red circles represent PCA loadings. (<bold>B</bold>) Posterior probability of being classified as FS. (<bold>C</bold>) Posterior probability of being classified as LTS.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-66960-fig3-figsupp8-v2.tif"/></fig><fig id="fig3s9" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 9.</label><caption><title>Spatial localization of 5-HT<sub>2A</sub>R positive cells in EC.</title><p>(<bold>A</bold>) 3D visualization of EC (purple). (<bold>B</bold>) 3D localization of all the 5-HT<sub>2A</sub>R-positive cells detected in EC using same perspective as (<bold>A</bold>). (<bold>C</bold>and <bold>D</bold>) Co-localization of 5-HT<sub>2A</sub>R and Sst, arrows point to colocalized cells (scale bar: 100 µm, n <sub>animals </sub>= 7, total number of 5-HT<sub>2A</sub>R-positive cells = 3570, average number of 5-HT<sub>2A</sub>R-positive cells per animal = 510 ± 80.32). (<bold>E</bold>) Spatial distribution of 5-HT<sub>2A</sub>R-positive cells and colocalized cells along the three dimensions depicted in (<bold>A</bold>) (Z dimension centered on the midline).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-66960-fig3-figsupp9-v2.tif"/></fig></fig-group><p>Suppression of activity can have either an intrinsic or synaptic origin (<xref ref-type="bibr" rid="bib104">Turrigiano, 2011</xref>). A substantial subset of EC excitatory neurons is known to express 5-HT<sub>1A</sub> receptor (5-HT<sub>1A</sub>R) and hyperpolarize upon 5-HT application via activation of G protein-coupled inwardly rectifying potassium (GIRK) channels (<xref ref-type="bibr" rid="bib85">Schmitz et al., 1998</xref>; <xref ref-type="bibr" rid="bib15">Chalmers and Watson, 1991</xref>). The suppression of SOs by 5-HT, however, was not influenced by blocking 5-HT<sub>1A</sub>R (WAY 100635, 100 nM) (<xref ref-type="fig" rid="fig3s3">Figure 3—figure supplement 3A,E</xref>). Blocking 5-HT<sub>3</sub>R (tropisetron, 1 µM), the receptor that characterizes one of the three main groups of interneurons, also did not have any impact on SOs suppression induced by 5-HT. Similarly, application of the 5-HT<sub>3</sub>R agonist m-CPBG (50 µM) did not have any effect on SOs (<xref ref-type="fig" rid="fig3s4">Figure 3—figure supplement 4</xref>). In contrast, blocking 5-HT<sub>2A</sub>R with the selective antagonist ketanserin (1 µM) (<xref ref-type="bibr" rid="bib77">Preller et al., 2018</xref>) strongly reduced the suppression power of 5-HT on SOs from 95 ± 4% to 57 ± 10.1% (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1B,E</xref>). The remaining suppression can be possibly explained by the activation of 5-HT<sub>1A</sub>R on excitatory cells, as is reflected by the reduced spiking activity of putative excitatory cells (<xref ref-type="fig" rid="fig3s5">Figure 3—figure supplement 5</xref>).</p><p>Selective activation of 5-HT<sub>2A</sub>R by α-methyl-5-HT (5 µM) mimicked the suppression of SOs observed after 5-HT wash-in (<xref ref-type="fig" rid="fig3s3">Figure 3—figure supplement 3C,E</xref>). Together, these results point to the importance of 5-HT<sub>2A</sub>R in the suppression of SOs. 5-HT<sub>2A</sub>R activation is known to cause an increase in intracellular calcium and consequent depolarization of the resting potential (RP) (<xref ref-type="bibr" rid="bib70">Nichols and Nichols, 2008</xref>). Accordingly, after 5-HT application, we found that a small group of neurons was depolarized (n = 6/48, 12.5%) (<xref ref-type="fig" rid="fig3s6">Figure 3—figure supplement 6B–C</xref>). Using a soft clustering approach with six electrophysiological parameters (see ‘Materials and methods’) we divided the recorded cells into three groups: Excitatory (Exc), fast-spiking (FS), and low-threshold spiking (LTS). Strikingly, the cells excited by 5-HT belonged exclusively to the LTS group (<xref ref-type="fig" rid="fig3">Figure 3G</xref>, <xref ref-type="fig" rid="fig3s6">Figure 3—figure supplement 6</xref>). A substantial proportion of LTS neurons express Sst (<xref ref-type="bibr" rid="bib102">Tremblay et al., 2016</xref>; <xref ref-type="bibr" rid="bib28">Gibson et al., 1999</xref>); therefore, we performed targeted patch-clamp recordings using a mouse line expressing tdTomato specifically in Sst-expressing interneurons (<xref ref-type="fig" rid="fig3">Figure 3H</xref>). A subgroup of Sst interneurons are FS cells (<xref ref-type="bibr" rid="bib107">Urban-Ciecko et al., 2018</xref>), only LTS Sst interneurons were considered in the following analysis. Sst interneurons depolarized upon 5-HT application (n = 19, ∆RP: 7.5 ± 1.23 mV) (<xref ref-type="fig" rid="fig3">Figure 3I–L</xref>) and in some cases continued to spike while SOs were suppressed (n = 8/17, 47.05%, mean <sub>spiking rate</sub> = 3.03 ± 0.39 spikes/s). This effect was blocked by ketanserin (n = 22) (<xref ref-type="fig" rid="fig3">Figure 3L</xref>). We confirmed the presence of 5-HT<sub>2A</sub>R in Sst interneurons using immunohistochemistry in mice expressing EGFP under the 5-HT<sub>2A</sub>R promoter. In accordance with a previous study we found the majority of 5-HT<sub>2A</sub>R positive cells in the deep layers of EC, with a peak in L6 (<xref ref-type="bibr" rid="bib111">Weber and Andrade, 2010</xref>). We observed that 11.8 ± 2.9% of the 5-HT<sub>2A</sub>R positive cells in EC colocalized with Sst (n = 7 mice) (<xref ref-type="fig" rid="fig3s9">Figure 3—figure supplement 9</xref>). These results suggest that Sst interneurons may provide the synaptic inhibition required for the suppression of SOs.</p></sec><sec id="s2-4"><title>Sst interneurons mediate the suppression of SOs by 5-HT in vitro</title><p>To evaluate the contribution of Sst interneurons to the 5-HT-mediated silencing of SOs we used an opto- and pharmacogenetic approach. First, we transgenically expressed channelrhodopsin-2 (ChR2) in Sst interneurons (<xref ref-type="fig" rid="fig4">Figure 4A</xref>). Light-stimulation of ChR2- expressing Sst interneurons in vitro suppressed SOs consistently (<xref ref-type="fig" rid="fig4">Figure 4D–F</xref>). Expectedly, upstate-associated spiking was also diminished (<xref ref-type="fig" rid="fig4">Figure 4C,E,F</xref>). At the end of the light stimulation, spontaneous upstates immediately reoccurred (<xref ref-type="fig" rid="fig4">Figure 4G–H</xref>), in line with a critical role of Sst interneurons in the modulation of SOs (<xref ref-type="bibr" rid="bib21">Fanselow et al., 2008</xref>; <xref ref-type="bibr" rid="bib27">Funk et al., 2017</xref>; <xref ref-type="bibr" rid="bib72">Niethard et al., 2018</xref>). We acknowledge that activation of PV interneurons can cause a similar suppression (<xref ref-type="bibr" rid="bib117">Zucca et al., 2017</xref>). While this experiment establishes the ability of Sst interneurons to suppress SOs, it does not causally link Sst interneuron activation to the suppression of SOs induced by 5-HT. Therefore, we generated a transgenic mouse line carrying a Cre-conditional expression cassette of the pharmacogenetic silencer hM4Di (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref>; <xref ref-type="bibr" rid="bib4">Armbruster et al., 2007</xref>). Homozygous Cre-conditional hM4Di transgenic mice and Sst-Cre mice were bred to obtain heterozygous Sst-Cre/hM4Di offspring, which allow specific inhibition of Sst interneuron activity using Clozapine-N-Oxide (CNO). Following application of 5-HT we observed a strong reduction of upstate incidence, which was partially restored by subsequent application of CNO (<xref ref-type="fig" rid="fig5">Figure 5A–B</xref>).</p><fig-group><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>Sst interneurons activation suppresses SOs.</title><p>(<bold>A</bold>) Experimental protocol: Sst interneurons expressing ChR2 are activated by light during intracellular recording of L3 neurons in EC. (<bold>B</bold>) Representative recordings from a L3 neuron during Sst interneuron activation. Scale bars: 10 mV, 0.5 s. (<bold>C</bold>) Spikes raster (top) and density plot (bottom) during light stimulation. (<bold>D</bold>) Upstate raster (top) and density plot (bottom) during light stimulation. (<bold>E</bold>) Left: spike frequency during baseline light stimulation (n = 14; p&lt;0.001, Wilcoxon signed rank test). Right: upstate incidence during baseline and light stimulation (n = 14; p&lt;0.001, Wilcoxon signed rank test). Patches represent 95% confidence interval, lines represent standard deviation. (<bold>F</bold>) Left: spike probability polar plot during Sst interneurons light activation. Right: upstate probability polar plot during Sst interneurons light activation. Note the absence of both spiking activity and upstates during Sst interneurons activation.</p><p><supplementary-material id="fig4sdata1"><label>Figure 4—source data 1.</label><caption><title>Source data for <xref ref-type="fig" rid="fig4">Figure 4E</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-66960-fig4-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-66960-fig4-v2.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 1.</label><caption><title>Vector construction and RMCE for the generation of a transgenic mouse line with Cre-conditional hM4Di expression.</title><p>(<bold>A</bold>) The coding sequence of hM4Di-mKate flanked by two opposing <italic>loxP</italic> and <italic>lox2272</italic> sites was placed in reverse orientation to the CAG- promoter in the pRMCE. In the acceptor ES cells the ROSA26 allele harbors a PGK promoter driving the hygromycin selection marker, flanked by two attP sites. RMCE by C31int replaces the hygromycin resistance by the neomycin resistance of the donor vector. Location of primer-binding sites in the Rosa26-hM4Di locus is indicated by green triangles. (<bold>B</bold>) Identification of successful genomic integration events and Cre-mediated inversion of the hM4Di coding sequence by PCRs. PCR one and PCR two test for correct integration of the 5’ and 3’ end of the construct into the ROSA26 locus. The lower band in PCR one results from the Neomycin resistance cassette of the feeder cells in the ES cell culture. PCR three tests for successful recombination of the FLEX site by Cre. A successful Cre-mediated recombination of the FLEX cassette was observed for clone 1, resulting in an 826 bp product in PCR 3. C: control cells (not electroporated), H: H<sub>2</sub>O input.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-66960-fig4-figsupp1-v2.tif"/></fig></fig-group><fig-group><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>Sst interneurons mediate the effect of 5-HT on SOs.</title><p>( <bold>A</bold>) Upstate raster plot during 5-HT and subsequent CNO application. Orange box represents 5-HT, purple boxes represent CNO. Note the appearance of upstates after CNO application. (<bold>B</bold>) Upstate incidence during 5-HT and 5-HT+CNO application (n = 15; p (baseline vs 5-HT)&lt;10–4, p (baseline vs CNO)=0.0482, p5-HT vs CNO = 0.0405, Kruskal-Wallis test). Patches represent 95% confidence intervals, lines represent standard deviation.</p><p><supplementary-material id="fig5sdata1"><label>Figure 5—source data 1.</label><caption><title>Source data for <xref ref-type="fig" rid="fig5">Figure 5B</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-66960-fig5-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-66960-fig5-v2.tif"/></fig><fig id="fig5s1" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 1.</label><caption><title>CNO application prevents 5-HT mediated upstates suppression.</title><p>(<bold>A</bold>) Upstate raster plot during CNO and subsequent 5_HT application. Orange box represents 5-HT, purple boxes represent CNO. CNO significantly prevents 5-HT-induced suppression of upstates. (<bold>B</bold>) Upstate incidence during 5-HT, CNO, and 5-HT+CNO application (n = 5, baseline: 1.13 ± 0.13 upstates/10 s, CNO: 1.13 ± 0.10 upstates/10 s, 5-HT: 0.93 ± 0.24 upstates/10 s). Patches represent 95% confidence intervals, lines represent standard deviation.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-66960-fig5-figsupp1-v2.tif"/></fig><fig id="fig5s2" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 2.</label><caption><title>CNO application in wild-type littermates and PV-hM4Di mice.</title><p>(<bold>A</bold>) CNO application in wild-type littermates. Top: Experimental protocol. Orange box represents 5-HT and purple boxes represent CNO application. Bottom: upstate incidence during 5-HT and 5-HT+CNO application, patches represent 95% confidence interval, lines represent standard deviation (n = 11 cells in four mice, baseline = 0.91 ± 0.10, 5-HT = 0.09 ± 0.04, CNO = 0.01 ± 0.01, p <sub>baseline vs 5-HT</sub> = 0.0004, p <sub>baseline vs CNO</sub> &lt;10<sup>−4</sup>, Kruskal-Wallis test) (<bold>B</bold>) Same as (<bold>A</bold>) but in in PV-hM4Di mice (n = 10 cells in four mice, baseline = 1.02 ± 0.08, 5-HT = 0.04 ± 0.03, CNO = 0.08 ± 0.07, p <sub>baseline vs 5-HT</sub> &lt; 10<sup>−4</sup>, p <sub>baseline vs CNO</sub> = 0.0003, Kruskal-Wallis test).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-66960-fig5-figsupp2-v2.tif"/></fig></fig-group><p>Activation of 5-HT<sub>1A</sub>R on excitatory cells by 5-HT and the resulting decreased network excitation drive might account for the fact that the incidence of upstates did not completely return to the baseline level upon CNO wash-in. Additionally, in further experiments in which CNO was applied before 5-HT, the significant reduction in upstate incidence typically seen after 5-HT wash-in was not observed (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1</xref>). CNO did not show any significant effect in both wild-type littermates and hM4Di-PV mice (<xref ref-type="fig" rid="fig5s2">Figure 5—figure supplement 2</xref>), indicating that the results observed are due to its specific effect on the activity of Sst interneurons. In summary, while activation of Sst interneurons either via 5-HT or directly by ChR2 suppresses SOs, the pharmacogenetic inactivation of Sst interneurons weakens the effect of 5-HT on SOs.</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>In this study, we show that the substitute amphetamines MDMA and Fen suppress default cortical network oscillations in vivo in the mEC. Furthermore, using an opto- and pharmacogenetic approach in vitro, we demonstrate that Sst interneurons, activated by 5-HT<sub>2A</sub>R, contribute to this suppression.</p><p>Organization of cortical activity is brain state-dependent, ranging continuously from ‘synchronized’ to ‘desynchronized’ states (<xref ref-type="bibr" rid="bib34">Harris and Thiele, 2011</xref>). SOs are on one end of this continuum, representing the prototypical synchronized state. Our results, in line with previous studies (<xref ref-type="bibr" rid="bib78">Puig et al., 2010</xref>; <xref ref-type="bibr" rid="bib30">Grandjean et al., 2019</xref>), show that 5-HT can suppress synchronized cortical activity; in addition, we identify Sst interneurons as contributing to this suppression.</p><p>Sst interneurons have been previously proposed to provide the inhibition necessary for the termination of upstates, due to their strongly facilitating synapses (<xref ref-type="bibr" rid="bib44">Krishnamurthy et al., 2012</xref>; <xref ref-type="bibr" rid="bib58">Melamed et al., 2008</xref>). Additionally, increased inhibition, as shown both in computational models and experimental data, can counteract temporal summation of inputs and reduce correlation due to tracking of shared inputs between inhibitory and excitatory populations (<xref ref-type="bibr" rid="bib92">Sippy and Yuste, 2013</xref>; <xref ref-type="bibr" rid="bib80">Renart et al., 2010</xref>; <xref ref-type="bibr" rid="bib95">Stringer et al., 2016</xref>). In the case of Sst interneurons, this would especially impact summation in distal compartments of pyramidal cells, due to the axonic targeting of Sst cells onto pyramids. Sst interneurons are specifically known to be sufficient to cause desynchronization in V1 (<xref ref-type="bibr" rid="bib16">Chen et al., 2015</xref>). While it is well known that Sst interneurons are potently excited by ACh in various cortical areas (<xref ref-type="bibr" rid="bib16">Chen et al., 2015</xref>; <xref ref-type="bibr" rid="bib73">Obermayer et al., 2018</xref>; <xref ref-type="bibr" rid="bib21">Fanselow et al., 2008</xref>), including mEC (<xref ref-type="bibr" rid="bib20">Desikan et al., 2018</xref>) and NE in frontal cortex (<xref ref-type="bibr" rid="bib42">Kawaguchi and Kubota, 1998</xref>), our work identifies them as a novel target of 5-HT regulation via 5-HT<sub>2A</sub>R. Recently, it has been proposed that inhibitory interneurons play a key role in mediating the effect of ACh and NE on cortical state transitions (<xref ref-type="bibr" rid="bib12">Cardin, 2019</xref>). Our results add a new level of complexity to this picture.</p><p>The excitation of Sst interneurons by 5-HT possibly contributes to the net inhibitory effect of 5-HT release observed in many cortical areas (<xref ref-type="bibr" rid="bib30">Grandjean et al., 2019</xref>; <xref ref-type="bibr" rid="bib87">Seillier et al., 2017</xref>; <xref ref-type="bibr" rid="bib7">Azimi et al., 2020</xref>), and could explain why the inhibition strength is linearly correlated to 5-HT<sub>2A</sub>R expression (<xref ref-type="bibr" rid="bib30">Grandjean et al., 2019</xref>). Giving further support to this idea, Sst interneurons in the somatosensory cortex show increased cFos levels following 5-HT<sub>2A</sub>R activation (<xref ref-type="bibr" rid="bib55">Martin and Nichols, 2016</xref>). Previous studies have reported either 5-HT<sub>2A</sub>R-dependent inhibition or 5-HT<sub>2A</sub>R-dependent activation of interneurons in the prefrontal cortex (PFC) (<xref ref-type="bibr" rid="bib1">Abi-Saab et al., 1999</xref>; <xref ref-type="bibr" rid="bib5">Ashby et al., 1990</xref>; <xref ref-type="bibr" rid="bib6">Athilingam et al., 2017</xref>), piriform cortex (<xref ref-type="bibr" rid="bib54">Marek and Aghajanian, 1994</xref>; <xref ref-type="bibr" rid="bib91">Sheldon and Aghajanian, 1990</xref>), cingulate cortex (<xref ref-type="bibr" rid="bib116">Zhou and Hablitz, 1999</xref>), cochlear nucleus (<xref ref-type="bibr" rid="bib99">Tang and Trussell, 2017</xref>), amygdala (<xref ref-type="bibr" rid="bib88">Sengupta et al., 2017</xref>), olfactory bulb (<xref ref-type="bibr" rid="bib76">Petzold et al., 2009</xref>; <xref ref-type="bibr" rid="bib33">Hardy et al., 2005</xref>), visual cortex (<xref ref-type="bibr" rid="bib61">Michaiel et al., 2019</xref>; <xref ref-type="bibr" rid="bib7">Azimi et al., 2020</xref>), and hippocampus (<xref ref-type="bibr" rid="bib115">Wyskiel and Andrade, 2016</xref>). However, none of these studies identified interneurons using molecular markers, so we do not exclude that different interneuron classes in other cortical areas might mediate the inhibitory downstream effects of 5-HT<sub>2A</sub>R. For example, in the PFC a subgroup of PV interneurons has been reported to be activated by this receptor (<xref ref-type="bibr" rid="bib6">Athilingam et al., 2017</xref>; <xref ref-type="bibr" rid="bib78">Puig et al., 2010</xref>). Furthermore, we know that PV neurons can reliably induce up to down state transitions (<xref ref-type="bibr" rid="bib117">Zucca et al., 2017</xref>). 5-HT modulation is also involved in gain regulation. In the olfactory cortex, 5-HT has a selective subtractive effect on stimulus evoked firing (<xref ref-type="bibr" rid="bib52">Lottem et al., 2016</xref>), and a recent study has shown in the visual cortex that the reduced gain of evoked responses is dependent on 5-HT<sub>2A</sub>R activation (<xref ref-type="bibr" rid="bib7">Azimi et al., 2020</xref>). Intriguingly, Sst interneurons have been shown to regulate subtractive inhibition (<xref ref-type="bibr" rid="bib96">Sturgill and Isaacson, 2015</xref>; <xref ref-type="bibr" rid="bib112">Wilson et al., 2012</xref>).</p><p>5-HT levels in the brain, similarly to other neuromodulators, are synchronized to the sleep wake cycle, with higher levels present during the waking state (<xref ref-type="bibr" rid="bib74">Oikonomou et al., 2019</xref>). How does this notion relate to activation of Sst interneurons by 5-HT<sub>2A</sub>R? A limitation of our study is the absence of data in naturalistic conditions, with anesthesia potentially being a confounding factor (<xref ref-type="bibr" rid="bib2">Adesnik et al., 2012</xref>). We can nonetheless speculate that Sst interneurons should be more active during states with higher 5-HT levels (wake&gt;SWS&gt;REM). A previous study directly measuring the activity of various neuronal classes across different states seems to support this idea. Sst interneurons in the dorsal cortical surface display their highest activity during waking states, lower activity during SWS and lowest activity during REM (<xref ref-type="bibr" rid="bib71">Niethard et al., 2016</xref>). Following pharmacological release of 5-HT in vivo, we observed increased spiking activity in a subgroup of neurons whose waveform features are compatible with Sst interneurons. Our in vitro data using 5-HT at a concentration commonly used in the field (<xref ref-type="bibr" rid="bib29">Gorinski et al., 2019</xref>; <xref ref-type="bibr" rid="bib110">Wang et al., 2016</xref>; <xref ref-type="bibr" rid="bib38">Huang et al., 2009</xref>) shows that Sst interneurons can be activated by 5-HT<sub>2A</sub>R, however, recordings during natural sleep and wake conditions in combination with optotagging will be needed to demonstrate conclusively that Sst interneurons are activated by 5-HT in physiological conditions in vivo. Potential differences between physiological and pharmacological 5-HT release are especially of interest considering the reported efficacy of MDMA in the treatment of PTSD and its recently approved status as breakthrough therapy (<xref ref-type="bibr" rid="bib39">Inserra et al., 2021</xref>; <xref ref-type="bibr" rid="bib62">Mithoefer et al., 2019</xref>).</p><p>While our data relative to MDMA application supports a role of 5-HT in modulating SOs in vivo we cannot exclude that other neuromodulators might play a role. For example, it is known that dopamine can suppress SOs in vitro (<xref ref-type="bibr" rid="bib56">Mayne et al., 2013</xref>). Fen, however, has been reported to selectively increase 5-HT concentration in the brain (<xref ref-type="bibr" rid="bib81">Rothman and Baumann, 2002</xref>) and has been used previously to specifically disentangle the effect of MDMA on different neuromodulatory systems (<xref ref-type="bibr" rid="bib35">Heifets et al., 2019</xref>). This, together with our in vitro results, suggests that 5-HT is most likely mediating the effect induced by MDMA/Fen.</p><p>Besides its involvement in various physiological brain processes, 5-HT is also associated with the etiology of various psychiatric disorders, as are Sst interneurons (<xref ref-type="bibr" rid="bib75">Pantazopoulos et al., 2017</xref>; <xref ref-type="bibr" rid="bib51">Lin and Sibille, 2015</xref>). Furthermore, 5-HT is linked to the psychological effect of many psychotropic drugs; specifically, 5-HT<sub>2A</sub>R activation has been reported to be essential for the psychological effects induced by various psychedelics (<xref ref-type="bibr" rid="bib69">Nichols, 2016</xref>), and in the case of MDMA, has been linked to perceptual and emotional alterations (<xref ref-type="bibr" rid="bib50">Liechti et al., 2000</xref>; <xref ref-type="bibr" rid="bib45">Kuypers et al., 2018</xref>). Broadband reduction in oscillatory power, triggered by 5-HT<sub>2A</sub>R, seems to be linked to the subjective effect of serotonergic drugs (<xref ref-type="bibr" rid="bib13">Carhart-Harris et al., 2016</xref>; <xref ref-type="bibr" rid="bib14">Carhart-Harris and Friston, 2019</xref>) and has been consistently observed in humans and rodents following administration of MDMA (<xref ref-type="bibr" rid="bib26">Frei et al., 2001</xref>; <xref ref-type="bibr" rid="bib47">Lansbergen et al., 2011</xref>) or various other 5-HT<sub>2A</sub>R agonists (<xref ref-type="bibr" rid="bib43">Kometer et al., 2015</xref>; <xref ref-type="bibr" rid="bib64">Muthukumaraswamy et al., 2013</xref>; <xref ref-type="bibr" rid="bib13">Carhart-Harris et al., 2016</xref>; <xref ref-type="bibr" rid="bib114">Wood et al., 2012</xref>). The link between 5-HT<sub>2A</sub>R and perception is further supported by the fact that several routinely used antipsychotic drugs are potent 5-HT<sub>2A</sub>R antagonists (<xref ref-type="bibr" rid="bib53">Marek et al., 2003</xref>; <xref ref-type="bibr" rid="bib59">Meltzer, 1999</xref>). Although the most recent attempts to explain the psychological effects of 5-HT<sub>2A</sub>R activation focus on the increased spiking of cortical pyramidal neurons in the deep layers (<xref ref-type="bibr" rid="bib14">Carhart-Harris and Friston, 2019</xref>; <xref ref-type="bibr" rid="bib69">Nichols, 2016</xref>), our study suggests that Sst interneurons may also play a role. Sst interneurons, in contrast to PV interneurons, form synapses on the dendrites of their target cell (<xref ref-type="bibr" rid="bib102">Tremblay et al., 2016</xref>). A wealth of evidence suggests that active dendritic processing in cortical pyramidal neurons has a critical influence on sensory perception (<xref ref-type="bibr" rid="bib98">Takahashi et al., 2016</xref>; <xref ref-type="bibr" rid="bib63">Murayama et al., 2009</xref>; <xref ref-type="bibr" rid="bib93">Smith et al., 2013</xref>; <xref ref-type="bibr" rid="bib79">Ranganathan et al., 2018</xref>) and, in accordance with their unique anatomical properties, Sst interneurons strongly influence dendritic computations and directly modulate perceptual thresholds (<xref ref-type="bibr" rid="bib98">Takahashi et al., 2016</xref>).</p><p>We propose that the novel link between 5-HT<sub>2A</sub>R and Sst interneurons might help elucidate the mechanisms underlying a host of psychiatric disorders and contribute to our understanding of how serotonergic drugs exert their psychological effects.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><p>All experiments were conducted according to regulations of the Landesamt für Gesundheit und Soziales (Berlin [T 0100/03], Berlin [G0298/18]) and the European legislation (European Directive 2010/63/EU).</p><sec id="s4-1"><title>Animals</title><p>Data for the in vivo part of the study was collected from C57Bl/6 mice (aged 6–10 weeks). Data for the in vitro part was collected from C57Bl/6 (P10-P17), Sst-tdTomato (P10-P30), Sst-Chr2-EYFP (P10-P16), hM4Di-Sst (P10-P15), hM4Di-Sst (+/-) (P10-P15) and hM4Di-PV (P10-P15) mice. Immunostainings to localize 5-HT<sub>2A</sub>R were performed on 5-HT<sub>2A</sub>R-EGFP mice (P20-P90) and immunostainings to localize 5-HT fibers were performed on an ePet-YFP mouse (P35). Sst-Cre mice (RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:IMSR_JAX:013044">IMSR_JAX:013044</ext-link>) have Cre recombinase targeted to the <italic>Sst</italic> locus; they were obtained from Jackson Laboratory (ME, USA). PV-Cre mice (RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:IMSR_JAX:008069">IMSR_JAX:008069</ext-link>) have Cre recombinase targeted to the <italic>Pvalb</italic> locus; they were obtained from Charles River Laboratory (MA, USA). tdTomato mice (Ai9, RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:IMSR_JAX:013044">IMSR_JAX:013044</ext-link>) were obtained from Jackson Laboratory. Chr2-EYFP mice (Ai32, RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:IMSR_JAX:012569">IMSR_JAX:012569</ext-link>) were obtained from Jackson Laboratory. ePet-Cre mice (RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:IMSR_JAX:012712">IMSR_JAX:012712</ext-link>) have Cre recombinase targeted to the <italic>Fev</italic> locus; they were obtained from Jackson Laboratory. 5-HT<sub>2A</sub>R-EGFP mice (RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:MMRRC_010915-UCD">MMRRC_010915-UCD</ext-link>) express EGFP reporter protein under the control of the <italic>Htr2a</italic> gene, they were obtained from the Mutant Mouse Resource and Research Centers (MMRRC, CA, USA). Generation of hM4Di mice is described in the paragraph ‘Generation of Cre-conditional hM4Di mice’. The animals were housed in a 12:12 hr light-dark cycle in singularly ventilated cages with ad libitum access to food and water. SOs in vitro recordings were performed on P12-P16 mice.</p></sec><sec id="s4-2"><title>Generation of Cre-conditional hM4Di mice</title><p>We produced a transgenic mouse line carrying a Cre-conditional hM4Di expression cassette in the Rosa26 locus. The transgene construct was inserted by recombination-mediated cassette exchange (RMCE). RMCE relies on recombination events between attB and attP recognition sites of the RMCE plasmid and genetically modified acceptor embryonic stem (ES) cells, mediated by the integrase of phage phiC31 (<xref ref-type="bibr" rid="bib36">Hitz et al., 2007</xref>). The RMCE construct is thereby shuttled into the Rosa26 locus of the ES cells, along with a Neomycin resistance cassette (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2A</xref>). The acceptor cell line IDG3.2-R26.10–3 (I3) was kindly provided by Ralf Kühn (GSF National Research Centre for Environment and Health, Institute of Developmental Genetics, Neuherberg, Germany).</p><p>We subcloned a Cre-conditional FLEX (flip-excision) cassette (<xref ref-type="bibr" rid="bib86">Schnütgen et al., 2003</xref>) into pRMCE, and inserted a strong CAG promoter (CMV immediate early enhancer/modified chicken β-actin promoter, from Addgene Plasmid #1378) in front of the FLEX-cassette to create pRMCE-CAG-Flex. The coding sequence of hM4Di-mKateT was inserted into the FLEX cassette in reverse orientation to the promoter (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2A</xref>). Finally, a rabbit globulin polyA cassette including stop codons in every reading frame was placed downstream of the FLEX cassette, in the same direction as hM4Di, in order to prevent unintended transcriptional read-through from potential endogenous promoters. The construct was completely sequenced before ES cell electroporation.</p><p>Electroporation of the RMCE construct together with a plasmid encoding C31int was performed by the transgene facility of the ‘Research Institute for Experimental Medicine’ (FEM, Charité, Berlin) according to published protocols (<xref ref-type="bibr" rid="bib37">Hitz et al., 2009</xref>; <xref ref-type="bibr" rid="bib36">Hitz et al., 2007</xref>). Recombinant clones were selected by incubation with 140 µg/ml G418 for at least 7 days. To activate hM4Di expression by recombination of the FLEX switch, selected clones were further transfected transiently with pCAG-Cre-EGFP using Roti-Fect (Carl Roth, Karlsruhe, Germany). G418-resistant clones were analyzed by PCR for successful integration and recombination of the construct (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2B</xref>), using the following primers:</p><list list-type="simple"><list-item><p>GT001 PGK3’-fw: <named-content content-type="sequence">CACGCTTCAAAAGCGCACGTCTG</named-content>;</p></list-item><list-item><p>GT002 Neo5’-rev: <named-content content-type="sequence">GTTGTGCCCAGTCATAGCCGAATAG</named-content>;</p></list-item><list-item><p>GT005 PolyA-fw: <named-content content-type="sequence">TTCCTCCTCTCCTGACTACTCC</named-content>;</p></list-item><list-item><p>GT006 Rosa3’-rev: <named-content content-type="sequence">TAAGCCTGCCCAGAAGACTC</named-content>;</p></list-item><list-item><p>GT013 hM4Di3’rec-rev: <named-content content-type="sequence">CAGATACTGCGACCTCCCTA</named-content></p></list-item></list><p>After verification of correct integration and functional FLEX-switch recombination, we generated chimeras by blastocyst injection of I3 ES cells. Heterozygous offsprings were mated with a Flpe deleter mouse line in order to remove the neomycin resistance cassette by Flp-mediated recombination.</p><p>Mice homozygous for the Rosa-CAG-FLEX-hM4Di-mKateT allele are viable and fertile and show now obvious phenotype. Importantly, application of CNO to these mice does not induce any behavioral effects. Homozygous Cre-conditional hM4Di transgenic mice and Sst-Cre mice (<xref ref-type="bibr" rid="bib100">Taniguchi et al., 2011</xref>) were maintained on a C57Bl/6 genetic background and were bred to obtain heterozygous Sst-Cre / hM4Di offsprings.</p></sec><sec id="s4-3"><title>Drugs</title><p>Urethane (U2500, Merck), Fenfluramine ((+)-Fenfluramine hydrochloride, F112, Merck), 5-HT (Serotonin creatinine sulfate monohydrate, H7752, Merck), m-CPBG (1-(3-Chlorophenyl)biguanide hydrochloride, C144, Merck), tropisetron (Tropisetron hydrochloride,Y0000616, Sigma), WAY-100635 (W108, Merck), α-Methylserotonin (α-Methylserotonin maleate salt, M110, Merck), MDMA ((±)3,4-methylenedioxymethamphetamine, 64057-70-1, Merck), CNO (Clozapine <italic>N</italic>-oxide dihydrochloride, 6329, Tocris) were dissolved in water for in vitro application and in 0.9% normal saline for in vivo application. Ketanserin (Ketanserin (+)-tartrate salt, S006, Merck) was dissolved in Dimethyl sulfoxide (DMSO).</p></sec><sec id="s4-4"><title>Surgery and in vivo recording</title><p>Before recordings mice were briefly anesthetized with isofluorane (2%) and then injected intraperitoneally with urethane (1.2 g/kg, Sigma Aldrich, Munich, Germany). The level of anesthesia was maintained so that hindlimb pinching produced no reflex movement and supplemental doses of urethane (0.2 g/kg) were delivered as needed. Upon cessation of reflexes the animals were mounted on a stereotaxic frame (Kopf Instruments, Tujunga, California), and body temperature was maintained at 38°C. The scalp was removed, and the skull was cleaned with saline solution. A craniotomy was performed at +3 mm ML, −3 mm AP, +3.25 mm DV to reach mEC.</p><p>Extracellular recordings from EC (<xref ref-type="fig" rid="fig1">Figures 1</xref>–<xref ref-type="fig" rid="fig2">2</xref>) were performed using a Cambridge Neurotech (Cambridge, United Kingdom) silicon probe (64-channels) (n = 15) or 32-channels (n = 3). The recording electrode was painted with the fluorescent dye DiI (Thermo Fisher Scientific, Schwerte, Germany) and then slowly lowered into the craniotomy using micromanipulators (Luigs and Neumann, Ratingen, Germany) at a 25° angle AP (toward the posterior side of the brain). The exposed brain was kept moist using saline solution. A ground wire connected to the amplifier was placed in the saline solution covering the skull to eliminate noise. Brain signals were recorded using a RHD2000 data acquisition system (Intan Technologies, Los Angeles, California) and sampled at 20 kHz. Recording quality was inspected on-line using the open-source RHD2000 Interface Software. A supplementary dose of urethane (0.2 g/kg) was injected right before the start of the recording to standardize anesthesia level across different experiments and avoid the arise of theta activity in the first 30 min of recording. Recordings began after a 10 min waiting period in which clear upstates could consistently be seen at a regular frequency.</p></sec><sec id="s4-5"><title>In vivo analysis</title><p>We selected the channel to use for upstate detection based on the standard deviation (STD) of the trace during baseline (first 5 min of recording): the channel with the highest STD was selected, as larger voltage deflection increases detection algorithm accuracy. Given the highly synchronous nature of SOs (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>) the spatial location of the channel selected was not considered. Upstates were detected comparing threshold crossing points in two signals: the delta-band filtered signal (0.5–4 Hz) and the population spike activity. Candidate upstates were identified in the delta-band filtered signal using two dynamic thresholds ‘a’ and ‘b’:<disp-formula id="equ1"><mml:math id="m1"><mml:mrow><mml:mi>a</mml:mi><mml:mo>=</mml:mo><mml:mi>m</mml:mi><mml:mo>+</mml:mo><mml:mfrac><mml:mi>σ</mml:mi><mml:mrow><mml:mn>1.5</mml:mn></mml:mrow></mml:mfrac></mml:mrow></mml:math></disp-formula><disp-formula id="equ2"><mml:math id="m2"><mml:mrow><mml:mi>b</mml:mi><mml:mo>=</mml:mo><mml:mi>m</mml:mi><mml:mo>+</mml:mo><mml:mfrac><mml:mi>σ</mml:mi><mml:mrow><mml:mn>0.8</mml:mn></mml:mrow></mml:mfrac></mml:mrow></mml:math></disp-formula>where σ is the standard deviation of the signal during the first five minutes of recording (baseline) and <italic>m</italic> is the centered moving median calculated using 60 s windows (Matlab function <italic>movmedian</italic>). The median was used instead of the mean to account for non-stationaries in the data. A candidate upstate was identified at first using the threshold crossings of the signal compared to ‘a’: candidates shorter than 200 ms were deleted and multiple candidates occurring within a window of 300 ms were joined together. Subsequently, the threshold ‘b’ was used to separate upstates occurring in close proximity: if the signal within one candidate crossed the threshold ‘b’ in more than one point then the candidate upstate was split in two at the midpoint between the two threshold crossings. Candidate upstates were finally confirmed if the population spike activity (calculated in 100 ms windows) within the candidate crossed a threshold of 1 σ (calculated during the baseline).</p></sec><sec id="s4-6"><title>Units detection and classification</title><p>Spike detection was performed offline using the template-based algorithm Kilosort2 <ext-link ext-link-type="uri" xlink:href="https://github.com/MouseLand/Kilosort2">https://github.com/MouseLand/Kilosort2</ext-link>; <xref ref-type="bibr" rid="bib22">Filippo, 2021a</xref>; copy archived at <ext-link ext-link-type="uri" xlink:href="https://archive.softwareheritage.org/swh:1:dir:c5206cc562377ff7d70825a0458997a2e980b30a;origin=https://github.com/MouseLand/Kilosort2;visit=swh:1:snp:0d6db4f974bbe0a3f7f659935f39197e88299b36;anchor=swh:1:rev:a1fccd9abf13ce5dc3340fae8050f9b1d0f8ab7a/">swh:1:rev:a1fccd9abf13ce5dc3340fae8050f9b1d0f8ab7a</ext-link>, with the following parameters:</p><list list-type="bullet"><list-item><p>ops.fshigh = 300</p></list-item><list-item><p>ops.fsslow = 8000</p></list-item><list-item><p>ops.minfr_goodchannels = 0</p></list-item><list-item><p>ops.Th = [8 4]</p></list-item><list-item><p>ops.Iam = 10</p></list-item><list-item><p>ops.AUCsplit = 0.9</p></list-item><list-item><p>ops.minFR = 1/1000</p></list-item><list-item><p>ops.momentum = [20 400]</p></list-item><list-item><p>ops.sigmaMask = 30</p></list-item><list-item><p>ops.ThPre = 8</p></list-item><list-item><p>ops.spkTh = −6</p></list-item><list-item><p>ops.nfilt_factor = 8</p></list-item><list-item><p>ops.loc_range = [3 1]</p></list-item><list-item><p>ops.criterionNoiseChannel = 0.2</p></list-item><list-item><p>ops.whiteningrange = 32</p></list-item><list-item><p>ops.ntbuff = 64</p></list-item></list><p>Manual curation of the results was performed using Phy <ext-link ext-link-type="uri" xlink:href="https://github.com/cortex-lab/phy">https://github.com/cortex-lab/phy</ext-link>; <xref ref-type="bibr" rid="bib23">Filippo, 2021b</xref>; copy archived at <ext-link ext-link-type="uri" xlink:href="https://archive.softwareheritage.org/swh:1:dir:3d51c829949d8ba8fa0a36bc5928f58ce1e157d8;origin=https://github.com/cortex-lab/phy;visit=swh:1:snp:d7f54c7694780300cff1fb7e427eb4f7632ce801;anchor=swh:1:rev:6ffe05a559bd0302e98ec60d5958ace719544713/">swh:1:rev:6ffe05a559bd0302e98ec60d5958ace719544713</ext-link>. Each Isolated unit satisfied the following two criteria: Refractory period (2 ms) violations &lt; 5%, fraction of spikes below detection threshold (as estimated by a gaussian fit to the distribution of the spike amplitudes)&lt;15%. Units with negative maximal waveform amplitude were further classified as putative excitatory if the latency (TP latency) was &gt;0.55 ms or putative inhibitory when TP latency &lt;0.55 ms. The value 0.55 was chosen in accordance with previous studies (<xref ref-type="bibr" rid="bib89">Senzai et al., 2019</xref>; <xref ref-type="bibr" rid="bib3">Antoine et al., 2019</xref>). In pharmacological classification, units were classified as ‘activated’ if their firing rate in the 25 min following drug injection was 2 σ (standard deviation) above the baseline rate for at least 5 min. Remaining units were pulled together in the category ‘non-activated’.</p></sec><sec id="s4-7"><title>Cross-correlogram analysis</title><p>Cross-correlogram based connectivity analysis was performed for every unit to identify inhibitory connections. Units with a spiking rate smaller than 0.3 spikes/s were discarded from the analysis. We used total spiking probability edges (TPSE) algorithm <ext-link ext-link-type="uri" xlink:href="https://github.com/biomemsLAB/TSPE">https://github.com/biomemsLAB/TSPE</ext-link>; <xref ref-type="bibr" rid="bib24">Filippo, 2021c</xref>; copy archived at <ext-link ext-link-type="uri" xlink:href="https://archive.softwareheritage.org/swh:1:dir:bbb1f453ed0bddeba9cc2f1c0f49027a7e42db0b;origin=https://github.com/biomemsLAB/TSPE;visit=swh:1:snp:3e9a4e0c1e421de4e399f0b0d108dac66b06eaa5;anchor=swh:1:rev:b780c753039a2f48201a6bb77dd8f5e65551a845/">swh:1:rev:b780c753039a2f48201a6bb77dd8f5e65551a845</ext-link>, <xref ref-type="bibr" rid="bib18">De Blasi et al., 2019</xref> to identify in a computationally efficient manner putative inhibitory connections between units and all clusters recorded. The parameters used were:</p><list list-type="bullet"><list-item><p>d = 0,</p></list-item><list-item><p>neg_wins = [2, 3, 4, 5, 6, 7, 8],</p></list-item><list-item><p>co_wins = 0,</p></list-item><list-item><p>pos_wins = [2, 3, 4, 5, 6],</p></list-item><list-item><p>FLAG_NORM = 1.</p></list-item></list><p>The connectivity vectors of each unit resulting from TSPE were sorted by inhibition strength. The top 20 connections were further analyzed using custom Matlab (RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_001622">SCR_001622</ext-link>) code. A connection was classified as inhibitory if the cross correlogram values (x) were smaller than the mean of x by more than one standard deviation (x &lt; mean(x) – std(x)) in at least four consecutive bins (bin size = 1 ms) in a window 4–9 ms after the center of the cross-correlogram.</p></sec><sec id="s4-8"><title>Slice preparation</title><p>We prepared acute near horizontal slices (∼15° off the horizontal plane) of the mEC from C57Bl/6 mice. Animals were decapitated following isoflurane anesthesia. The brains were quickly removed and placed in ice-cold (∼4° C) ACSF (pH 7.4) containing (in mM) 85 NaCl, 25 NaHCO<sub>3</sub>, 75 Sucrose, 10 Glucose, 2.5 KCl, 1.25 NaH<sub>2</sub>PO<sub>4</sub>, 3.5MgSO<sub>4</sub>, 0.5 CaCl<sub>2</sub>, and aerated with 95% O<sub>2</sub>, 5% CO<sub>2</sub>. Tissue blocks containing the brain region of interest were mounted on a vibratome (Leica VT 1200, Leica Microsystems), cut at 400 μm thickness, and incubated at 35°C for 30 min. The slices were then transferred to ACSF containing (in mM) 85 NaCl, 25 NaHCO<sub>3</sub>, 75 Sucrose, 10 Glucose, 2.5 KCl, 1.25 NaH<sub>2</sub>PO<sub>4</sub>, 3.5 MgSO<sub>4</sub>, 0.5 CaCl<sub>2</sub>. The slices were stored at room temperature in a submerged chamber for 1–5 hr before being transferred to the recording chamber.</p></sec><sec id="s4-9"><title>In vitro recording</title><p>In order to perform whole-cell recordings slices were transferred to a submersion style recording chamber located on the stage of an upright, fixed-stage microscope (BX51WI, Olympus) equipped with a water immersion objective (×60, Olympus) and a near-infrared charge-coupled device (CCD) camera. The slices were perfused with ACSF (∼35°C bubbled with 95% O<sub>2</sub>–5% CO<sub>2</sub>) at 3–5 ml/ min to maintain neuronal health throughout the slice. The ACSF had the same composition as the incubation solution except for the concentrations of calcium and magnesium, which were reduced to 1.2 and 1.0 mM, respectively. Recording electrodes with impedance of 3–5 MΩ were pulled from borosilicate glass capillaries (Harvard Apparatus, Kent, UK; 1.5 mm OD) using a micropipette electrode puller (DMZ Universal Puller). The intracellular solution contained the following (in mM): 135 K-gluconate, 6 KCl, 2 MgCl<sub>2</sub>, 0.2 EGTA, 5 Na2- phosphocreatine, 2 Na2-ATP, 0.5 Na2-GTP, 10 HEPES buffer, and 0.2% biocytin. The pH was adjusted to 7.2 with KOH. Recordings were performed using Multiclamp 700A/B amplifiers (Molecular Devices, San Jose, California). The seal resistance was &gt;1 GΩ. Capacitance compensation was maximal and bridge balance adjusted. Access resistance was constantly monitored. Signals were filtered at 6 kHz, sampled at 20 kHz, and digitized using the Digidata 1550 and pClamp 10 (Molecular Devices, San Jose, California). Activation light was delivered by a 460 nm laser (DPSS lasers, Santa Clara, California) using a 460–480 nm bandpass excitation filter. Stimulation consisted of 500 ms pulses at 1 Hz.</p><p>Stimulation experiments were performed using a bipolar micro-electrode (glass pipette filled with ACSF solution, wrapped by a fine grounding wire) connected to an isolated voltage stimulator (ISO-Flex, A.M.P.I., Israel). A 4x objective (Olympus) was used to visually guide the stimulating electrode into the mEC. Stimulation power was adjusted to achieve consistent upstate generation during baseline (&gt;95%). Each stimulus had a duration of 50 μs and the inter-stimulus interval was 8–10 s.</p></sec><sec id="s4-10"><title>In vitro analysis</title><p>In vitro upstates were detected in Matlab using an algorithm similar to the one described in the in vivo analysis method section. We used a coincident detection in two signals. In multicellular recordings, we used the membrane potential of two cells, and in single-cell recordings, we used membrane potential and the envelope of the gamma filtered trace (50–250 Hz), as upstates are characterized by an increase in gamma activity (<xref ref-type="bibr" rid="bib67">Neske, 2015</xref>).</p><p>The baseline condition was defined as the last 120 s before drug application, while the post-drug application condition was defined as the 120 s of recording after drug application (Total recording duration: 600 s).</p><p>Excitatory (Exc), fast-spiking (FS), and low-threshold spiking (LTS) neurons were classified using Gaussian mixture models (GMM) with a soft clustering approach in Matlab. Input resistance (R<sub>in</sub>), Δafter-hyperpolarization (ΔAHP), sag, rheobase, spike width and resting potential (RP) were extracted from each neuron and used in the classification. The first two components of the principal component analysis (PCA) were used to fit the data to a Gaussian mixture model distribution. Initial values were set according to the k-means algorithm with centroid positioned at x and y position: 5, 0; −15,–15; −15, 10. This centroid were placed according to the loadings of the PCA to identify three clusters with the following main features:</p><list list-type="bullet"><list-item><p>Cluster 1 (putative Exc): high spike width, low AHP, low rheobase.</p></list-item><list-item><p>Cluster 2 (putative FS): low spike width, low SAG, high rheobase, low R<sub>in</sub>.</p></list-item><list-item><p>Cluster 3 (putative LTS): low spike width, high SAG, high AHP, high R<sub>in</sub>.</p></list-item></list><p>Covariance matrices were diagonal and not shared. Neurons with a posterior probability of belonging to any of the three clusters of &lt;90% were discarded from further analysis (1/49).</p><p>While the majority of Sst-interneurons display LTS features, a minority (~10%) belong to the FS group (<xref ref-type="bibr" rid="bib106">Urban-Ciecko et al., 2015</xref>). To distinguish FS and LTS interneurons in the Sst-Td Tomato mice, we employed the GMM with posterior probability threshold of 90%. Only LTS Sst neurons were considered for further analysis.</p></sec><sec id="s4-11"><title>Histological analysis</title><p>For the postmortem electrode track reconstructions of the in vivo recordings, mice were not perfused; rather, brains were extracted from the skull, post-fixed in 4% PFA overnight at 4°C and afterwards cut with a vibratome (Leica Microsystems, Wetzlar Germany) in 100 μM thick sequential sagittal slices. Images were taken using a 1.25x objective and stitched together using the microscope software (BX61, Olympus). Afterwards, we used AllenCCF code <ext-link ext-link-type="uri" xlink:href="https://github.com/cortex-lab/allenCCF">https://github.com/cortex-lab/allenCCF</ext-link>; <xref ref-type="bibr" rid="bib25">Filippo, 2021d</xref>; copy archived at <ext-link ext-link-type="uri" xlink:href="https://archive.softwareheritage.org/swh:1:dir:f272cb5c5c9014d76e0b323460daf339921a8b46;origin=https://github.com/cortex-lab/allenCCF;visit=swh:1:snp:875bc4274cde98b95f285e107453145809f253da;anchor=swh:1:rev:80fb1326ccaf6ae765944173c7465f650adebabe/">swh:1:rev:80fb1326ccaf6ae765944173c7465f650adebabe</ext-link>, to identify electrode shank location (<xref ref-type="bibr" rid="bib90">Shamash et al., 2018</xref>).</p><p>For the anatomical reconstructions of recorded cells in vitro, brain slices were fixed with 4% paraformaldehyde in 0.1 M phosphate buffer (PB) for at least 24 hr at 4°C. After being washed three times in 0.1 M PBS, slices were then incubated in PBS containing 1% Triton X-100% and 5% normal goat serum for 4 hr at room temperature (RT). To visualize biocytin-filled cells we used Streptavidin Alexa 488 conjugate (1:500, Invitrogen Corporation, Carlsbad, CA, RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2315383">AB_2315383</ext-link>). WFS1 (1:1000, Rabbit, Proteintech, IL, USA, RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2880717">AB_2880717</ext-link>) was used in a subset of experiments to visualize the L2/L3 border, and Sst (1:1000, Rat, Bachem, Switzerland, RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2890072">AB_2890072</ext-link>) was used in the 5-HT<sub>2A</sub>R localization analysis. Slices were incubated with primary antibodies for 48 hr at RT. After rinsing two times in PBS, sections were incubated in the PBS solution containing 0.5% Triton X-100, Alexa fluor 488, Alexa fluor 555 and Alexa fluor 647 (Invitrogen Corporation, Carlsbad, CA) according to the number of antibodies used. Slices were mounted in Fluoroshield (Sigma-Aldrich) under coverslips 2–3 hr after incubation with the secondary antibodies and stored at 4°C.</p><p>Labeled cells were visualized using 20x or 40x objectives on a confocal microscope system (SP8, Leica, RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_018169">SCR_018169</ext-link>). For the 5-HT<sub>2A</sub>R localization analysis, images of the whole EC were acquired and stitched together using the auto stitching method, without smoothing. Z stacks were acquired every 30 µM. The image stacks obtained were registered and combined in Fiji (RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_002285">SCR_002285</ext-link>) to form a montage of the sections. Cell counting was executed using the Fiji multi-point tool. X-Y-Z coordinates of each 5-HT<sub>2A</sub>R-EGFP-positive cell were exported to Matlab and subsequently, using custom written code in Matlab, we semi-automatically inspected each cell for colocalization between EGFP(5-HT<sub>2A</sub>R) and Sst.</p></sec><sec id="s4-12"><title>Statistical analysis</title><p>All datasets were tested to determine normality of the distribution either using D’Agostino-Pearson omnibus normality test or Shapiro-Wilk normality test. Student’s t-test and one-way ANOVA were used for testing mean differences in normally distributed data. Wilcoxon matched-pairs signed rank test and Kruskal-Wallis were used for non-normally distributed datasets. Dunn-Sidak multiple comparison test was used to compare datasets with three or more groups. Kolmogorov-Smirnov test was used to compare cumulative distributions. Statistical analysis was performed using Prism (6.01, RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_002798">SCR_002798</ext-link>) and Matlab. All data are expressed as mean ± SEM. Asterisks in figures represent p-values smaller than 0.05, unless stated otherwise in the legend.</p></sec></sec></body><back><sec id="s5" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Data curation, Software, Formal analysis, Investigation, Visualization, Writing - original draft, Project administration, Writing - review and editing</p></fn><fn fn-type="con" id="con2"><p>Conceptualization, Resources, Methodology, Writing - review and editing</p></fn><fn fn-type="con" id="con3"><p>Investigation, Writing - review and editing</p></fn><fn fn-type="con" id="con4"><p>Investigation, Writing - review and editing</p></fn><fn fn-type="con" id="con5"><p>Resources, Methodology, Writing - review and editing</p></fn><fn fn-type="con" id="con6"><p>Resources, Writing - review and editing</p></fn><fn fn-type="con" id="con7"><p>Conceptualization, Supervision, Investigation, Methodology, Writing - review and editing</p></fn><fn fn-type="con" id="con8"><p>Conceptualization, Resources, Supervision, Funding acquisition, Writing - original draft, Writing - review and editing</p></fn></fn-group></sec><sec id="s6" sec-type="supplementary-material"><title>Additional files</title><supplementary-material id="transrepform"><label>Transparent reporting form</label><media mime-subtype="pdf" mimetype="application" xlink:href="elife-66960-transrepform-v2.pdf"/></supplementary-material></sec><sec id="s7" sec-type="data-availability"><title>Data availability</title><p>A database for the <italic>in vivo</italic> data is available at <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.6084/m9.figshare.14229545">http://dx.doi.org/10.6084/m9.figshare.14229545</ext-link>. Custom code used for the analysis is available at <ext-link ext-link-type="uri" xlink:href="https://github.com/Schmitz-lab/De-Filippo-et-al-2021">https://github.com/Schmitz-lab/De-Filippo-et-al-2021</ext-link> (copy archived at <ext-link ext-link-type="uri" xlink:href="https://archive.softwareheritage.org/swh:1:rev:eda027f20c4f267762bc46c47f976fff49a0aa84/">https://archive.softwareheritage.org/swh:1:rev:eda027f20c4f267762bc46c47f976fff49a0aa84/</ext-link>). Code used for spike sorting is available at <ext-link ext-link-type="uri" xlink:href="https://github.com/MouseLand/Kilosort2">https://github.com/MouseLand/Kilosort2</ext-link> (copy archived at <ext-link ext-link-type="uri" xlink:href="https://archive.softwareheritage.org/swh:1:rev:a1fccd9abf13ce5dc3340fae8050f9b1d0f8ab7a/">https://archive.softwareheritage.org/swh:1:rev:a1fccd9abf13ce5dc3340fae8050f9b1d0f8ab7a/</ext-link>). Code used for manual curation of sorted spikes is available at <ext-link ext-link-type="uri" xlink:href="https://github.com/cortex-lab/phy">https://github.com/cortex-lab/phy</ext-link> (copy archived at <ext-link ext-link-type="uri" xlink:href="https://archive.softwareheritage.org/swh:1:rev:6ffe05a559bd0302e98ec60d5958ace719544713/">https://archive.softwareheritage.org/swh:1:rev:6ffe05a559bd0302e98ec60d5958ace719544713/</ext-link>). Code used to estimate neuronal connectivity is available at <ext-link ext-link-type="uri" xlink:href="https://github.com/biomemsLAB/TSPE">https://github.com/biomemsLAB/TSPE</ext-link> (copy archived at <ext-link ext-link-type="uri" xlink:href="https://archive.softwareheritage.org/swh:1:rev:b780c753039a2f48201a6bb77dd8f5e65551a845/">https://archive.softwareheritage.org/swh:1:rev:b780c753039a2f48201a6bb77dd8f5e65551a845/</ext-link>).</p><p>The following dataset was generated:</p><p><element-citation id="dataset1" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><name><surname>de</surname><given-names>Filippo R</given-names></name></person-group><year iso-8601-date="2021">2021</year><data-title>Somatostatin interneurons activated by 5-HT2A receptor suppress slow oscillations in medial entorhinal cortex</data-title><source>figshare</source><pub-id assigning-authority="figshare" pub-id-type="doi">10.6084/m9.figshare.14229545</pub-id></element-citation></p></sec><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abi-Saab</surname> <given-names>WM</given-names></name><name><surname>Bubser</surname> <given-names>M</given-names></name><name><surname>Roth</surname> <given-names>RH</given-names></name><name><surname>Deutch</surname> <given-names>AY</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>5-HT2 receptor regulation of extracellular GABA levels in the prefrontal cortex</article-title><source>Neuropsychopharmacology</source><volume>20</volume><fpage>92</fpage><lpage>96</lpage><pub-id pub-id-type="doi">10.1016/S0893-133X(98)00046-3</pub-id><pub-id pub-id-type="pmid">9885788</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adesnik</surname> <given-names>H</given-names></name><name><surname>Bruns</surname> <given-names>W</given-names></name><name><surname>Taniguchi</surname> <given-names>H</given-names></name><name><surname>Huang</surname> <given-names>ZJ</given-names></name><name><surname>Scanziani</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>A neural circuit for spatial summation in visual cortex</article-title><source>Nature</source><volume>490</volume><fpage>226</fpage><lpage>231</lpage><pub-id pub-id-type="doi">10.1038/nature11526</pub-id><pub-id pub-id-type="pmid">23060193</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Antoine</surname> <given-names>MW</given-names></name><name><surname>Langberg</surname> <given-names>T</given-names></name><name><surname>Schnepel</surname> <given-names>P</given-names></name><name><surname>Feldman</surname> <given-names>DE</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Increased Excitation-Inhibition ratio stabilizes synapse and circuit excitability in four autism mouse models</article-title><source>Neuron</source><volume>101</volume><fpage>648</fpage><lpage>661</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2018.12.026</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Armbruster</surname> <given-names>BN</given-names></name><name><surname>Li</surname> <given-names>X</given-names></name><name><surname>Pausch</surname> <given-names>MH</given-names></name><name><surname>Herlitze</surname> <given-names>S</given-names></name><name><surname>Roth</surname> <given-names>BL</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Evolving the lock to fit the key to create a family of G protein-coupled receptors potently activated by an inert ligand</article-title><source>PNAS</source><volume>104</volume><fpage>5163</fpage><lpage>5168</lpage><pub-id pub-id-type="doi">10.1073/pnas.0700293104</pub-id><pub-id pub-id-type="pmid">17360345</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ashby</surname> <given-names>CR</given-names></name><name><surname>Jiang</surname> <given-names>LH</given-names></name><name><surname>Kasser</surname> <given-names>RJ</given-names></name><name><surname>Wang</surname> <given-names>RY</given-names></name></person-group><year iso-8601-date="1990">1990</year><article-title>Electrophysiological characterization of 5-hydroxytryptamine2 receptors in the rat medial prefrontal cortex</article-title><source>The Journal of Pharmacology and Experimental Therapeutics</source><volume>252</volume><fpage>171</fpage><lpage>178</lpage><pub-id pub-id-type="pmid">2137174</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Athilingam</surname> <given-names>JC</given-names></name><name><surname>Ben-Shalom</surname> <given-names>R</given-names></name><name><surname>Keeshen</surname> <given-names>CM</given-names></name><name><surname>Sohal</surname> <given-names>VS</given-names></name><name><surname>Bender</surname> <given-names>KJ</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Serotonin enhances excitability and gamma frequency temporal integration in mouse prefrontal fast-spiking interneurons</article-title><source>eLife</source><volume>6</volume><elocation-id>e31991</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.31991</pub-id><pub-id pub-id-type="pmid">29206101</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Azimi</surname> <given-names>Z</given-names></name><name><surname>Barzan</surname> <given-names>R</given-names></name><name><surname>Spoida</surname> <given-names>K</given-names></name><name><surname>Surdin</surname> <given-names>T</given-names></name><name><surname>Wollenweber</surname> <given-names>P</given-names></name><name><surname>Mark</surname> <given-names>MD</given-names></name><name><surname>Herlitze</surname> <given-names>S</given-names></name><name><surname>Jancke</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Separable gain control of ongoing and evoked activity in the visual cortex by serotonergic input</article-title><source>eLife</source><volume>9</volume><elocation-id>e53552</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.53552</pub-id><pub-id pub-id-type="pmid">32252889</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barthó</surname> <given-names>P</given-names></name><name><surname>Hirase</surname> <given-names>H</given-names></name><name><surname>Monconduit</surname> <given-names>L</given-names></name><name><surname>Zugaro</surname> <given-names>M</given-names></name><name><surname>Harris</surname> <given-names>KD</given-names></name><name><surname>Buzsáki</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Characterization of neocortical principal cells and interneurons by network interactions and extracellular features</article-title><source>Journal of Neurophysiology</source><volume>92</volume><fpage>600</fpage><lpage>608</lpage><pub-id pub-id-type="doi">10.1152/jn.01170.2003</pub-id><pub-id pub-id-type="pmid">15056678</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baumann</surname> <given-names>MH</given-names></name><name><surname>Ayestas</surname> <given-names>MA</given-names></name><name><surname>Dersch</surname> <given-names>CM</given-names></name><name><surname>Brockington</surname> <given-names>A</given-names></name><name><surname>Rice</surname> <given-names>KC</given-names></name><name><surname>Rothman</surname> <given-names>RB</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Effects of phentermine and fenfluramine on extracellular dopamine and serotonin in rat nucleus accumbens: therapeutic implications</article-title><source>Synapse</source><volume>36</volume><fpage>102</fpage><lpage>113</lpage><pub-id pub-id-type="doi">10.1002/(SICI)1098-2396(200005)36:2&lt;102::AID-SYN3&gt;3.0.CO;2-#</pub-id><pub-id pub-id-type="pmid">10767057</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beed</surname> <given-names>P</given-names></name><name><surname>de Filippo</surname> <given-names>R</given-names></name><name><surname>Holman</surname> <given-names>C</given-names></name><name><surname>Johenning</surname> <given-names>FW</given-names></name><name><surname>Leibold</surname> <given-names>C</given-names></name><name><surname>Caputi</surname> <given-names>A</given-names></name><name><surname>Monyer</surname> <given-names>H</given-names></name><name><surname>Schmitz</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Layer 3 pyramidal cells in the medial entorhinal cortex orchestrate Up-Down states and entrain the deep layers differentially</article-title><source>Cell Reports</source><volume>33</volume><elocation-id>108470</elocation-id><pub-id pub-id-type="doi">10.1016/j.celrep.2020.108470</pub-id><pub-id pub-id-type="pmid">33296656</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beierlein</surname> <given-names>M</given-names></name><name><surname>Gibson</surname> <given-names>JR</given-names></name><name><surname>Connors</surname> <given-names>BW</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Two dynamically distinct inhibitory networks in layer 4 of the neocortex</article-title><source>Journal of Neurophysiology</source><volume>90</volume><fpage>2987</fpage><lpage>3000</lpage><pub-id pub-id-type="doi">10.1152/jn.00283.2003</pub-id><pub-id pub-id-type="pmid">12815025</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cardin</surname> <given-names>JA</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Functional flexibility in cortical circuits</article-title><source>Current Opinion in Neurobiology</source><volume>58</volume><fpage>175</fpage><lpage>180</lpage><pub-id pub-id-type="doi">10.1016/j.conb.2019.09.008</pub-id><pub-id pub-id-type="pmid">31585330</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carhart-Harris</surname> <given-names>RL</given-names></name><name><surname>Muthukumaraswamy</surname> <given-names>S</given-names></name><name><surname>Roseman</surname> <given-names>L</given-names></name><name><surname>Kaelen</surname> <given-names>M</given-names></name><name><surname>Droog</surname> <given-names>W</given-names></name><name><surname>Murphy</surname> <given-names>K</given-names></name><name><surname>Tagliazucchi</surname> <given-names>E</given-names></name><name><surname>Schenberg</surname> <given-names>EE</given-names></name><name><surname>Nest</surname> <given-names>T</given-names></name><name><surname>Orban</surname> <given-names>C</given-names></name><name><surname>Leech</surname> <given-names>R</given-names></name><name><surname>Williams</surname> <given-names>LT</given-names></name><name><surname>Williams</surname> <given-names>TM</given-names></name><name><surname>Bolstridge</surname> <given-names>M</given-names></name><name><surname>Sessa</surname> <given-names>B</given-names></name><name><surname>McGonigle</surname> <given-names>J</given-names></name><name><surname>Sereno</surname> <given-names>MI</given-names></name><name><surname>Nichols</surname> <given-names>D</given-names></name><name><surname>Hellyer</surname> <given-names>PJ</given-names></name><name><surname>Hobden</surname> <given-names>P</given-names></name><name><surname>Evans</surname> <given-names>J</given-names></name><name><surname>Singh</surname> <given-names>KD</given-names></name><name><surname>Wise</surname> <given-names>RG</given-names></name><name><surname>Curran</surname> <given-names>HV</given-names></name><name><surname>Feilding</surname> <given-names>A</given-names></name><name><surname>Nutt</surname> <given-names>DJ</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Neural correlates of the LSD experience revealed by multimodal neuroimaging</article-title><source>PNAS</source><volume>113</volume><fpage>4853</fpage><lpage>4858</lpage><pub-id pub-id-type="doi">10.1073/pnas.1518377113</pub-id><pub-id pub-id-type="pmid">27071089</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carhart-Harris</surname> <given-names>RL</given-names></name><name><surname>Friston</surname> <given-names>KJ</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>REBUS and the anarchic brain: toward a unified model of the brain action of psychedelics</article-title><source>Pharmacological Reviews</source><volume>71</volume><fpage>316</fpage><lpage>344</lpage><pub-id pub-id-type="doi">10.1124/pr.118.017160</pub-id><pub-id pub-id-type="pmid">31221820</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chalmers</surname> <given-names>DT</given-names></name><name><surname>Watson</surname> <given-names>SJ</given-names></name></person-group><year iso-8601-date="1991">1991</year><article-title>Comparative anatomical distribution of 5-HT1A receptor mRNA and 5-HT1A binding in rat brain--a combined in situ hybridisation/in vitro receptor autoradiographic study</article-title><source>Brain Research</source><volume>561</volume><fpage>51</fpage><lpage>60</lpage><pub-id pub-id-type="doi">10.1016/0006-8993(91)90748-K</pub-id><pub-id pub-id-type="pmid">1797349</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname> <given-names>N</given-names></name><name><surname>Sugihara</surname> <given-names>H</given-names></name><name><surname>Sur</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>An acetylcholine-activated microcircuit drives temporal dynamics of cortical activity</article-title><source>Nature Neuroscience</source><volume>18</volume><fpage>892</fpage><lpage>902</lpage><pub-id pub-id-type="doi">10.1038/nn.4002</pub-id><pub-id pub-id-type="pmid">25915477</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Craig</surname> <given-names>MT</given-names></name><name><surname>Mayne</surname> <given-names>EW</given-names></name><name><surname>Bettler</surname> <given-names>B</given-names></name><name><surname>Paulsen</surname> <given-names>O</given-names></name><name><surname>McBain</surname> <given-names>CJ</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Distinct roles of GABAB1a- and GABAB1b-containing GABAB receptors in spontaneous and evoked termination of persistent cortical activity</article-title><source>The Journal of Physiology</source><volume>591</volume><fpage>835</fpage><lpage>843</lpage><pub-id pub-id-type="doi">10.1113/jphysiol.2012.248088</pub-id><pub-id pub-id-type="pmid">23266934</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Blasi</surname> <given-names>S</given-names></name><name><surname>Ciba</surname> <given-names>M</given-names></name><name><surname>Bahmer</surname> <given-names>A</given-names></name><name><surname>Thielemann</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Total spiking probability edges: a cross-correlation based method for effective connectivity estimation of cortical spiking neurons</article-title><source>Journal of Neuroscience Methods</source><volume>312</volume><fpage>169</fpage><lpage>181</lpage><pub-id pub-id-type="doi">10.1016/j.jneumeth.2018.11.013</pub-id><pub-id pub-id-type="pmid">30500352</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Descarries</surname> <given-names>L</given-names></name><name><surname>Riad</surname> <given-names>M</given-names></name><name><surname>Parent</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2010">2010</year><chapter-title>CHAPTER 1.4 - Ultrastructure of the Serotonin Innervation in the Mammalian Central Nervous System</chapter-title><person-group person-group-type="editor"><name><surname>Müller</surname> <given-names>CP</given-names></name><name><surname>Jacobs</surname> <given-names>BL</given-names></name></person-group><source>Handbook of Behavioral Neuroscience</source><publisher-loc>Amsterdam, Netherlands</publisher-loc><publisher-name>Elsevier</publisher-name><fpage>65</fpage><lpage>101</lpage><pub-id pub-id-type="doi">10.1016/S1569-7339(10)70072-2</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Desikan</surname> <given-names>S</given-names></name><name><surname>Koser</surname> <given-names>DE</given-names></name><name><surname>Neitz</surname> <given-names>A</given-names></name><name><surname>Monyer</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Target selectivity of septal cholinergic neurons in the medial and lateral entorhinal cortex</article-title><source>PNAS</source><volume>115</volume><fpage>E2644</fpage><lpage>E2652</lpage><pub-id pub-id-type="doi">10.1073/pnas.1716531115</pub-id><pub-id pub-id-type="pmid">29487212</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fanselow</surname> <given-names>EE</given-names></name><name><surname>Richardson</surname> <given-names>KA</given-names></name><name><surname>Connors</surname> <given-names>BW</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Selective, state-dependent activation of somatostatin-expressing inhibitory interneurons in mouse neocortex</article-title><source>Journal of Neurophysiology</source><volume>100</volume><fpage>2640</fpage><lpage>2652</lpage><pub-id pub-id-type="doi">10.1152/jn.90691.2008</pub-id><pub-id pub-id-type="pmid">18799598</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="software"><person-group person-group-type="author"><name><surname>Filippo</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2021">2021a</year><data-title>Kilosort</data-title><source>Software Heritage</source><version designator="swh:1:rev:a1fccd9abf13ce5dc3340fae8050f9b1d0f8ab7a">swh:1:rev:a1fccd9abf13ce5dc3340fae8050f9b1d0f8ab7a</version><ext-link ext-link-type="uri" xlink:href="https://archive.softwareheritage.org/swh:1:dir:c5206cc562377ff7d70825a0458997a2e980b30a;origin=https://github.com/MouseLand/Kilosort2;visit=swh:1:snp:0d6db4f974bbe0a3f7f659935f39197e88299b36;anchor=swh:1:rev:a1fccd9abf13ce5dc3340fae8050f9b1d0f8ab7a/">https://archive.softwareheritage.org/swh:1:dir:c5206cc562377ff7d70825a0458997a2e980b30a;origin=https://github.com/MouseLand/Kilosort2;visit=swh:1:snp:0d6db4f974bbe0a3f7f659935f39197e88299b36;anchor=swh:1:rev:a1fccd9abf13ce5dc3340fae8050f9b1d0f8ab7a/</ext-link></element-citation></ref><ref id="bib23"><element-citation publication-type="software"><person-group person-group-type="author"><name><surname>Filippo</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2021">2021b</year><data-title>phy</data-title><source>Software Heritage</source><version designator="swh:1:rev:6ffe05a559bd0302e98ec60d5958ace719544713">swh:1:rev:6ffe05a559bd0302e98ec60d5958ace719544713</version><ext-link ext-link-type="uri" xlink:href="https://archive.softwareheritage.org/swh:1:dir:3d51c829949d8ba8fa0a36bc5928f58ce1e157d8;origin=https://github.com/cortex-lab/phy;visit=swh:1:snp:d7f54c7694780300cff1fb7e427eb4f7632ce801;anchor=swh:1:rev:6ffe05a559bd0302e98ec60d5958ace719544713/">https://archive.softwareheritage.org/swh:1:dir:3d51c829949d8ba8fa0a36bc5928f58ce1e157d8;origin=https://github.com/cortex-lab/phy;visit=swh:1:snp:d7f54c7694780300cff1fb7e427eb4f7632ce801;anchor=swh:1:rev:6ffe05a559bd0302e98ec60d5958ace719544713/</ext-link></element-citation></ref><ref id="bib24"><element-citation publication-type="software"><person-group person-group-type="author"><name><surname>Filippo</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2021">2021c</year><data-title>TSPE</data-title><source>Software Heritage</source><version designator="swh:1:rev:b780c753039a2f48201a6bb77dd8f5e65551a845">swh:1:rev:b780c753039a2f48201a6bb77dd8f5e65551a845</version><ext-link ext-link-type="uri" xlink:href="https://archive.softwareheritage.org/swh:1:dir:bbb1f453ed0bddeba9cc2f1c0f49027a7e42db0b;origin=https://github.com/biomemsLAB/TSPE;visit=swh:1:snp:3e9a4e0c1e421de4e399f0b0d108dac66b06eaa5;anchor=swh:1:rev:b780c753039a2f48201a6bb77dd8f5e65551a845/">https://archive.softwareheritage.org/swh:1:dir:bbb1f453ed0bddeba9cc2f1c0f49027a7e42db0b;origin=https://github.com/biomemsLAB/TSPE;visit=swh:1:snp:3e9a4e0c1e421de4e399f0b0d108dac66b06eaa5;anchor=swh:1:rev:b780c753039a2f48201a6bb77dd8f5e65551a845/</ext-link></element-citation></ref><ref id="bib25"><element-citation publication-type="software"><person-group person-group-type="author"><name><surname>Filippo</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2021">2021d</year><data-title>allenCCF</data-title><source>Software Heritage</source><version designator="swh:1:rev:80fb1326ccaf6ae765944173c7465f650adebabe">swh:1:rev:80fb1326ccaf6ae765944173c7465f650adebabe</version><ext-link ext-link-type="uri" xlink:href="https://archive.softwareheritage.org/swh:1:dir:f272cb5c5c9014d76e0b323460daf339921a8b46;origin=https://github.com/cortex-lab/allenCCF;visit=swh:1:snp:875bc4274cde98b95f285e107453145809f253da;anchor=swh:1:rev:80fb1326ccaf6ae765944173c7465f650adebabe/">https://archive.softwareheritage.org/swh:1:dir:f272cb5c5c9014d76e0b323460daf339921a8b46;origin=https://github.com/cortex-lab/allenCCF;visit=swh:1:snp:875bc4274cde98b95f285e107453145809f253da;anchor=swh:1:rev:80fb1326ccaf6ae765944173c7465f650adebabe/</ext-link></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frei</surname> <given-names>E</given-names></name><name><surname>Gamma</surname> <given-names>A</given-names></name><name><surname>Pascual-Marqui</surname> <given-names>R</given-names></name><name><surname>Lehmann</surname> <given-names>D</given-names></name><name><surname>Hell</surname> <given-names>D</given-names></name><name><surname>Vollenweider</surname> <given-names>FX</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Localization of MDMA-induced brain activity in healthy volunteers using low resolution brain electromagnetic tomography (LORETA)</article-title><source>Human Brain Mapping</source><volume>14</volume><fpage>152</fpage><lpage>165</lpage><pub-id pub-id-type="doi">10.1002/hbm.1049</pub-id><pub-id pub-id-type="pmid">11559960</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Funk</surname> <given-names>CM</given-names></name><name><surname>Peelman</surname> <given-names>K</given-names></name><name><surname>Bellesi</surname> <given-names>M</given-names></name><name><surname>Marshall</surname> <given-names>W</given-names></name><name><surname>Cirelli</surname> <given-names>C</given-names></name><name><surname>Tononi</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Role of Somatostatin-Positive cortical interneurons in the generation of sleep slow waves</article-title><source>The Journal of Neuroscience</source><volume>37</volume><fpage>9132</fpage><lpage>9148</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.1303-17.2017</pub-id><pub-id pub-id-type="pmid">28821651</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gibson</surname> <given-names>JR</given-names></name><name><surname>Beierlein</surname> <given-names>M</given-names></name><name><surname>Connors</surname> <given-names>BW</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Two networks of electrically coupled inhibitory neurons in neocortex</article-title><source>Nature</source><volume>402</volume><fpage>75</fpage><lpage>79</lpage><pub-id pub-id-type="doi">10.1038/47035</pub-id><pub-id pub-id-type="pmid">10573419</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gorinski</surname> <given-names>N</given-names></name><name><surname>Bijata</surname> <given-names>M</given-names></name><name><surname>Prasad</surname> <given-names>S</given-names></name><name><surname>Wirth</surname> <given-names>A</given-names></name><name><surname>Abdel Galil</surname> <given-names>D</given-names></name><name><surname>Zeug</surname> <given-names>A</given-names></name><name><surname>Bazovkina</surname> <given-names>D</given-names></name><name><surname>Kondaurova</surname> <given-names>E</given-names></name><name><surname>Kulikova</surname> <given-names>E</given-names></name><name><surname>Ilchibaeva</surname> <given-names>T</given-names></name><name><surname>Zareba-Koziol</surname> <given-names>M</given-names></name><name><surname>Papaleo</surname> <given-names>F</given-names></name><name><surname>Scheggia</surname> <given-names>D</given-names></name><name><surname>Kochlamazashvili</surname> <given-names>G</given-names></name><name><surname>Dityatev</surname> <given-names>A</given-names></name><name><surname>Smyth</surname> <given-names>I</given-names></name><name><surname>Krzystyniak</surname> <given-names>A</given-names></name><name><surname>Wlodarczyk</surname> <given-names>J</given-names></name><name><surname>Richter</surname> <given-names>DW</given-names></name><name><surname>Strekalova</surname> <given-names>T</given-names></name><name><surname>Sigrist</surname> <given-names>S</given-names></name><name><surname>Bang</surname> <given-names>C</given-names></name><name><surname>Hobuß</surname> <given-names>L</given-names></name><name><surname>Fiedler</surname> <given-names>J</given-names></name><name><surname>Thum</surname> <given-names>T</given-names></name><name><surname>Naumenko</surname> <given-names>VS</given-names></name><name><surname>Pandey</surname> <given-names>G</given-names></name><name><surname>Ponimaskin</surname> <given-names>E</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Attenuated palmitoylation of serotonin receptor 5-HT1A affects receptor function and contributes to depression-like behaviors</article-title><source>Nature Communications</source><volume>10</volume><elocation-id>3924</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-019-11876-5</pub-id><pub-id pub-id-type="pmid">31477731</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grandjean</surname> <given-names>J</given-names></name><name><surname>Corcoba</surname> <given-names>A</given-names></name><name><surname>Kahn</surname> <given-names>MC</given-names></name><name><surname>Upton</surname> <given-names>AL</given-names></name><name><surname>Deneris</surname> <given-names>ES</given-names></name><name><surname>Seifritz</surname> <given-names>E</given-names></name><name><surname>Helmchen</surname> <given-names>F</given-names></name><name><surname>Mann</surname> <given-names>EO</given-names></name><name><surname>Rudin</surname> <given-names>M</given-names></name><name><surname>Saab</surname> <given-names>BJ</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>A brain-wide functional map of the serotonergic responses to acute stress and fluoxetine</article-title><source>Nature Communications</source><volume>10</volume><elocation-id>350</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-018-08256-w</pub-id><pub-id pub-id-type="pmid">30664643</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Green</surname> <given-names>AR</given-names></name><name><surname>Mechan</surname> <given-names>AO</given-names></name><name><surname>Elliott</surname> <given-names>JM</given-names></name><name><surname>O'Shea</surname> <given-names>E</given-names></name><name><surname>Colado</surname> <given-names>MI</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, &quot;ecstasy&quot;)</article-title><source>Pharmacological Reviews</source><volume>55</volume><fpage>463</fpage><lpage>508</lpage><pub-id pub-id-type="doi">10.1124/pr.55.3.3</pub-id><pub-id pub-id-type="pmid">12869661</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hardebo</surname> <given-names>JE</given-names></name><name><surname>Owman</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="1980">1980</year><article-title>Barrier mechanisms for neurotransmitter monoamines and their precursors at the blood-brain interface</article-title><source>Annals of Neurology</source><volume>8</volume><fpage>1</fpage><lpage>11</lpage><pub-id pub-id-type="doi">10.1002/ana.410080102</pub-id><pub-id pub-id-type="pmid">6105837</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hardy</surname> <given-names>A</given-names></name><name><surname>Palouzier-Paulignan</surname> <given-names>B</given-names></name><name><surname>Duchamp</surname> <given-names>A</given-names></name><name><surname>Royet</surname> <given-names>JP</given-names></name><name><surname>Duchamp-Viret</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>5-Hydroxytryptamine action in the rat olfactory bulb: in vitro electrophysiological patch-clamp recordings of juxtaglomerular and mitral cells</article-title><source>Neuroscience</source><volume>131</volume><fpage>717</fpage><lpage>731</lpage><pub-id pub-id-type="doi">10.1016/j.neuroscience.2004.10.034</pub-id><pub-id pub-id-type="pmid">15730876</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harris</surname> <given-names>KD</given-names></name><name><surname>Thiele</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Cortical state and attention</article-title><source>Nature Reviews Neuroscience</source><volume>12</volume><fpage>509</fpage><lpage>523</lpage><pub-id pub-id-type="doi">10.1038/nrn3084</pub-id><pub-id pub-id-type="pmid">21829219</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heifets</surname> <given-names>BD</given-names></name><name><surname>Salgado</surname> <given-names>JS</given-names></name><name><surname>Taylor</surname> <given-names>MD</given-names></name><name><surname>Hoerbelt</surname> <given-names>P</given-names></name><name><surname>Cardozo Pinto</surname> <given-names>DF</given-names></name><name><surname>Steinberg</surname> <given-names>EE</given-names></name><name><surname>Walsh</surname> <given-names>JJ</given-names></name><name><surname>Sze</surname> <given-names>JY</given-names></name><name><surname>Malenka</surname> <given-names>RC</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Distinct neural mechanisms for the prosocial and rewarding properties of MDMA</article-title><source>Science Translational Medicine</source><volume>11</volume><elocation-id>eaaw6435</elocation-id><pub-id pub-id-type="doi">10.1126/scitranslmed.aaw6435</pub-id><pub-id pub-id-type="pmid">31826983</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hitz</surname> <given-names>C</given-names></name><name><surname>Wurst</surname> <given-names>W</given-names></name><name><surname>Kühn</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Conditional brain-specific knockdown of MAPK using cre/loxP regulated RNA interference</article-title><source>Nucleic Acids Research</source><volume>35</volume><elocation-id>e90</elocation-id><pub-id pub-id-type="doi">10.1093/nar/gkm475</pub-id><pub-id pub-id-type="pmid">17586814</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hitz</surname> <given-names>C</given-names></name><name><surname>Steuber-Buchberger</surname> <given-names>P</given-names></name><name><surname>Delic</surname> <given-names>S</given-names></name><name><surname>Wurst</surname> <given-names>W</given-names></name><name><surname>Kühn</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Generation of shRNA transgenic mice</article-title><source>Methods in Molecular Biology</source><volume>530</volume><fpage>101</fpage><lpage>129</lpage><pub-id pub-id-type="doi">10.1007/978-1-59745-471-1_6</pub-id><pub-id pub-id-type="pmid">19266327</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname> <given-names>CC</given-names></name><name><surname>Liang</surname> <given-names>YC</given-names></name><name><surname>Lee</surname> <given-names>CC</given-names></name><name><surname>Wu</surname> <given-names>MY</given-names></name><name><surname>Hsu</surname> <given-names>KS</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Repeated cocaine administration decreases 5-HT(2A) receptor-mediated serotonergic enhancement of synaptic activity in rat medial prefrontal cortex</article-title><source>Neuropsychopharmacology</source><volume>34</volume><fpage>1979</fpage><lpage>1992</lpage><pub-id pub-id-type="doi">10.1038/npp.2009.10</pub-id><pub-id pub-id-type="pmid">19212317</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Inserra</surname> <given-names>A</given-names></name><name><surname>De Gregorio</surname> <given-names>D</given-names></name><name><surname>Gobbi</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Psychedelics in psychiatry: neuroplastic, immunomodulatory, and neurotransmitter mechanisms</article-title><source>Pharmacological Reviews</source><volume>73</volume><fpage>202</fpage><lpage>277</lpage><pub-id pub-id-type="doi">10.1124/pharmrev.120.000056</pub-id><pub-id pub-id-type="pmid">33328244</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Isomura</surname> <given-names>Y</given-names></name><name><surname>Sirota</surname> <given-names>A</given-names></name><name><surname>Ozen</surname> <given-names>S</given-names></name><name><surname>Montgomery</surname> <given-names>S</given-names></name><name><surname>Mizuseki</surname> <given-names>K</given-names></name><name><surname>Henze</surname> <given-names>DA</given-names></name><name><surname>Buzsáki</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Integration and segregation of activity in entorhinal-hippocampal subregions by neocortical slow oscillations</article-title><source>Neuron</source><volume>52</volume><fpage>871</fpage><lpage>882</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2006.10.023</pub-id><pub-id pub-id-type="pmid">17145507</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaur</surname> <given-names>S</given-names></name><name><surname>Junek</surname> <given-names>A</given-names></name><name><surname>Black</surname> <given-names>MA</given-names></name><name><surname>Semba</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Effects of ibotenate and 192IgG-saporin lesions of the nucleus basalis magnocellularis/substantia innominata on spontaneous sleep and wake states and on recovery sleep after sleep deprivation in rats</article-title><source>Journal of Neuroscience</source><volume>28</volume><fpage>491</fpage><lpage>504</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.1585-07.2008</pub-id><pub-id pub-id-type="pmid">18184792</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kawaguchi</surname> <given-names>Y</given-names></name><name><surname>Kubota</surname> <given-names>Y</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Neurochemical features and synaptic connections of large physiologically-identified GABAergic cells in the rat frontal cortex</article-title><source>Neuroscience</source><volume>85</volume><fpage>677</fpage><lpage>701</lpage><pub-id pub-id-type="doi">10.1016/S0306-4522(97)00685-4</pub-id><pub-id pub-id-type="pmid">9639265</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kometer</surname> <given-names>M</given-names></name><name><surname>Pokorny</surname> <given-names>T</given-names></name><name><surname>Seifritz</surname> <given-names>E</given-names></name><name><surname>Volleinweider</surname> <given-names>FX</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Psilocybin-induced spiritual experiences and insightfulness are associated with synchronization of neuronal oscillations</article-title><source>Psychopharmacology</source><volume>232</volume><fpage>3663</fpage><lpage>3676</lpage><pub-id pub-id-type="doi">10.1007/s00213-015-4026-7</pub-id><pub-id pub-id-type="pmid">26231498</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krishnamurthy</surname> <given-names>P</given-names></name><name><surname>Silberberg</surname> <given-names>G</given-names></name><name><surname>Lansner</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>A cortical attractor network with martinotti cells driven by facilitating synapses</article-title><source>PLOS ONE</source><volume>7</volume><elocation-id>e30752</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0030752</pub-id><pub-id pub-id-type="pmid">22523533</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuypers</surname> <given-names>KPC</given-names></name><name><surname>de la Torre</surname> <given-names>R</given-names></name><name><surname>Farre</surname> <given-names>M</given-names></name><name><surname>Pizarro</surname> <given-names>N</given-names></name><name><surname>Xicota</surname> <given-names>L</given-names></name><name><surname>Ramaekers</surname> <given-names>JG</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>MDMA-induced indifference to negative sounds is mediated by the 5-HT<sub>2A</sub> receptor</article-title><source>Psychopharmacology</source><volume>235</volume><fpage>481</fpage><lpage>490</lpage><pub-id pub-id-type="doi">10.1007/s00213-017-4699-1</pub-id><pub-id pub-id-type="pmid">28735368</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kvitsiani</surname> <given-names>D</given-names></name><name><surname>Ranade</surname> <given-names>S</given-names></name><name><surname>Hangya</surname> <given-names>B</given-names></name><name><surname>Taniguchi</surname> <given-names>H</given-names></name><name><surname>Huang</surname> <given-names>JZ</given-names></name><name><surname>Kepecs</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Distinct behavioural and network correlates of two interneuron types in prefrontal cortex</article-title><source>Nature</source><volume>498</volume><fpage>363</fpage><lpage>366</lpage><pub-id pub-id-type="doi">10.1038/nature12176</pub-id><pub-id pub-id-type="pmid">23708967</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lansbergen</surname> <given-names>MM</given-names></name><name><surname>Dumont</surname> <given-names>GJ</given-names></name><name><surname>van Gerven</surname> <given-names>JM</given-names></name><name><surname>Buitelaar</surname> <given-names>JK</given-names></name><name><surname>Verkes</surname> <given-names>RJ</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Acute effects of MDMA (3,4-methylenedioxymethamphetamine) on EEG oscillations: alone and in combination with ethanol or THC (delta-9-tetrahydrocannabinol)</article-title><source>Psychopharmacology</source><volume>213</volume><fpage>745</fpage><lpage>756</lpage><pub-id pub-id-type="doi">10.1007/s00213-010-2031-4</pub-id><pub-id pub-id-type="pmid">20924751</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname> <given-names>S-H</given-names></name><name><surname>Dan</surname> <given-names>Y</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Neuromodulation of brain states</article-title><source>Neuron</source><volume>76</volume><fpage>209</fpage><lpage>222</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2012.09.012</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lemieux</surname> <given-names>M</given-names></name><name><surname>Chauvette</surname> <given-names>S</given-names></name><name><surname>Timofeev</surname> <given-names>I</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Neocortical inhibitory activities and long-range afferents contribute to the synchronous onset of silent states of the neocortical slow oscillation</article-title><source>Journal of Neurophysiology</source><volume>113</volume><fpage>768</fpage><lpage>779</lpage><pub-id pub-id-type="doi">10.1152/jn.00858.2013</pub-id><pub-id pub-id-type="pmid">25392176</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liechti</surname> <given-names>ME</given-names></name><name><surname>Saur</surname> <given-names>MR</given-names></name><name><surname>Gamma</surname> <given-names>A</given-names></name><name><surname>Hell</surname> <given-names>D</given-names></name><name><surname>Vollenweider</surname> <given-names>FX</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Psychological and physiological effects of MDMA (&quot;Ecstasy&quot;) after pretreatment with the 5-HT(2) antagonist ketanserin in healthy humans</article-title><source>Neuropsychopharmacology</source><volume>23</volume><fpage>396</fpage><lpage>404</lpage><pub-id pub-id-type="doi">10.1016/S0893-133X(00)00126-3</pub-id><pub-id pub-id-type="pmid">10989266</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname> <given-names>LC</given-names></name><name><surname>Sibille</surname> <given-names>E</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Somatostatin, neuronal vulnerability and behavioral emotionality</article-title><source>Molecular Psychiatry</source><volume>20</volume><fpage>377</fpage><lpage>387</lpage><pub-id pub-id-type="doi">10.1038/mp.2014.184</pub-id><pub-id pub-id-type="pmid">25600109</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lottem</surname> <given-names>E</given-names></name><name><surname>Lörincz</surname> <given-names>ML</given-names></name><name><surname>Mainen</surname> <given-names>ZF</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Optogenetic activation of dorsal raphe serotonin neurons rapidly inhibits spontaneous but not Odor-Evoked activity in olfactory cortex</article-title><source>Journal of Neuroscience</source><volume>36</volume><fpage>7</fpage><lpage>18</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.3008-15.2016</pub-id><pub-id pub-id-type="pmid">26740645</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marek</surname> <given-names>GJ</given-names></name><name><surname>Carpenter</surname> <given-names>LL</given-names></name><name><surname>McDougle</surname> <given-names>CJ</given-names></name><name><surname>Price</surname> <given-names>LH</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Synergistic action of 5-HT2A antagonists and selective serotonin reuptake inhibitors in neuropsychiatric disorders</article-title><source>Neuropsychopharmacology</source><volume>28</volume><fpage>402</fpage><lpage>412</lpage><pub-id pub-id-type="doi">10.1038/sj.npp.1300057</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marek</surname> <given-names>GJ</given-names></name><name><surname>Aghajanian</surname> <given-names>GK</given-names></name></person-group><year iso-8601-date="1994">1994</year><article-title>Excitation of interneurons in piriform cortex by 5-hydroxytryptamine: blockade by MDL 100,907, a highly selective 5-HT2A receptor antagonist</article-title><source>European Journal of Pharmacology</source><volume>259</volume><fpage>137</fpage><lpage>141</lpage><pub-id pub-id-type="doi">10.1016/0014-2999(94)90502-9</pub-id><pub-id pub-id-type="pmid">7957607</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martin</surname> <given-names>DA</given-names></name><name><surname>Nichols</surname> <given-names>CD</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Psychedelics recruit multiple cellular types and produce complex transcriptional responses within the brain</article-title><source>EBioMedicine</source><volume>11</volume><fpage>262</fpage><lpage>277</lpage><pub-id pub-id-type="doi">10.1016/j.ebiom.2016.08.049</pub-id><pub-id pub-id-type="pmid">27649637</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mayne</surname> <given-names>EW</given-names></name><name><surname>Craig</surname> <given-names>MT</given-names></name><name><surname>McBain</surname> <given-names>CJ</given-names></name><name><surname>Paulsen</surname> <given-names>O</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Dopamine suppresses persistent network activity via D(1) -like dopamine receptors in rat medial entorhinal cortex</article-title><source>The European Journal of Neuroscience</source><volume>37</volume><fpage>1242</fpage><lpage>1247</lpage><pub-id pub-id-type="doi">10.1111/ejn.12125</pub-id><pub-id pub-id-type="pmid">23336973</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McGinty</surname> <given-names>DJ</given-names></name><name><surname>Harper</surname> <given-names>RM</given-names></name></person-group><year iso-8601-date="1976">1976</year><article-title>Dorsal raphe neurons: depression of firing during sleep in cats</article-title><source>Brain Research</source><volume>101</volume><fpage>569</fpage><lpage>575</lpage><pub-id pub-id-type="doi">10.1016/0006-8993(76)90480-7</pub-id><pub-id pub-id-type="pmid">1244990</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Melamed</surname> <given-names>O</given-names></name><name><surname>Barak</surname> <given-names>O</given-names></name><name><surname>Silberberg</surname> <given-names>G</given-names></name><name><surname>Markram</surname> <given-names>H</given-names></name><name><surname>Tsodyks</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Slow oscillations in neural networks with facilitating synapses</article-title><source>Journal of Computational Neuroscience</source><volume>25</volume><fpage>308</fpage><lpage>316</lpage><pub-id pub-id-type="doi">10.1007/s10827-008-0080-z</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meltzer</surname> <given-names>HY</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>The role of serotonin in antipsychotic drug action</article-title><source>Neuropsychopharmacology</source><volume>21</volume><fpage>106S</fpage><lpage>115</lpage><pub-id pub-id-type="doi">10.1016/S0893-133X(99)00046-9</pub-id><pub-id pub-id-type="pmid">10432496</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miao</surname> <given-names>C</given-names></name><name><surname>Cao</surname> <given-names>Q</given-names></name><name><surname>Moser</surname> <given-names>MB</given-names></name><name><surname>Moser</surname> <given-names>EI</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Parvalbumin and somatostatin interneurons control different Space-Coding networks in the medial entorhinal cortex</article-title><source>Cell</source><volume>171</volume><fpage>507</fpage><lpage>521</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2017.08.050</pub-id><pub-id pub-id-type="pmid">28965758</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Michaiel</surname> <given-names>AM</given-names></name><name><surname>Parker</surname> <given-names>PRL</given-names></name><name><surname>Niell</surname> <given-names>CM</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>A hallucinogenic Serotonin-2A receptor agonist reduces visual response gain and alters temporal dynamics in mouse V1</article-title><source>Cell Reports</source><volume>26</volume><fpage>3475</fpage><lpage>3483</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2019.02.104</pub-id><pub-id pub-id-type="pmid">30917304</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mithoefer</surname> <given-names>MC</given-names></name><name><surname>Feduccia</surname> <given-names>AA</given-names></name><name><surname>Jerome</surname> <given-names>L</given-names></name><name><surname>Mithoefer</surname> <given-names>A</given-names></name><name><surname>Wagner</surname> <given-names>M</given-names></name><name><surname>Walsh</surname> <given-names>Z</given-names></name><name><surname>Hamilton</surname> <given-names>S</given-names></name><name><surname>Yazar-Klosinski</surname> <given-names>B</given-names></name><name><surname>Emerson</surname> <given-names>A</given-names></name><name><surname>Doblin</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>MDMA-assisted psychotherapy for treatment of PTSD: study design and rationale for phase 3 trials based on pooled analysis of six phase 2 randomized controlled trials</article-title><source>Psychopharmacology</source><volume>236</volume><fpage>2735</fpage><lpage>2745</lpage><pub-id pub-id-type="doi">10.1007/s00213-019-05249-5</pub-id><pub-id pub-id-type="pmid">31065731</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murayama</surname> <given-names>M</given-names></name><name><surname>Pérez-Garci</surname> <given-names>E</given-names></name><name><surname>Nevian</surname> <given-names>T</given-names></name><name><surname>Bock</surname> <given-names>T</given-names></name><name><surname>Senn</surname> <given-names>W</given-names></name><name><surname>Larkum</surname> <given-names>ME</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Dendritic encoding of sensory stimuli controlled by deep cortical interneurons</article-title><source>Nature</source><volume>457</volume><fpage>1137</fpage><lpage>1141</lpage><pub-id pub-id-type="doi">10.1038/nature07663</pub-id><pub-id pub-id-type="pmid">19151696</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Muthukumaraswamy</surname> <given-names>SD</given-names></name><name><surname>Carhart-Harris</surname> <given-names>RL</given-names></name><name><surname>Moran</surname> <given-names>RJ</given-names></name><name><surname>Brookes</surname> <given-names>MJ</given-names></name><name><surname>Williams</surname> <given-names>TM</given-names></name><name><surname>Errtizoe</surname> <given-names>D</given-names></name><name><surname>Sessa</surname> <given-names>B</given-names></name><name><surname>Papadopoulos</surname> <given-names>A</given-names></name><name><surname>Bolstridge</surname> <given-names>M</given-names></name><name><surname>Singh</surname> <given-names>KD</given-names></name><name><surname>Feilding</surname> <given-names>A</given-names></name><name><surname>Friston</surname> <given-names>KJ</given-names></name><name><surname>Nutt</surname> <given-names>DJ</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Broadband cortical desynchronization underlies the human psychedelic state</article-title><source>Journal of Neuroscience</source><volume>33</volume><fpage>15171</fpage><lpage>15183</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.2063-13.2013</pub-id><pub-id pub-id-type="pmid">24048847</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Muzerelle</surname> <given-names>A</given-names></name><name><surname>Scotto-Lomassese</surname> <given-names>S</given-names></name><name><surname>Bernard</surname> <given-names>JF</given-names></name><name><surname>Soiza-Reilly</surname> <given-names>M</given-names></name><name><surname>Gaspar</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Conditional anterograde tracing reveals distinct targeting of individual serotonin cell groups (B5-B9) to the forebrain and brainstem</article-title><source>Brain Structure and Function</source><volume>221</volume><fpage>535</fpage><lpage>561</lpage><pub-id pub-id-type="doi">10.1007/s00429-014-0924-4</pub-id><pub-id pub-id-type="pmid">25403254</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Namiki</surname> <given-names>S</given-names></name><name><surname>Norimoto</surname> <given-names>H</given-names></name><name><surname>Kobayashi</surname> <given-names>C</given-names></name><name><surname>Nakatani</surname> <given-names>K</given-names></name><name><surname>Matsuki</surname> <given-names>N</given-names></name><name><surname>Ikegaya</surname> <given-names>Y</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Layer III neurons control synchronized waves in the immature cerebral cortex</article-title><source>Journal of Neuroscience</source><volume>33</volume><fpage>987</fpage><lpage>1001</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.2522-12.2013</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neske</surname> <given-names>GT</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>The slow oscillation in cortical and thalamic networks: mechanisms and functions</article-title><source>Frontiers in Neural Circuits</source><volume>9</volume><elocation-id>88</elocation-id><pub-id pub-id-type="doi">10.3389/fncir.2015.00088</pub-id><pub-id pub-id-type="pmid">26834569</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neske</surname> <given-names>GT</given-names></name><name><surname>Patrick</surname> <given-names>SL</given-names></name><name><surname>Connors</surname> <given-names>BW</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Contributions of diverse excitatory and inhibitory neurons to recurrent network activity in cerebral cortex</article-title><source>Journal of Neuroscience</source><volume>35</volume><fpage>1089</fpage><lpage>1105</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.2279-14.2015</pub-id><pub-id pub-id-type="pmid">25609625</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nichols</surname> <given-names>DE</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Psychedelics</article-title><source>Pharmacological Reviews</source><volume>68</volume><fpage>264</fpage><lpage>355</lpage><pub-id pub-id-type="doi">10.1124/pr.115.011478</pub-id><pub-id pub-id-type="pmid">26841800</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nichols</surname> <given-names>DE</given-names></name><name><surname>Nichols</surname> <given-names>CD</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Serotonin receptors</article-title><source>Chemical Reviews</source><volume>108</volume><fpage>1614</fpage><lpage>1641</lpage><pub-id pub-id-type="doi">10.1021/cr078224o</pub-id><pub-id pub-id-type="pmid">18476671</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Niethard</surname> <given-names>N</given-names></name><name><surname>Hasegawa</surname> <given-names>M</given-names></name><name><surname>Itokazu</surname> <given-names>T</given-names></name><name><surname>Oyanedel</surname> <given-names>CN</given-names></name><name><surname>Born</surname> <given-names>J</given-names></name><name><surname>Sato</surname> <given-names>TR</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Sleep-Stage-Specific regulation of cortical excitation and inhibition</article-title><source>Current Biology</source><volume>26</volume><fpage>2739</fpage><lpage>2749</lpage><pub-id pub-id-type="doi">10.1016/j.cub.2016.08.035</pub-id><pub-id pub-id-type="pmid">27693142</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Niethard</surname> <given-names>N</given-names></name><name><surname>Ngo</surname> <given-names>HV</given-names></name><name><surname>Ehrlich</surname> <given-names>I</given-names></name><name><surname>Born</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Cortical circuit activity underlying sleep slow oscillations and spindles</article-title><source>PNAS</source><volume>115</volume><fpage>E9220</fpage><lpage>E9229</lpage><pub-id pub-id-type="doi">10.1073/pnas.1805517115</pub-id><pub-id pub-id-type="pmid">30209214</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Obermayer</surname> <given-names>J</given-names></name><name><surname>Heistek</surname> <given-names>TS</given-names></name><name><surname>Kerkhofs</surname> <given-names>A</given-names></name><name><surname>Goriounova</surname> <given-names>NA</given-names></name><name><surname>Kroon</surname> <given-names>T</given-names></name><name><surname>Baayen</surname> <given-names>JC</given-names></name><name><surname>Idema</surname> <given-names>S</given-names></name><name><surname>Testa-Silva</surname> <given-names>G</given-names></name><name><surname>Couey</surname> <given-names>JJ</given-names></name><name><surname>Mansvelder</surname> <given-names>HD</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Lateral inhibition by martinotti interneurons is facilitated by cholinergic inputs in human and mouse neocortex</article-title><source>Nature Communications</source><volume>9</volume><elocation-id>4101</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-018-06628-w</pub-id><pub-id pub-id-type="pmid">30291244</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oikonomou</surname> <given-names>G</given-names></name><name><surname>Altermatt</surname> <given-names>M</given-names></name><name><surname>Zhang</surname> <given-names>RW</given-names></name><name><surname>Coughlin</surname> <given-names>GM</given-names></name><name><surname>Montz</surname> <given-names>C</given-names></name><name><surname>Gradinaru</surname> <given-names>V</given-names></name><name><surname>Prober</surname> <given-names>DA</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>The serotonergic raphe promote sleep in zebrafish and mice</article-title><source>Neuron</source><volume>103</volume><fpage>686</fpage><lpage>701</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2019.05.038</pub-id><pub-id pub-id-type="pmid">31248729</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pantazopoulos</surname> <given-names>H</given-names></name><name><surname>Wiseman</surname> <given-names>JT</given-names></name><name><surname>Markota</surname> <given-names>M</given-names></name><name><surname>Ehrenfeld</surname> <given-names>L</given-names></name><name><surname>Berretta</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Decreased numbers of Somatostatin-Expressing neurons in the amygdala of subjects with bipolar disorder or schizophrenia: relationship to circadian rhythms</article-title><source>Biological Psychiatry</source><volume>81</volume><fpage>536</fpage><lpage>547</lpage><pub-id pub-id-type="doi">10.1016/j.biopsych.2016.04.006</pub-id><pub-id pub-id-type="pmid">27259817</pub-id></element-citation></ref><ref id="bib76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Petzold</surname> <given-names>GC</given-names></name><name><surname>Hagiwara</surname> <given-names>A</given-names></name><name><surname>Murthy</surname> <given-names>VN</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Serotonergic modulation of odor input to the mammalian olfactory bulb</article-title><source>Nature Neuroscience</source><volume>12</volume><fpage>784</fpage><lpage>791</lpage><pub-id pub-id-type="doi">10.1038/nn.2335</pub-id><pub-id pub-id-type="pmid">19430472</pub-id></element-citation></ref><ref id="bib77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Preller</surname> <given-names>KH</given-names></name><name><surname>Burt</surname> <given-names>JB</given-names></name><name><surname>Ji</surname> <given-names>JL</given-names></name><name><surname>Schleifer</surname> <given-names>CH</given-names></name><name><surname>Adkinson</surname> <given-names>BD</given-names></name><name><surname>Stämpfli</surname> <given-names>P</given-names></name><name><surname>Seifritz</surname> <given-names>E</given-names></name><name><surname>Repovs</surname> <given-names>G</given-names></name><name><surname>Krystal</surname> <given-names>JH</given-names></name><name><surname>Murray</surname> <given-names>JD</given-names></name><name><surname>Vollenweider</surname> <given-names>FX</given-names></name><name><surname>Anticevic</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Changes in global and thalamic brain connectivity in LSD-induced altered states of consciousness are attributable to the 5-HT2A receptor</article-title><source>eLife</source><volume>7</volume><elocation-id>e35082</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.35082</pub-id><pub-id pub-id-type="pmid">30355445</pub-id></element-citation></ref><ref id="bib78"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Puig</surname> <given-names>MV</given-names></name><name><surname>Watakabe</surname> <given-names>A</given-names></name><name><surname>Ushimaru</surname> <given-names>M</given-names></name><name><surname>Yamamori</surname> <given-names>T</given-names></name><name><surname>Kawaguchi</surname> <given-names>Y</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Serotonin modulates fast-spiking interneuron and synchronous activity in the rat prefrontal cortex through 5-HT1A and 5-HT2A receptors</article-title><source>Journal of Neuroscience</source><volume>30</volume><fpage>2211</fpage><lpage>2222</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.3335-09.2010</pub-id><pub-id pub-id-type="pmid">20147548</pub-id></element-citation></ref><ref id="bib79"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ranganathan</surname> <given-names>GN</given-names></name><name><surname>Apostolides</surname> <given-names>PF</given-names></name><name><surname>Harnett</surname> <given-names>MT</given-names></name><name><surname>Xu</surname> <given-names>N-L</given-names></name><name><surname>Druckmann</surname> <given-names>S</given-names></name><name><surname>Magee</surname> <given-names>JC</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Active dendritic integration and mixed neocortical network representations during an adaptive sensing behavior</article-title><source>Nature Neuroscience</source><volume>21</volume><fpage>1583</fpage><lpage>1590</lpage><pub-id pub-id-type="doi">10.1038/s41593-018-0254-6</pub-id></element-citation></ref><ref id="bib80"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Renart</surname> <given-names>A</given-names></name><name><surname>de la Rocha</surname> <given-names>J</given-names></name><name><surname>Bartho</surname> <given-names>P</given-names></name><name><surname>Hollender</surname> <given-names>L</given-names></name><name><surname>Parga</surname> <given-names>N</given-names></name><name><surname>Reyes</surname> <given-names>A</given-names></name><name><surname>Harris</surname> <given-names>KD</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>The asynchronous state in cortical circuits</article-title><source>Science</source><volume>327</volume><fpage>587</fpage><lpage>590</lpage><pub-id pub-id-type="doi">10.1126/science.1179850</pub-id><pub-id pub-id-type="pmid">20110507</pub-id></element-citation></ref><ref id="bib81"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rothman</surname> <given-names>RB</given-names></name><name><surname>Baumann</surname> <given-names>MH</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Therapeutic and adverse actions of serotonin transporter substrates</article-title><source>Pharmacology &amp; Therapeutics</source><volume>95</volume><fpage>73</fpage><lpage>88</lpage><pub-id pub-id-type="doi">10.1016/S0163-7258(02)00234-6</pub-id><pub-id pub-id-type="pmid">12163129</pub-id></element-citation></ref><ref id="bib82"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roux</surname> <given-names>L</given-names></name><name><surname>Stark</surname> <given-names>E</given-names></name><name><surname>Sjulson</surname> <given-names>L</given-names></name><name><surname>Buzsáki</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>In vivo optogenetic identification and manipulation of GABAergic interneuron subtypes</article-title><source>Current Opinion in Neurobiology</source><volume>26</volume><fpage>88</fpage><lpage>95</lpage><pub-id pub-id-type="doi">10.1016/j.conb.2013.12.013</pub-id><pub-id pub-id-type="pmid">24440414</pub-id></element-citation></ref><ref id="bib83"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rudy</surname> <given-names>B</given-names></name><name><surname>Fishell</surname> <given-names>G</given-names></name><name><surname>Lee</surname> <given-names>S</given-names></name><name><surname>Hjerling-Leffler</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Three groups of interneurons account for nearly 100% of neocortical GABAergic neurons</article-title><source>Developmental Neurobiology</source><volume>71</volume><fpage>45</fpage><lpage>61</lpage><pub-id pub-id-type="doi">10.1002/dneu.20853</pub-id><pub-id pub-id-type="pmid">21154909</pub-id></element-citation></ref><ref id="bib84"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sanchez-Vives</surname> <given-names>MV</given-names></name><name><surname>Massimini</surname> <given-names>M</given-names></name><name><surname>Mattia</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Shaping the default activity pattern of the cortical network</article-title><source>Neuron</source><volume>94</volume><fpage>993</fpage><lpage>1001</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2017.05.015</pub-id><pub-id pub-id-type="pmid">28595056</pub-id></element-citation></ref><ref id="bib85"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schmitz</surname> <given-names>D</given-names></name><name><surname>Gloveli</surname> <given-names>T</given-names></name><name><surname>Empson</surname> <given-names>RM</given-names></name><name><surname>Draguhn</surname> <given-names>A</given-names></name><name><surname>Heinemann</surname> <given-names>U</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Serotonin reduces synaptic excitation in the superficial medial entorhinal cortex of the rat via a presynaptic mechanism</article-title><source>The Journal of Physiology</source><volume>508</volume><fpage>119</fpage><lpage>129</lpage><pub-id pub-id-type="doi">10.1111/j.1469-7793.1998.119br.x</pub-id><pub-id pub-id-type="pmid">9490827</pub-id></element-citation></ref><ref id="bib86"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schnütgen</surname> <given-names>F</given-names></name><name><surname>Doerflinger</surname> <given-names>N</given-names></name><name><surname>Calléja</surname> <given-names>C</given-names></name><name><surname>Wendling</surname> <given-names>O</given-names></name><name><surname>Chambon</surname> <given-names>P</given-names></name><name><surname>Ghyselinck</surname> <given-names>NB</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>A directional strategy for monitoring Cre-mediated recombination at the cellular level in the mouse</article-title><source>Nature Biotechnology</source><volume>21</volume><fpage>562</fpage><lpage>565</lpage><pub-id pub-id-type="doi">10.1038/nbt811</pub-id><pub-id pub-id-type="pmid">12665802</pub-id></element-citation></ref><ref id="bib87"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seillier</surname> <given-names>L</given-names></name><name><surname>Lorenz</surname> <given-names>C</given-names></name><name><surname>Kawaguchi</surname> <given-names>K</given-names></name><name><surname>Ott</surname> <given-names>T</given-names></name><name><surname>Nieder</surname> <given-names>A</given-names></name><name><surname>Pourriahi</surname> <given-names>P</given-names></name><name><surname>Nienborg</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Serotonin decreases the gain of visual responses in awake macaque V1</article-title><source>The Journal of Neuroscience</source><volume>37</volume><fpage>11390</fpage><lpage>11405</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.1339-17.2017</pub-id><pub-id pub-id-type="pmid">29042433</pub-id></element-citation></ref><ref id="bib88"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sengupta</surname> <given-names>A</given-names></name><name><surname>Bocchio</surname> <given-names>M</given-names></name><name><surname>Bannerman</surname> <given-names>DM</given-names></name><name><surname>Sharp</surname> <given-names>T</given-names></name><name><surname>Capogna</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Control of amygdala circuits by 5-HT neurons via 5-HT and glutamate cotransmission</article-title><source>The Journal of Neuroscience</source><volume>37</volume><fpage>1785</fpage><lpage>1796</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.2238-16.2016</pub-id></element-citation></ref><ref id="bib89"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Senzai</surname> <given-names>Y</given-names></name><name><surname>Fernandez-Ruiz</surname> <given-names>A</given-names></name><name><surname>Buzsáki</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Layer-Specific physiological features and interlaminar interactions in the primary visual cortex of the mouse</article-title><source>Neuron</source><volume>101</volume><fpage>500</fpage><lpage>513</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2018.12.009</pub-id><pub-id pub-id-type="pmid">30635232</pub-id></element-citation></ref><ref id="bib90"><element-citation publication-type="preprint"><person-group person-group-type="author"><name><surname>Shamash</surname> <given-names>P</given-names></name><name><surname>Carandini</surname> <given-names>M</given-names></name><name><surname>Harris</surname> <given-names>K</given-names></name><name><surname>Steinmetz</surname> <given-names>N</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>A tool for analyzing electrode tracks from slice histology</article-title><source>bioRxiv</source><pub-id pub-id-type="doi">10.1101/447995</pub-id></element-citation></ref><ref id="bib91"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sheldon</surname> <given-names>PW</given-names></name><name><surname>Aghajanian</surname> <given-names>GK</given-names></name></person-group><year iso-8601-date="1990">1990</year><article-title>Serotonin (5-HT) induces IPSPs in pyramidal layer cells of rat piriform cortex: evidence for the involvement of a 5-HT2-activated interneuron</article-title><source>Brain Research</source><volume>506</volume><fpage>62</fpage><lpage>69</lpage><pub-id pub-id-type="doi">10.1016/0006-8993(90)91199-Q</pub-id><pub-id pub-id-type="pmid">2105822</pub-id></element-citation></ref><ref id="bib92"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sippy</surname> <given-names>T</given-names></name><name><surname>Yuste</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Decorrelating action of inhibition in neocortical networks</article-title><source>Journal of Neuroscience</source><volume>33</volume><fpage>9813</fpage><lpage>9830</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.4579-12.2013</pub-id><pub-id pub-id-type="pmid">23739978</pub-id></element-citation></ref><ref id="bib93"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname> <given-names>SL</given-names></name><name><surname>Smith</surname> <given-names>IT</given-names></name><name><surname>Branco</surname> <given-names>T</given-names></name><name><surname>Häusser</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Dendritic spikes enhance stimulus selectivity in cortical neurons in vivo</article-title><source>Nature</source><volume>503</volume><fpage>115</fpage><lpage>120</lpage><pub-id pub-id-type="doi">10.1038/nature12600</pub-id></element-citation></ref><ref id="bib94"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Steriade</surname> <given-names>M</given-names></name><name><surname>Nuñez</surname> <given-names>A</given-names></name><name><surname>Amzica</surname> <given-names>F</given-names></name></person-group><year iso-8601-date="1993">1993</year><article-title>A novel slow (&lt; 1 hz) oscillation of neocortical neurons in vivo: depolarizing and hyperpolarizing components</article-title><source>The Journal of Neuroscience</source><volume>13</volume><fpage>3252</fpage><lpage>3265</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.13-08-03252.1993</pub-id><pub-id pub-id-type="pmid">8340806</pub-id></element-citation></ref><ref id="bib95"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stringer</surname> <given-names>C</given-names></name><name><surname>Pachitariu</surname> <given-names>M</given-names></name><name><surname>Steinmetz</surname> <given-names>NA</given-names></name><name><surname>Okun</surname> <given-names>M</given-names></name><name><surname>Bartho</surname> <given-names>P</given-names></name><name><surname>Harris</surname> <given-names>KD</given-names></name><name><surname>Sahani</surname> <given-names>M</given-names></name><name><surname>Lesica</surname> <given-names>NA</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Inhibitory control of correlated intrinsic variability in cortical networks</article-title><source>eLife</source><volume>5</volume><elocation-id>e19695</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.19695</pub-id><pub-id pub-id-type="pmid">27926356</pub-id></element-citation></ref><ref id="bib96"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sturgill</surname> <given-names>JF</given-names></name><name><surname>Isaacson</surname> <given-names>JS</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Somatostatin cells regulate sensory response fidelity via subtractive inhibition in olfactory cortex</article-title><source>Nature Neuroscience</source><volume>18</volume><fpage>531</fpage><lpage>535</lpage><pub-id pub-id-type="doi">10.1038/nn.3971</pub-id><pub-id pub-id-type="pmid">25751531</pub-id></element-citation></ref><ref id="bib97"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tahvildari</surname> <given-names>B</given-names></name><name><surname>Wölfel</surname> <given-names>M</given-names></name><name><surname>Duque</surname> <given-names>A</given-names></name><name><surname>McCormick</surname> <given-names>DA</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Selective functional interactions between excitatory and inhibitory cortical neurons and differential contribution to persistent activity of the slow oscillation</article-title><source>Journal of Neuroscience</source><volume>32</volume><fpage>12165</fpage><lpage>12179</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.1181-12.2012</pub-id><pub-id pub-id-type="pmid">22933799</pub-id></element-citation></ref><ref id="bib98"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takahashi</surname> <given-names>N</given-names></name><name><surname>Oertner</surname> <given-names>TG</given-names></name><name><surname>Hegemann</surname> <given-names>P</given-names></name><name><surname>Larkum</surname> <given-names>ME</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Active cortical dendrites modulate perception</article-title><source>Science</source><volume>354</volume><fpage>1587</fpage><lpage>1590</lpage><pub-id pub-id-type="doi">10.1126/science.aah6066</pub-id><pub-id pub-id-type="pmid">28008068</pub-id></element-citation></ref><ref id="bib99"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tang</surname> <given-names>ZQ</given-names></name><name><surname>Trussell</surname> <given-names>LO</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Serotonergic modulation of sensory representation in a central multisensory circuit is pathway specific</article-title><source>Cell Reports</source><volume>20</volume><fpage>1844</fpage><lpage>1854</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2017.07.079</pub-id><pub-id pub-id-type="pmid">28834748</pub-id></element-citation></ref><ref id="bib100"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taniguchi</surname> <given-names>H</given-names></name><name><surname>He</surname> <given-names>M</given-names></name><name><surname>Wu</surname> <given-names>P</given-names></name><name><surname>Kim</surname> <given-names>S</given-names></name><name><surname>Paik</surname> <given-names>R</given-names></name><name><surname>Sugino</surname> <given-names>K</given-names></name><name><surname>Kvitsiani</surname> <given-names>D</given-names></name><name><surname>Kvitsani</surname> <given-names>D</given-names></name><name><surname>Fu</surname> <given-names>Y</given-names></name><name><surname>Lu</surname> <given-names>J</given-names></name><name><surname>Lin</surname> <given-names>Y</given-names></name><name><surname>Miyoshi</surname> <given-names>G</given-names></name><name><surname>Shima</surname> <given-names>Y</given-names></name><name><surname>Fishell</surname> <given-names>G</given-names></name><name><surname>Nelson</surname> <given-names>SB</given-names></name><name><surname>Huang</surname> <given-names>ZJ</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>A resource of cre driver lines for genetic targeting of GABAergic neurons in cerebral cortex</article-title><source>Neuron</source><volume>71</volume><fpage>995</fpage><lpage>1013</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2011.07.026</pub-id><pub-id pub-id-type="pmid">21943598</pub-id></element-citation></ref><ref id="bib101"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trainito</surname> <given-names>C</given-names></name><name><surname>von Nicolai</surname> <given-names>C</given-names></name><name><surname>Miller</surname> <given-names>EK</given-names></name><name><surname>Siegel</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Extracellular spike waveform dissociates four functionally distinct cell classes in primate cortex</article-title><source>Current Biology</source><volume>29</volume><fpage>2973</fpage><lpage>2982</lpage><pub-id pub-id-type="doi">10.1016/j.cub.2019.07.051</pub-id><pub-id pub-id-type="pmid">31447374</pub-id></element-citation></ref><ref id="bib102"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tremblay</surname> <given-names>R</given-names></name><name><surname>Lee</surname> <given-names>S</given-names></name><name><surname>Rudy</surname> <given-names>B</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>GABAergic interneurons in the neocortex: from cellular properties to circuits</article-title><source>Neuron</source><volume>91</volume><fpage>260</fpage><lpage>292</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2016.06.033</pub-id><pub-id pub-id-type="pmid">27477017</pub-id></element-citation></ref><ref id="bib103"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tukker</surname> <given-names>JJ</given-names></name><name><surname>Beed</surname> <given-names>P</given-names></name><name><surname>Schmitz</surname> <given-names>D</given-names></name><name><surname>Larkum</surname> <given-names>ME</given-names></name><name><surname>Sachdev</surname> <given-names>RNS</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Up and down states and memory consolidation across somatosensory, entorhinal, and hippocampal cortices</article-title><source>Frontiers in Systems Neuroscience</source><volume>14</volume><elocation-id>22</elocation-id><pub-id pub-id-type="doi">10.3389/fnsys.2020.00022</pub-id><pub-id pub-id-type="pmid">32457582</pub-id></element-citation></ref><ref id="bib104"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Turrigiano</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Too many cooks? intrinsic and synaptic homeostatic mechanisms in cortical circuit refinement</article-title><source>Annual Review of Neuroscience</source><volume>34</volume><fpage>89</fpage><lpage>103</lpage><pub-id pub-id-type="doi">10.1146/annurev-neuro-060909-153238</pub-id><pub-id pub-id-type="pmid">21438687</pub-id></element-citation></ref><ref id="bib105"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Unger</surname> <given-names>EK</given-names></name><name><surname>Keller</surname> <given-names>JP</given-names></name><name><surname>Altermatt</surname> <given-names>M</given-names></name><name><surname>Liang</surname> <given-names>R</given-names></name><name><surname>Matsui</surname> <given-names>A</given-names></name><name><surname>Dong</surname> <given-names>C</given-names></name><name><surname>Hon</surname> <given-names>OJ</given-names></name><name><surname>Yao</surname> <given-names>Z</given-names></name><name><surname>Sun</surname> <given-names>J</given-names></name><name><surname>Banala</surname> <given-names>S</given-names></name><name><surname>Flanigan</surname> <given-names>ME</given-names></name><name><surname>Jaffe</surname> <given-names>DA</given-names></name><name><surname>Hartanto</surname> <given-names>S</given-names></name><name><surname>Carlen</surname> <given-names>J</given-names></name><name><surname>Mizuno</surname> <given-names>GO</given-names></name><name><surname>Borden</surname> <given-names>PM</given-names></name><name><surname>Shivange</surname> <given-names>AV</given-names></name><name><surname>Cameron</surname> <given-names>LP</given-names></name><name><surname>Sinning</surname> <given-names>S</given-names></name><name><surname>Underhill</surname> <given-names>SM</given-names></name><name><surname>Olson</surname> <given-names>DE</given-names></name><name><surname>Amara</surname> <given-names>SG</given-names></name><name><surname>Temple Lang</surname> <given-names>D</given-names></name><name><surname>Rudnick</surname> <given-names>G</given-names></name><name><surname>Marvin</surname> <given-names>JS</given-names></name><name><surname>Lavis</surname> <given-names>LD</given-names></name><name><surname>Lester</surname> <given-names>HA</given-names></name><name><surname>Alvarez</surname> <given-names>VA</given-names></name><name><surname>Fisher</surname> <given-names>AJ</given-names></name><name><surname>Prescher</surname> <given-names>JA</given-names></name><name><surname>Kash</surname> <given-names>TL</given-names></name><name><surname>Yarov-Yarovoy</surname> <given-names>V</given-names></name><name><surname>Gradinaru</surname> <given-names>V</given-names></name><name><surname>Looger</surname> <given-names>LL</given-names></name><name><surname>Tian</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Directed evolution of a selective and sensitive serotonin sensor via machine learning</article-title><source>Cell</source><volume>183</volume><fpage>1986</fpage><lpage>2002</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2020.11.040</pub-id><pub-id pub-id-type="pmid">33333022</pub-id></element-citation></ref><ref id="bib106"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Urban-Ciecko</surname> <given-names>J</given-names></name><name><surname>Fanselow</surname> <given-names>EE</given-names></name><name><surname>Barth</surname> <given-names>AL</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Neocortical somatostatin neurons reversibly silence excitatory transmission via GABAb receptors</article-title><source>Current Biology</source><volume>25</volume><fpage>722</fpage><lpage>731</lpage><pub-id pub-id-type="doi">10.1016/j.cub.2015.01.035</pub-id><pub-id pub-id-type="pmid">25728691</pub-id></element-citation></ref><ref id="bib107"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Urban-Ciecko</surname> <given-names>J</given-names></name><name><surname>Jouhanneau</surname> <given-names>JS</given-names></name><name><surname>Myal</surname> <given-names>SE</given-names></name><name><surname>Poulet</surname> <given-names>JFA</given-names></name><name><surname>Barth</surname> <given-names>AL</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Precisely timed nicotinic activation drives SST inhibition in neocortical circuits</article-title><source>Neuron</source><volume>97</volume><fpage>611</fpage><lpage>625</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2018.01.037</pub-id><pub-id pub-id-type="pmid">29420933</pub-id></element-citation></ref><ref id="bib108"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Strien</surname> <given-names>NM</given-names></name><name><surname>Cappaert</surname> <given-names>NL</given-names></name><name><surname>Witter</surname> <given-names>MP</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>The anatomy of memory: an interactive overview of the parahippocampal-hippocampal network</article-title><source>Nature Reviews Neuroscience</source><volume>10</volume><fpage>272</fpage><lpage>282</lpage><pub-id pub-id-type="doi">10.1038/nrn2614</pub-id><pub-id pub-id-type="pmid">19300446</pub-id></element-citation></ref><ref id="bib109"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vanderwolf</surname> <given-names>CH</given-names></name><name><surname>Baker</surname> <given-names>GB</given-names></name></person-group><year iso-8601-date="1986">1986</year><article-title>Evidence that serotonin mediates non-cholinergic neocortical low voltage fast activity, non-cholinergic hippocampal rhythmical slow activity and contributes to intelligent behavior</article-title><source>Brain Research</source><volume>374</volume><fpage>342</fpage><lpage>356</lpage><pub-id pub-id-type="doi">10.1016/0006-8993(86)90428-2</pub-id><pub-id pub-id-type="pmid">2941111</pub-id></element-citation></ref><ref id="bib110"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>H</given-names></name><name><surname>Hu</surname> <given-names>L</given-names></name><name><surname>Liu</surname> <given-names>C</given-names></name><name><surname>Su</surname> <given-names>Z</given-names></name><name><surname>Wang</surname> <given-names>L</given-names></name><name><surname>Pan</surname> <given-names>G</given-names></name><name><surname>Guo</surname> <given-names>Y</given-names></name><name><surname>He</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>5-HT2 receptors mediate functional modulation of GABAa receptors and inhibitory synaptic transmissions in human iPS-derived neurons</article-title><source>Scientific Reports</source><volume>6</volume><elocation-id>20033</elocation-id><pub-id pub-id-type="doi">10.1038/srep20033</pub-id><pub-id pub-id-type="pmid">26837719</pub-id></element-citation></ref><ref id="bib111"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weber</surname> <given-names>ET</given-names></name><name><surname>Andrade</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Htr2a gene and 5-HT(2A) Receptor expression in the cerebral cortex studied using genetically modified mice</article-title><source>Frontiers in Neuroscience</source><volume>4</volume><elocation-id>00036</elocation-id><pub-id pub-id-type="doi">10.3389/fnins.2010.00036</pub-id></element-citation></ref><ref id="bib112"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilson</surname> <given-names>NR</given-names></name><name><surname>Runyan</surname> <given-names>CA</given-names></name><name><surname>Wang</surname> <given-names>FL</given-names></name><name><surname>Sur</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Division and subtraction by distinct cortical inhibitory networks in vivo</article-title><source>Nature</source><volume>488</volume><fpage>343</fpage><lpage>348</lpage><pub-id pub-id-type="doi">10.1038/nature11347</pub-id><pub-id pub-id-type="pmid">22878717</pub-id></element-citation></ref><ref id="bib113"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wolansky</surname> <given-names>T</given-names></name><name><surname>Clement</surname> <given-names>EA</given-names></name><name><surname>Peters</surname> <given-names>SR</given-names></name><name><surname>Palczak</surname> <given-names>MA</given-names></name><name><surname>Dickson</surname> <given-names>CT</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Hippocampal slow oscillation: a novel EEG state and its coordination with ongoing neocortical activity</article-title><source>Journal of Neuroscience</source><volume>26</volume><fpage>6213</fpage><lpage>6229</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.5594-05.2006</pub-id><pub-id pub-id-type="pmid">16763029</pub-id></element-citation></ref><ref id="bib114"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wood</surname> <given-names>J</given-names></name><name><surname>Kim</surname> <given-names>Y</given-names></name><name><surname>Moghaddam</surname> <given-names>B</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Disruption of prefrontal cortex large scale neuronal activity by different classes of psychotomimetic drugs</article-title><source>Journal of Neuroscience</source><volume>32</volume><fpage>3022</fpage><lpage>3031</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.6377-11.2012</pub-id><pub-id pub-id-type="pmid">22378875</pub-id></element-citation></ref><ref id="bib115"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wyskiel</surname> <given-names>DR</given-names></name><name><surname>Andrade</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Serotonin excites hippocampal CA1 GABAergic interneurons at the stratum radiatum-stratum lacunosum moleculare border</article-title><source>Hippocampus</source><volume>26</volume><fpage>1107</fpage><lpage>1114</lpage><pub-id pub-id-type="doi">10.1002/hipo.22611</pub-id><pub-id pub-id-type="pmid">27328460</pub-id></element-citation></ref><ref id="bib116"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname> <given-names>FM</given-names></name><name><surname>Hablitz</surname> <given-names>JJ</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Activation of serotonin receptors modulates synaptic transmission in rat cerebral cortex</article-title><source>Journal of Neurophysiology</source><volume>82</volume><fpage>2989</fpage><lpage>2999</lpage><pub-id pub-id-type="doi">10.1152/jn.1999.82.6.2989</pub-id><pub-id pub-id-type="pmid">10601434</pub-id></element-citation></ref><ref id="bib117"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zucca</surname> <given-names>S</given-names></name><name><surname>D'Urso</surname> <given-names>G</given-names></name><name><surname>Pasquale</surname> <given-names>V</given-names></name><name><surname>Vecchia</surname> <given-names>D</given-names></name><name><surname>Pica</surname> <given-names>G</given-names></name><name><surname>Bovetti</surname> <given-names>S</given-names></name><name><surname>Moretti</surname> <given-names>C</given-names></name><name><surname>Varani</surname> <given-names>S</given-names></name><name><surname>Molano-Mazón</surname> <given-names>M</given-names></name><name><surname>Chiappalone</surname> <given-names>M</given-names></name><name><surname>Panzeri</surname> <given-names>S</given-names></name><name><surname>Fellin</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>An inhibitory gate for state transition in cortex</article-title><source>eLife</source><volume>6</volume><elocation-id>e26177</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.26177</pub-id><pub-id pub-id-type="pmid">28509666</pub-id></element-citation></ref></ref-list></back><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.66960.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group><contrib contrib-type="editor"><name><surname>Vinck</surname><given-names>Martin</given-names></name><role>Reviewing Editor</role><aff><institution>Ernst Strüngmann Institute (ESI) for Neuroscience in Cooperation with Max Planck Society</institution><country>Germany</country></aff></contrib></contrib-group><contrib-group><contrib contrib-type="reviewer"><name><surname>Fernandez-Ruiz</surname><given-names>Antonio</given-names> </name><role>Reviewer</role><aff><country>United States</country></aff></contrib></contrib-group></front-stub><body><boxed-text><p>In the interests of transparency, eLife publishes the most substantive revision requests and the accompanying author responses.</p></boxed-text><p><bold>Acceptance summary:</bold></p><p>This paper identifies a mechanism through which serotonin, one of the brain's major neuromodulators, affects network activity, through 5HT2a-mediated activation of a major subclass of GABAergic interneurons – Somatostatin-positive interneurons. These findings advance our understanding of how brain state affects cortical circuits through the action of specific cell classes.</p><p><bold>Decision letter after peer review:</bold></p><p>[Editors’ note: the authors submitted for reconsideration following the decision after peer review. What follows is the decision letter after the first round of review.]</p><p>Thank you for submitting your work entitled &quot;Serotonin suppresses slow oscillations by activating somatostatin interneurons via the 5-HT<sub>2A</sub> receptor&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by four peer reviewers, one of whom is a member of our Board of Reviewing Editors, and the evaluation has been overseen by a Senior Editor. The following individual involved in review of your submission has agreed to reveal their identity: Antonio Fernandez-Ruiz (Reviewer #3).</p><p>Our decision has been reached after consultation between the reviewers. Based on these discussions and the individual reviews below, we regret to inform you that your work will not be considered further for publication in <italic>eLife</italic> at present. However given the interest of the reviewers in the topic, we welcome a resubmission to e<italic>Life</italic> if it is possible to run additional experiments requested by the reviewers; this submission would be treated as a new submission but would be send to the same reviewers. Although the reviewers made several positive comments, they identified several major issues, in particular: 1) The interpretation and framing of the paper in terms of slow oscillations, which was questioned by several reviewers. 2) The selectivity of pharmacological manipulation (see Reviewer 2), and 3) Data analysis. The reviewers agreed that while recordings without anesthesia would enhance the manuscript, these experiments are beyond the scope of the paper, although this limitation needs to be discussed more clearly.</p><p><italic>Reviewer #1:</italic></p><p>This paper shows that slow oscillations in entorhinal cortex are affected by serotonin, in particular acting through 5HT2AR receptor, and that this effect is mediated by Somatostatin interneurons. Although the generality of this finding for other cortical areas and natural (i.e. not anesthesized) conditions remains to be established, I find this is a set of novel findings that could be important to understand control of brain state and also clinical applications. Critique:</p><p>1) A clear short-coming of the paper is the lack of recordings during naturally occurring slow waves. If it is reasonable to conduct these experiments, this would greatly enhance the paper. In particular potential effects of anesthesia on SSt interneurons need to be taken into account (see Adesnik and Scanziani, 2012).</p><p>2) A second critical question is whether there is at all an effect on slow oscillations. It appears to me that there is a massive suppression of spiking activity such that the circuit is essentially in a sustained downstate that is not at all representative of the desynchronized state as one normally finds it, and what would have happened with stimulating the Raphe Nucleus. So the conclusion that there's an effect on slow oscillations is not entirely clear to me. This pertains to Figure 1 and 4, for instance.</p><p>Would blocking 5HT2aRs during normal wake-to-sleep or arousal-to-SWS transitions abolish slow oscillations? If one would stimulate the Raphe and blocks 5HT2aR what would one predict? I understand these are difficult experiments to do, but does the paper bear relevance for these more naturalistic scenarios?</p><p>3) For completeness it would be useful to comment on the other GABAergic cells that have 5HT3Rs and explain why their contribution is not relevant for different pharmacological agents or more in general.</p><p><italic>Reviewer #2:</italic></p><p>The manuscript by De Filippo et al. presents a combined in vivo / in vitro study of the cellular mechanisms of network dynamics in the entorhinal cortex (EC). The main findings support 5-HT suppression of slow oscillatory activity, mediated by 5-HT2AR activation of SOM interneurons. This is a novel finding, potentially of general interest. My major concerns relate to the strength of the in vivo evidence and the framing of the study.</p><p>Concerns related to in vivo data</p><p>1) The authors present clear demonstration that the pharmacological agents used suppress the slow oscillation (SO) in EC. Given that none of these drugs are truly selective and that they are presented i.p., the authors provide no direct evidence that these effects are 1) mediated by 5-HT release and 2) mediated by 5-HT release in the entorhinal cortex. This can be addressed by preventing drug-mediated SO reduction with local application of 5-HT2AR antagonists directly in the EC.</p><p>2) The in vivo single unit data does not support the activation of SOM interneurons.</p><p>a) The activated neurons appear to include both putative inhibitory (fast spiking) and putative excitatory (non-fast spiking) neurons (Figure 2C), rather than an intermediate, potential SOM population. If the activated neurons include both FS inhibitory and non-FS excitatory neurons, one would expect TP latency of the population to be intermediate as shown in Figure 2B,C.</p><p>b) Given the inability to identify SOM interneurons based on waveform alone, additional characterization of the activated units is necessary. First, do the CCGs of the activated units indicate inhibitory connections? These data are notably missing (or not easily extracted from Figure 2—figure supplement 1).</p><p>c) Second, definitely identifying SOM interneurons in vivo would require some type of tagging.</p><p>Concerns related to the Introduction</p><p>3) Motivating this study by discussing psychological processes, psychiatric disorders, sleep/wake cycles or psychoactive drugs is highly tenuous and misleading. This study does not address any of these processes. Alternatively, the Introduction lacks even a superficial description of topics that are highly relevant to this study, including neuroanatomy and neural circuitry of the EC, physiological properties of GABAergic interneurons in the EC, previous studies of the slow oscillation and involvement of different neuronal cell types in the EC, and neuromodulation of different interneuron subtypes, especially known patterns of neuromodulatory receptor expression on SOM interneurons.</p><p><italic>Reviewer #3:</italic></p><p>The manuscript by De Filipo et al. presents a well-executed and novel study on the role of somatostatin positive (Som) interneurons in the generation of cortical slow oscillations (SO) in the entorhinal area. The authors employ a combination of mouse in vivo recordings under anesthesia, slice physiology, together with pharmacological and chemo/optogenetic manipulations to shown that entorhinal SO are suppressed by serotonin activation of Som interneurons. The present work provides new data on an interesting topic that can have broader implications to understand the relationship between neuromodulators, state-dependent brain oscillations and different interneuron subtypes. The experimental approaches are rigorous and adequately support the authors claims. However, the study has some limitations that cast doubts on the specificity of the effects reported. Additional analysis may be sufficient to clarify these doubts.</p><p>1) The authors need to show more convincing evidence that the effects 5-HT and the manipulations reported in Figure 1 are specific of the SO and not a general dampened of entorhinal activity. More extensive analysis of the current data will suffice for that purpose. Figure 1H suggests that there may be a reduction in power in other frequencies than δ, but is not clearly appreciated (using a log frequency axis will facilitate it). A power spectrum comparison before, during and after drug application is necessary to evaluate the changes in all frequencies. Entorhinal cortex displays prominent γ oscillations, even during sleep and urethane anesthesia, are those also affected? This should be specifically quantified. Under urethane there is an alternation between a SO and a slow theta (~3-4Hz) state. Are theta oscillations also affected by the pharmacological manipulations?</p><p>2) More comprehensive analysis of the effect of the different manipulations on SO reported through the manuscript should be performed, not only the rate of up states. For example, distribution of durations, inter-event intervals, amplitude of the remaining up states, etc. These will help to better understand the nature of the effects of serotonin release on SO.</p><p>3) Expanding the analysis and discussion of the contribution of PV interneurons will help establish the specificity of the role of Som interneurons. The results of the experiment with hM4Di-PV are encouraging in this regard. The authors do have fast-spiking, narrow-waveform cells (thus putative PV+ interneurons) in their dataset; however, there is very little discussion about this through the text. The results in Figure 4 provide evidence of the ability of Som interneurons to suppress SO. However, I would expect a very similar effect from PV activation. Unless the authors have evidence of the opposite, they should acknowledge this.</p><p><italic>Reviewer #4:</italic></p><p>In this manuscript, De Filippo et al. identify somatostatin-containing interneurons (SOM) of the entorhinal cortex (EC) as targets of serotonergic neurons in the dorsal raphe and describe their involvement in the mediation of slow oscillations in the EC, using an array of techniques such as pharmacology, optogenetics and DREADD.</p><p>The manuscript is well and the analysis is solid. While there is no doubt this study demonstrates convincingly the involvement of SOM neurons in the regulation of SO, it fails to convincingly rule out other cell types which could equally contribute to the cortical dynamics under investigation. In that respect, I am left with some lingering doubts as to whether or not something was missed in the study and would therefore appreciate some clarifications on the part of the authors (see major point below).</p><p>1) Some previous studies (for example, Ferezou et al., 2002) have shown that VIP/CCK GABAergic cells express 5-HT3 receptors, which are ionotropic receptors and can therefore respond very fast (with a depolarization, therefore an activation) to serotonergic neuromodulation. How come the authors do not mention this study (and others) and could they give an explanation as to why none of these neocortical cells (presumably also present in the EC?) were identified in their study as activated? Alternatively, using mCPBG in a similar fashion to how α-methyl5-HT was used in Figure 3 to rule out involvement of 5-HT3R would be valuable. The authors also mention the fact that only 11% of the cells expressing 5-HT2AR promoter were SOM. Could they please elaborate on the remaining 89% of cells?</p><p>2) Studies in the somatosensory cortex of awake mice (presumably therefore at a time when 5-HT release is highest) showed that L2/3 SOM neurons were not correlated with other neuronal cell types at the level of their membrane potentials and that they hyperpolarized and therefore reduce their spiking during active wake (when the mouse movedits whiskers (Gentet et al., 2012, Muñoz et al., 2017)). The authors should discuss their findings in the light of these papers considering that they argue that serotonin activates SOM neurons in the EC and 5-HT release is highest during wake, and therefore presumably, even more so during active wake.</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.66960.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><p>[Editors’ note: the authors resubmitted a revised version of the paper for consideration. What follows is the authors’ response to the first round of review.]</p><disp-quote content-type="editor-comment"><p>Reviewer #1:</p><p>This paper shows that slow oscillations in entorhinal cortex are affected by serotonin, in particular acting through 5HT2AR receptor, and that this effect is mediated by Somatostatin interneurons. Although the generality of this finding for other cortical areas and natural (i.e. not anesthesized) conditions remains to be established, I find this is a set of novel findings that could be important to understand control of brain state and also clinical applications. Critique:</p><p>1) A clear short-coming of the paper is the lack of recordings during naturally occurring slow waves. If it is reasonable to conduct these experiments, this would greatly enhance the paper. In particular potential effects of anesthesia on SSt interneurons need to be taken into account (see Adesnik and Scanziani, 2012).</p></disp-quote><p>Recording during natural sleep together with application of either MDMA or fenfluramine (Fen) would be problematic as both these compounds act as sleep suppressant in both rodents and humans (Myers et al., 1993, Fornal and Radulovacki, 1983, Balogh et al., 2004, Randall et al., 2009). We agree that more effort should be put in studying the effect of 5-HT on Som interneurons in vivo and we plan on doing so in a following work in awake head-fixed condition. In accordance with the reviewing and senior editors’ opinions, we believe that these experiments would go beyond the aims of our current study. We modified the text to explicitly state that the absence of data in naturalistic conditions represent a limitation of our work.</p><disp-quote content-type="editor-comment"><p>2) A second critical question is whether there is at all an effect on slow oscillations. It appears to me that there is a massive suppression of spiking activity such that the circuit is essentially in a sustained downstate that is not at all representative of the desynchronized state as one normally finds it, and what would have happened with stimulating the Raphe Nucleus. So the conclusion that there's an effect on slow oscillations is not entirely clear to me. This pertains to Figure 1 and 4, for instance.</p><p>Would blocking 5HT2aRs during normal wake-to-sleep or arousal-to-SWS transitions abolish slow oscillations? If one would stimulate the Raphe and blocks 5HT2aR what would one predict? I understand these are difficult experiments to do, but does the paper bear relevance for these more naturalistic scenarios?</p></disp-quote><p>The choice of the word “desynchronization” was unfortunate as what we observe in our data does not reflect in vivo awake classic “desynchronization”(Chen et al., 2015), we revised the Discussion to claim instead that 5-HT suppresses synchronized activity. We agree that the effect we see, both in vivo and in vitro, can be described as a general dampening of spiking activity. We consider suppression of upstates to be equal to suppression of slow oscillations (SO), as we do not believe that a constant downstate can be categorized as slow oscillation. Our usage of the terms upstate and downstate follow what, in our view, is the field convention (Harris and Thiele, 2011), some works use a different definition (see (Niethard et al., 2018)).</p><p>We use SO as a proxy to understand the effect of 5-HT on networks of cortical neurons but we do not aim to make conclusive statements about the relevance of our findings in natural sleep. For example, during natural sleep (both slow-wave sleep and REM) the level of 5-HT in the brain are at the lowest (Oikonomou et al., 2019, Unger et al., 2020, McGinty and Harper, 1976), thus, the increase of 5-HT during sleep would be of itself an artificial condition. We investigated in a new set of experiments (<xref ref-type="fig" rid="sa2fig1">Author response image 1</xref> and Figure 3) the effect of Raphe 5-HT neurons optogenetic activation during anesthesia in the same cortical region (medial entorhinal cortex). We did not see suppression of SO but only a decrease in spiking rate during upstates. Decrease in spiking following the same manipulation has been reported in a previous study in somatosensory and motor areas (Grandjean et al., 2019). Our explanation for this difference is that the amount of 5-HT released using pharmacological or optogenetic release is probably considerably different. As we explain in the revised text, MDMA and Fen (5 mg/kg) have been reported to induce a ~20-fold increase in peak 5-HT concentration both in monkey and rodent brain (Udo de Haes et al., 2006, Gołembiowska et al., 2016). On the other hand, light activated 5-HT neurons in ePet mice seems to fire at a physiological rate (≈ 3 Hz) (Ranade and Mainen, 2009, Sakai and Crochet, 2001) even when stimulated at higher frequencies. (Grandjean et al., 2019). In consequence it is likely that optogenetic activation is not eliciting the release of enough 5-HT to cause SO suppression and Som interneurons activation during anesthesia. We decided to include these data as we think that the different effect of pharmacological and optogenetic release of 5-HT might be of interest to the community especially considering the potential usage of MDMA as medication for post-traumatic stress disorder (Mithoefer et al., 2019, Inserra et al., 2021).</p><p>We do not believe that 5-HT is solely responsible for SO suppression between sleep to wake transition, it is known that acetylcholine (Chen et al., 2015) and noradrenaline (Steriade et al., 1993) can both suppress SO, and both of them are also synced with the wake cycle (higher levels during wake compared to slow wave sleep (Watson et al., 2012, Mitchell and Weinshenker, 2010). This makes pharmacology experiments in sleeping condition difficult to interpret in our opinion. In the future we will focus on 5-HT2A pharmacological manipulations in vivo awake conditions, we believe that these experiments go beyond the aims of the current study.</p><fig id="sa2fig1"><label>Author response image 1.</label><caption><title>SO are not suppressed by optogenetic activation of Raphe 5-HT neurons during anesthesia.</title><p>(A) DRN immunohistochemistry image showing ChR2-YFP infection in DRN serotonergic neurons. 5-HT in red, YFP in green. Scale bars: 50 µm. (B) 3D visualization of microelectrodes location for all experiments and optic fiber (black) location. EC represented in grey, dorsal Raphe nuclei (DRN) in pink. (C) Top: upstates raster plot. Bottom: upstates density using Gaussian kernel density estimation. (D) Histogram of upstates incidence during baseline and laser stimulation (n animals = 4onedr, baseline: 2.25 ± 0.13 upstates/10s, laser: 2.11 ± 0.14 upstates/10s). (E) Left: normalized spike population activity during baseline (black) and laser stimulation (blue) in mEC L3/5 (n = 108, p &lt; 0.05, unpaired t-test with Holm-Šidák correction). Right: heatmap showing average spike rate difference per cluster between stimulation and baseline during upstates, some units show reduced spiking during stimulation. (F) Left: normalized spike population activity during baseline (black) and laser stimulation (blue) in CA1 (n = 140, p &gt; 0.05, unpaired t-test with Holm-Šidák correction). Right: heatmap showing average spike rate difference per cluster between stimulation and baseline during upstates, no clear difference in spiking activity.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-66960-resp-fig1-v2.tif"/></fig><disp-quote content-type="editor-comment"><p>3) For completeness it would be useful to comment on the other GABAergic cells that have 5HT3Rs and explain why their contribution is not relevant for different pharmacological agents or more in general.</p></disp-quote><p>We performed a new set of in vitro experiment to complement some already available preliminary data on 5-HT<sub>3</sub>R and we can confirm that in vitro application of either 5-HT<sub>3</sub>R agonist and antagonist do not have any effect on SO (Figure 3—figure supplement 4). We integrated these results in the main text.</p><disp-quote content-type="editor-comment"><p>Reviewer #2:</p><p>The manuscript by De Filippo et al. presents a combined in vivo / in vitro study of the cellular mechanisms of network dynamics in the entorhinal cortex (EC). The main findings support 5-HT suppression of slow oscillatory activity, mediated by 5-HT2AR activation of SOM interneurons. This is a novel finding, potentially of general interest. My major concerns relate to the strength of the in vivo evidence and the framing of the study.</p><p>Concerns related to in vivo data</p><p>1) The authors present clear demonstration that the pharmacological agents used suppress the slow oscillation (SO) in EC. Given that none of these drugs are truly selective and that they are presented i.p., the authors provide no direct evidence that these effects are 1) mediated by 5-HT release and 2) mediated by 5-HT release in the entorhinal cortex. This can be addressed by preventing drug-mediated SO reduction with local application of 5-HT2AR antagonists directly in the EC.</p></disp-quote><p>To address whether the suppression we see in vivo is selectively mediated by 5-HT we performed new in vivo anesthetized recordings in ePet-cre mice where we activated, using an optogenetic approach, 5-HT neurons in the dorsal raphe nucleus (DRN) (<xref ref-type="fig" rid="sa2fig1">Author response image 1</xref>/Figure 3), this experimental paradigm enabled us to have better temporal control on 5-HT release.</p><p>Our in vitro data show that suppression of SO is not mediated exclusively by 5-HT<sub>2A</sub>R and this is reflected by the fact that even in presence of ketanserin (5-HT<sub>2A</sub>R antagonist) 5-HT is still able to significantly suppress SO (Figure 4—figure supplement 3 B-E, ≈ 60% incidence reduction). This, however, is not surprising because in mEC pyramidal cells are known to express 5-HT<sub>1A</sub>R, a receptor that causes hyperpolarization via activation of G protein-coupled inwardly rectifying potassium (GIRK) channels (Schmitz et al., 1998, Chalmers and Watson, 1991). We decided not to inject ketanserin together with MDMA/Fen in vivo because the potential action of 5-HT<sub>1A</sub>R would make the result difficult to interpret. For example, the amount of 5-HT released by these compounds (MDMA/Fen), vastly greater than physiological, could activate 5-HT<sub>1A</sub>R to an extent that would suppress SO without the need of 5-HT<sub>2A</sub>R.</p><p>In contrast to the application of MDMA/Fen, after optogenetic 5-HT release, we did not observe suppression of upstate incidence but only a reduction in spiking rate during upstates. A possible explanation might be that the amount of 5-HT released via optogenetic activation is considerably less compared to the pharmacological release. These results prevent us to claim that the effect we see in vivo is due solely to 5-HT release, nonetheless, we like to underline that Fen has been used before as a 5-HT selective releaser with the specific purpose of disentangle the effect of MDMA (Heifets et al., 2019). To strengthen the link between suppression and 5-HT2AR we performed a new set of in vitro experiments showing that ketanserin (5-HT<sub>2A</sub>R antagonist) dampens the suppressive power of fenfluramine (Figure 3—figure supplement 1). In this revised version we are careful to avoid strong statement such as “5-HT is sufficient to suppress slow oscillations in vivo”, nonetheless, considering our in vitro data, we believe it is legitimate to state that 5-HT plays a role in the suppression. We discuss this in the penultimate paragraph of the Discussion. We agree that more effort should be put in studying the effect of 5-HT on Som interneurons in vivo and we plan on doing this in a following work in awake head-fixed condition. We would prefer to focus on more naturalistic conditions to disentangle the relationship between Som interneurons and 5-HT especially because anesthesia is known to be a confounding factory particularly in the case of Som interneurons (Adesnik et al., 2012).</p><p>We believe, however, that these experiments would go beyond the aims of our current study as they would also require a new animal license.</p><disp-quote content-type="editor-comment"><p>2) The in vivo single unit data does not support the activation of SOM interneurons.</p><p>a) The activated neurons appear to include both putative inhibitory (fast spiking) and putative excitatory (non-fast spiking) neurons (Figure 2C), rather than an intermediate, potential SOM population. If the activated neurons include both FS inhibitory and non-FS excitatory neurons, one would expect TP latency of the population to be intermediate as shown in Figure 2B,C.</p><p>b) Given the inability to identify SOM interneurons based on waveform alone, additional characterization of the activated units is necessary. First, do the CCGs of the activated units indicate inhibitory connections? These data are notably missing (or not easily extracted from Figure 2—figure supplement 1).</p><p>c) Second, definitely identifying SOM interneurons in vivo would require some type of tagging.</p></disp-quote><p>a) We agree that our data do not prove conclusively the involvement of Som Interneurons in SO suppression in vivo. We also agree that if the activated neurons were to be equally putative FS and putative excitatory the final TP latency average would be in between these two groups. To understand whether this is the case we looked at the cumulative probability distribution (Figure 2B, middle panel) where we can see a clear difference between the three groups. This is reflected by the fact that units with TP latency between 0.4 and 0.7 ms have much higher likelihood (from ~40% to ~80%, red line, right y-axis) of being part of the “activated” group compared to units with any other TP latency (Figure 3B bottom). If the “activated” units were to be equally distributed across TP latencies we should not have such peak in our opinion. We added a clarification in the text. In conclusion, we believe that these data support our in vitro data regarding Som interneurons.</p><p>b) CCG based connectivity analysis requires a minimum baseline firing rate to be effective, now we explain this detail in the legend and not only in the Materials and methods section. The threshold we used is 0.3 spikes/s, units missing from the analysis have a lower firing rate. We acknowledge that this analysis does not help in characterizing the intermediate population as inhibitory therefore we are open to remove the image as superfluous.</p><p>c) We agree and we revised the text to clarify that our data do not demonstrate conclusively the involvement of Som interneurons in vivo. We consider our in vitro experiment to show conclusively the involvement of Som interneurons activated by 5-HT<sub>2A</sub> in SO suppression. Our in vivo data merely support this notion as Som interneurons in vivo might have a TP latency in between FS and excitatory neurons (Trainito et al., 2019). Optotagging in vivo would answer the question conclusively however the location of the entorhinal cortex (EC) makes this experiment particularly challenging, to have a decent chance of finding responsive units we should use Neuropixels probes together with an external optic fiber. The number of responsive units In Sst-cre mice found by the Allen institute using Neuropixels has also discouraged us from performing optotagging (8/350 units, example found at <ext-link ext-link-type="uri" xlink:href="https://allensdk.readthedocs.io/en/latest/_static/examples/nb/ecephys_optotagging.html">https://allensdk.readthedocs.io/en/latest/_static/examples/nb/ecephys_optotagging.html</ext-link>). Moreover anesthesia is a known confounding factor especially in the case of Som interneurons (Adesnik et al., 2012), for this reason we would prefer to focus on non-anesthetized conditions, something we plan to do in our next work.</p><disp-quote content-type="editor-comment"><p>Concerns related to the Introduction</p><p>3) Motivating this study by discussing psychological processes, psychiatric disorders, sleep/wake cycles or psychoactive drugs is highly tenuous and misleading. This study does not address any of these processes. Alternatively, the Introduction lacks even a superficial description of topics that are highly relevant to this study, including neuroanatomy and neural circuitry of the EC, physiological properties of GABAergic interneurons in the EC, previous studies of the slow oscillation and involvement of different neuronal cell types in the EC, and neuromodulation of different interneuron subtypes, especially known patterns of neuromodulatory receptor expression on SOM interneurons.</p></disp-quote><p>We agree and changed the Introduction adding a description of EC neuroanatomy and role in slow oscillations. We also removed from the Introduction references to psychological processes, psychiatric disorders. We kept the description of the relationship between sleep/wake cycles and 5-HT as this provides a frame of reference to the relationship between 5-HT and slow oscillations. We address neuromodulation in the Discussion.</p><p>“Som interneurons are specifically known to be sufficient to cause desynchronization in V1 (Chen et al., 2015), while it is well known that they are potently excited by ACh in various cortical areas (Chen et al., 2015, Obermayer et al., 2018, Fanselow et al., 2008) including mEC (Desikan et al., 2018) and NE in frontal cortex (Kawaguchi and Kubota, 1998), our work identifies them as a novel target of 5-HT regulation via 5-HT<sub>2A</sub>R. Recently it has been proposed that inhibitory interneurons play a key role in mediating the effect of ACh and NE on cortical state transitions (Cardin, 2019), our results add a new level of complexity to this picture.”</p><disp-quote content-type="editor-comment"><p>Reviewer #3:</p><p>The manuscript by De Filipo et al. presents a well-executed and novel study on the role of somatostatin positive (Som) interneurons in the generation of cortical slow oscillations (SO) in the entorhinal area. The authors employ a combination of mouse in vivo recordings under anesthesia, slice physiology, together with pharmacological and chemo/optogenetic manipulations to shown that entorhinal SO are suppressed by serotonin activation of Som interneurons. The present work provides new data on an interesting topic that can have broader implications to understand the relationship between neuromodulators, state-dependent brain oscillations and different interneuron subtypes. The experimental approaches are rigorous and adequately support the authors claims. However, the study has some limitations that cast doubts on the specificity of the effects reported. Additional analysis may be sufficient to clarify these doubts.</p><p>1) The authors need to show more convincing evidence that the effects 5-HT and the manipulations reported in Figure 1 are specific of the SO and not a general dampened of entorhinal activity. More extensive analysis of the current data will suffice for that purpose. Figure 1H suggests that there may be a reduction in power in other frequencies than δ, but is not clearly appreciated (using a log frequency axis will facilitate it). A power spectrum comparison before, during and after drug application is necessary to evaluate the changes in all frequencies. Entorhinal cortex displays prominent γ oscillations, even during sleep and urethane anesthesia, are those also affected? This should be specifically quantified. Under urethane there is an alternation between a SO and a slow theta (~3-4Hz) state. Are theta oscillations also affected by the pharmacological manipulations?</p></disp-quote><p>A comprehensive analysis of the effect of MDMA/Fenf to different frequency bands has been added in Figure 1—figure supplement 2. Prominent theta oscillations were not observed in our experiments (Figure 1-2), at the start of every recording session an additional dose of urethane (0.2 g/kg) was injected to stabilize upstates frequency, in the following 30 min we never observed strong theta oscillations.</p><disp-quote content-type="editor-comment"><p>2) More comprehensive analysis of the effect of the different manipulations on SO reported through the manuscript should be performed, not only the rate of up states. For example, distribution of durations, inter-event intervals, amplitude of the remaining up states, etc. These will help to better understand the nature of the effects of serotonin release on SO.</p></disp-quote><p>Additional analysis has been performed in: Figure 1—figure supplement 3, Figure 3—figure supplement 1 and Figure 3—figure supplement 5.</p><disp-quote content-type="editor-comment"><p>3) Expanding the analysis and discussion of the contribution of PV interneurons will help establish the specificity of the role of Som interneurons. The results of the experiment with hM4Di-PV are encouraging in this regard. The authors do have fast-spiking, narrow-waveform cells (thus putative PV+ interneurons) in their dataset; however, there is very little discussion about this through the text. The results in Figure 4 provide evidence of the ability of Som interneurons to suppress SO. However, I would expect a very similar effect from PV activation. Unless the authors have evidence of the opposite, they should acknowledge this.</p></disp-quote><p>We agree with the reviewer that PV neurons activation have an effect on upstates that is comparable to Som neurons, we explicitly state this in the revised text citing a recent work that investigated effect of Som and PV neurons on upstates (Zucca et al., 2017). Our in vivo data (Figure 2) show a small number of FS units (TP latency &lt; 0.4 ms) activated by 5-HT. However, in vitro, we did not see any activation from FS neurons (Figure 4—figure supplement 6). We acknowledge that the sample size of FS neurons is too small to conclusively talk about the role of PV neurons, moreover, PV neurons have been shown to be activated by 5-HT in prefrontal cortex (Athilingam et al., 2017, Puig et al., 2010). In conclusion, we do not exclude that a minority of FS cells are activated by 5-HT, even in entorhinal cortex, but in our opinion, this does not detract from the finding that Som neurons are activated by 5-HT, a discovery not previously reported in any brain area. Following the reviewer suggestion, we are open to perform additional analysis on PV neurons of our in vivo dataset.</p><disp-quote content-type="editor-comment"><p>Reviewer #4:</p><p>In this manuscript, De Filippo et al. identify somatostatin-containing interneurons (SOM) of the entorhinal cortex (EC) as targets of serotonergic neurons in the dorsal raphe and describe their involvement in the mediation of slow oscillations in the EC, using an array of techniques such as pharmacology, optogenetics and DREADD.</p><p>The manuscript is well and the analysis is solid. While there is no doubt this study demonstrates convincingly the involvement of SOM neurons in the regulation of SO, it fails to convincingly rule out other cell types which could equally contribute to the cortical dynamics under investigation. In that respect, I am left with some lingering doubts as to whether or not something was missed in the study and would therefore appreciate some clarifications on the part of the authors (see major point below).</p><p>1) Some previous studies (for example, Ferezou et al., 2002) have shown that VIP/CCK GABAergic cells express 5-HT3 receptors, which are ionotropic receptors and can therefore respond very fast (with a depolarization, therefore an activation) to serotonergic neuromodulation. How come the authors do not mention this study (and others) and could they give an explanation as to why none of these neocortical cells (presumably also present in the EC?) were identified in their study as activated? Alternatively, using mCPBG in a similar fashion to how α-methyl5-HT was used in Figure 3 to rule out involvement of 5-HT3R would be valuable. The authors also mention the fact that only 11% of the cells expressing 5-HT2AR promoter were SOM. Could they please elaborate on the remaining 89% of cells?</p></disp-quote><p>We thank the reviewer for this concern. We have performed additional experiments to address the role of the 5HT<sub>3</sub> expressing interneurons. Our results show that their involvement in the modulation of upstates in the medial entorhinal cortex is negligible (Figure 3—figure supplement 4). The 5HT<sub>3</sub>agonist, m-CPBG caused no reduction in the upstate frequency and the 5HT<sub>3</sub> antagonist, Tropisetron failed to block the suppression of upstates by serotonin.</p><p>The majority of 5HT<sub>2A</sub> cells were found in L6 as also reported by Weber and Andrade (2010). This is reflected by the peak density at ~800 µm in Figure 4—figure supplement 9 E (left). We did not analyze further the dataset using the 5-HT<sub>2A</sub>R-EGFP mouse (Weber and Andrade, 2010) as we discovered from personal communication with Dr. Andrade that in this mouse not all cells expressing 5-HT<sub>2A</sub>R are expressing the GFP marker. Future studies will be conducted using 5-HT<sub>2A</sub>R-cre mice.</p><disp-quote content-type="editor-comment"><p>2) Studies in the somatosensory cortex of awake mice (presumably therefore at a time when 5-HT release is highest) showed that L2/3 SOM neurons were not correlated with other neuronal cell types at the level of their membrane potentials and that they hyperpolarized and therefore reduce their spiking during active wake (when the mouse movedits whiskers (Gentet et al., 2012, Muñoz et al., 2017)). The authors should discuss their findings in the light of these papers considering that they argue that serotonin activates SOM neurons in the EC and 5-HT release is highest during wake, and therefore presumably, even more so during active wake.</p></disp-quote><p>We thank the reviewer for this question. We now discuss the relationship between sleep-wake and Som interneurons in the text:</p><p>“5-HT levels in the brain, similarly to other neuromodulators, are synchronized to the sleep wake cycle, with higher levels present during wake state (Oikonomou et al., 2019). How does this notion relate to activation of Som interneurons by 5-HT<sub>2A</sub>R? A limitation of our study is the absence of data in naturalistic conditions, with anesthesia potentially being a confounding factor (Adesnik et al., 2012). We can nonetheless speculate that Som interneurons should be more active during states with higher 5-HT levels (wake&gt;SWS&gt;REM). A previous study directly measuring the activity of various neurons classes across different states seem to support this idea. Som interneurons in the dorsal cortical surface display highest activity during wake, lower during SWS and lowest during REM (Niethard et al., 2016)… “</p><p>In a recent review from our lab (Tukker et al., 2020) we have discussed important differences between the somatosensory and entorhinal cortices in the initiation, propagation and regulation of up down states. Although we have not investigated Som neurons in the somatosensory cortex and their modulation by serotonin in this paper regarding up-down states, we predict that there might be differences compared to entorhinal cortex. Further in the paper from Muñoz et al., 2017 it is evident that Som has layer specific modulation / participation during whisker stimulation. Further studies will hopefully investigate the modulation of Som interneurons in a layer specific manner during brain states in different cortices.</p></body></sub-article></article>